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genetic background. 
Figure 8. pp.104  No defects in adult hematopoietic development in  
Ago2S388A/FL; Mx-Cre mice upon Cre-induction. 
Figure 9. pp.107  Ago2 S388 phosphorylation is not necessary for erythroid  
development in a cell-autonomous fashion. 
Figure 10. pp.109  Ago2 S388 phosphorylation is not necessary for lymphoid  
and myeloid development in a cell-autonomous fashion. 
Figure 11. pp.111  Ago2 S388 phosphorylation is dispensable for oogenesis. 
Figure 12. pp.113  Ago2S388A/S388A animals are viable and fertile in a  
C57Bl/6N genetic background. 
Figure 13. pp.114-115 No defects in adult hematopoietic development in  
Ago2S388A/S388A animals in a C57Bl/6N genetic background. 
Figure 14. pp.117  No defects in HSC and early hematopoietic progenitors in  
Ago2S388A/S388A animals in a C57Bl/6N genetic background. 
Figure 15. pp.120  Ago2 phosphorylation at S388 is not necessary for MK2- 
dependent endotoxic response. 
Figure 16. pp.123  Ago2S388A/S388A homozygous mutants are lethal in 129S2  
genetic background. 
Figure 17. pp.124  Ago2S388A/S388A homozygous mutants are viable in a reverse  
F2 genetic background. 
Figure 18. pp.127  No differences in phosphorylation levels of Ago2 S388  
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between 129S2 and C57Bl/6N at blastocyst stage. 
Figure 19. pp.153  Targeting strategy and validation of the Miwi2tdTomato  
allele. 
Figure 20. pp.155  Miwi2 expression marks two populations of    
spermatogonia in juvenile mouse testis. 
Figure 21. pp.157  TdTomato+ c-Kit- cell population possesses a surface  
marker profile reminiscent of SSCs. 
Figure 22. pp.159  TdTomato+ c-Kit+ cell population possesses a surface  
marker profile of more differentiated spermatogonia. 
Figure 23. pp.161  Cell cycle profile of tdTomato+ c-Kit- and tdTomato+  
c-Kit+ cells. 
Figure 24. pp.163  Expression profile of tdTomato+ c-Kit- reveals a stem cell 
 signature. 
Figure 25. pp.166  Adult and juvenile tdTomato+ c-Kit- cells share similar  
surface marker expression profiles. 
Table 1. pp.37  Post-translational modification of the human Ago2  
protein. 
  
6	  
Acknowledgement 	  
My sincere thanks go to Dr. Dònal O’Carroll. He was an invaluable source of ideas, 
comments and technical suggestions during my PhD in his lab. It was a great 
opportunity to learn from him to thoroughly think and analyse every single experiment, 
without losing the focus on the main target of the project. Furthermore, I would like to 
express my gratitude to all the members of my Thesis Advisory Committee, and in 
particular to Prof. Stephen M. Keyse, for their valuable and beneficial suggestions. 
 
I would like to acknowledge the people in the several EMBL Facilities that helped and 
supported me in this thesis work. In particular, I would like to thank Dr. Giulia Bolasco 
from the EMBL Monterotondo Microscopy Facility and Dr. Pedro Moreira from the 
EMBL Monterotondo Transgenic Facility for their assistance with microscopes and the 
generation of transgenic mice, respectively. In addition, my gratitude goes to Dr. Philip 
Hublitz from the EMBL Monterotondo Gene Expression Facility for his services in the 
creation of the targeting constructs as well as to the numerous suggestions during my 
PhD. Finally, I would like to thank Dr. Daniel Bilbao-Cortes from the EMBL Flow 
Cytometry facility for his enormous help and support during the several hours spent at 
the flow cytometer. 
 
My immense gratitude goes to all the previous and present members of the O’Carroll 
group and the members of the Buonomo group. In particular, I would like to 
acknowledge Dr. Claudia Carrieri for the help and the data sharing for the Miwi2 project 
(Fig. 19). Furthermore, my special thanks go to Maria Placentino: her hard work was 
endlessly in the purification and testing of the phospho-specific antibody as well as in 
the final characterization of the Ago2 phenotype (Fig. 16 and 18). Finally, I would like 
to thank the PhD and post-doc community in EMBL Monterotondo that made my years 
in the lab much more acceptable, and sometimes funny too. 
 
Last, the biggest thanks go to my family, my dad Carlo, my mom Sonia and my little 
sister Chiara. They have been always supportive during the darkest periods and helped 
7	  
me to continue on my journey to become a scientist when I was discouraged. I would 
not reach the end of my PhD without their constant care and affection.	  
  
8	  
Declaration 
I hereby declare that the following thesis is based on the results of investigations 
conducted by myself and that this thesis is of my own composition. Work other that my 
own is clearly indicated in the text by reference to the original publications. This 
dissertation has not in whole, or in part, been previously submitted for a higher degree. 
 
 
 
         Stefano Comazzetto 
 
 
I certify that Stefano Comazzetto has spent the equivalent of eight terms in research 
work at the Mouse Biology Unit, EMBL Monterotondo, and that he has fulfilled the 
conditions of the Ordinance General No. 14 of the University of Dundee and is qualified 
to submit the accompanying thesis in application for the degree of Doctor of Philosophy. 
 
 
       
         Dr. Dònal O’Carroll 
  
9	  
Summary 	  
Argonaute proteins are known regulators of gene expression through their association 
with small non-coding RNAs. Specifically in mammals, microRNAs (miRNA) and short 
interfering RNAs (siRNAs) bind to Ago-like subclade of the Argonaute family to 
regulate gene expression, while Piwi-interacting RNAs (piRNAs) associate with PIWI 
proteins to silence transposons in the germ line. 
In mammals, genetic experiments revealed that Ago2 is the central effector for both 
siRNA and miRNA silencing pathways in several developmental processes. 
Phosphorylation of serine 388 of murine protein is dependent on the MK2 and Akt/PKB 
pathways and regulates Ago2 localization. I created a nonphoshorylatable Ago2S388A 
allele to study this phosphorylation event during mouse development. Lack of Ago2 
phosphorylation is dispensable for adult hematopoiesis, oogenesis, and for the MK2-
dependent endotoxic stress response. Furthermore, I discovered a partially penetrant 
lethal phenotype of Ago2S388A/S388A embryos at peri-implantation in mixed 
129P2xC57Bl6N and 129S2 genetic backgrounds, but not in C57Bl/6N background. In 
conclusion, I demonstrated for the first time that mutation of a post-translational 
modification site has a differential phenotypic outcome depending on the genetic 
background. 
Genetic ablation of PIWI-proteins in the mouse leads to a block in male meiosis. 
Strikingly, loss of Miwi2 causes an additional progressive loss of germ cells, 
reminiscent of a stem cell phenotype. However, Miwi2 levels are high in fetal testis and 
become undetectable soon after birth. I generated a Miwi2tdTomato transcriptional reporter 
allele and proved that Miwi2 expression marks a subpopulation of spermatogonial cells 
that possesses surface markers, cell cycle and gene expression profile reminiscent of 
stem cells in juvenile testis. Comparison of juvenile and adult Miwi2-expressing cells 
revealed a significant difference in Thy-1 surface expression, which could be indicative 
of a higher self-renewal capacity in young cells. In summary, these data posit that 
Miwi2 expression defines a population of bona fide stem cells in the mouse testis. 
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Abbreviation 
 
ADAR   Adenosine deaminase acting on RNA 
ADP   Adenosine diphosphate 
Ago1   Argonaute 1 
Ago2   Argonaute 2 
Ago3   Argonaute 3 
Akt/PKB  Protein kinase B 
Aal   A aligned spermatogonia 
Apr   A paired spermatogonia 
As   A single spermatogonia 
As   Arsenite trioxide 
Aub   Aubergine 
C3PO   Tanslin/Component 3 of promoter of RISC 
CFU-E   Colony forming unit erythroid 
c-Kit   V-Kit Hardy-Zuckerman 4 feline sarcoma viral oncogene 
homolog 
CNV   Copy number variant 
C-P4H(I)  Type I collagen prolyl-4-hydroxylase 
c-Ret   Proto-oncogene tyrosine-protein kinase receptor 
DAPI   4',6-diamidino-2-phenylindole 
D-Gal   D-Galactose 
DCL-3   Endoribonuclease Dicer homolog 3 
DCL-4   Endoribonuclease Dicer homolog 4 
DGCR8  DiGeorge syndrome critical region 8 
DP   Double-positive T cell progenitor 
Drosophila  Drosophila melanogaster 
dsRNA  Double stranded RNA 
DTA   Diphteria toxin A 
E-cad   Cadherin 1 
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EGFR   Epidermal growth factor receptor 
endo-siRNA  Endogenous short interfering RNA 
EpCAM  Epithelial cell adhesion molecule 
ERK   Extracellular signal-regulated kinase 
ESC   Embryonic stem cell 
FACS   Fluorescent-activated cell sorting 
GDNF   Glial cell line-derived neurotrophic factor 
GFP   Green fluorescent protein 
GFRA1  GDNF-family receptor alpha 1 
GMP   Granulo-monocyte precursor  
GSC   Germline stem cell 
GWAS  Genome-wide association studies 
H3K9   Histone 3 lysine 9 
H3K9me3  Histone 3 lysine 9 trimethylated 
Hb   Hemoglobin 
hc-siRNA  Heterochromatin-associated siRNA 
HCT   Hematocrit 
HDAC1  Histone deacetylase 1 
Hen1   Helix-loop-helix protein 1 
HMGA2  High mobility group AT-hook protein 2 
hnRNP A1  Heterogenous nuclear ribonucleoprotein A1 
HSC   Hematopoietic stem cell 
ICM   Inner cell mass 
IL-6   Interleukin 6 
In   Intermediate spermatogonia 
IRES   Internal ribosomal entry site 
kb   Kilobase 
KSRP   KH-type slicing regulator protein 
Lgr5   Leucine-rich repeat-containing G-protein coupled receptor 
Lin28   Protein lin-28 
LMPP   Lymphoid-primed multipotent progenitor cell 
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LPS   Lypopolysaccharide 
LT-HSC  Long-term hematopoietic stem cell 
MAPK   Mitogen-activated protein kinase 
MitoPLD  Mitochondrial cardiolipin hydrolase 
MACS   Magnetic-activated cell sorting 
MCH   Mean cell hemoglobin 
MCHC  Mean corpuscular hemoglobin concentration 
MCV   Mean cell volume 
MHC-I  Major hystocompatibility complex I 
MK2   Mitogen-activated protein kinase activated protein kinase 2 
MK3   Mitogen-activated protein kinase activated protein kinase 3 
MK5   Mitogen-activated protein kinase activated protein kinase 5 
MKK3   Dual-specificity mitogen-activated protein kinase kinase 3 
MKK6   Dual-specificity mitogen-activated protein kinase kinase 6 
miRNA  MicroRNA 
MPP   Multiple progenitor cell 
mRNA   Messenger RNA 
MT   Mouse transcript 
mTORC2  Target of rapamycin complex 2 
Mx   Interferon-induced GTP-binding protein Mx1 
Ngn3   Neurogenin 3 
Neo   Neomycin 
NRIF   Neurotrophin receptor-interacting factor 
nt   Nucleotide 
Oct-4   POU domain, class 5, transcription factor 1 
p68/Ddx5  Probable ATP-dependent RNA helicase DDX5 
p72/Ddx17  Probable ATP-dependent RNA helicase DDX17 
PGC   Primordial germ cell 
PDK1   Pyruvate dehydrogenase kinase isoform 1 
PI3K   Phosphatidylinositide 3-kinases 
PI(3,4,5)P3  Phosphatidylinositol 3,4,5 triphosphate 
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piRNA   Piwi-interacting RNA 
PLZF   Promyelocytic leukaemia zinc finger 
PND   Post-natal day 
P-bodies  Processing bodies 
PARP   Poly(ADP-ribose) polymerase 
Poly I:C  Polyinosinic:polycytidylic acid 
Pre-B   Precursor B cell 
Pre-CFU-E  Pre-colony forming unit erythroid precursor  
Pre-GM  Pre-granulo monocyte precursor 
Pre-MegE  Premegakaryocyte/erythroid precursor 
pre-miRNA  Precursor microRNA 
pri-miRNA  Primary microRNA 
Pro-B   Progenitor B cell 
PTGS   Post-transcriptional gene silencing 
RBC   Red blood cell count 
Rdp1   RNA-dependent RNA polymerase 1 
RDR2   RNA-dependent RNA polymerase 2 
RDR6   RNA-dependent RNA polymerase 6 
RDW   Red blood cell distribution width 
RF1   Reverse F1 generation 
RF2   Reverse F2 generation 
RISC   RNA-induced silencing complex 
RITS   RNA-induced transcriptional silencing complex 
RLC   RISC-loading complex 
RNAi   RNA interference 
RNA Pol II  RNA polymerase II 
RNA Pol IV  RNA polymerase IV 
Sca-1   Stem cell antigen 1 
SG   Stress granules 
SINE   Short interspersed repetitive sequence 
siRNA   Short interfering RNA 
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SNP   Single nucleotide polymorphism 
SSC   Spermatogonial stem cell 
ssRNA   Single stranded RNA 
tasiRNA  Trans-acting short interfering RNA 
TGFβ1  Transforming growth factor beta 1 
TNF-α   Tumour necrosis factor alpha 
TRBP   Tar-binding protein 
TRIM71/Lin41 E3 ubiquitin-protein ligase TRIM71 
UTR   Untranslated region 
Zp3   Zona pellucida 3 protein 
XRN1   5’-3’ exoribonuclease 1 
XRN4   5’-3’ exoribonuclease 4 
  
15	  
Chapter 1: Introduction 
 
1.1 Argonaute proteins bind distinct classes of small non-coding RNAs 
 
Over the past years the study of gene expression revealed a new layer of regulation 
through the discovery of several classes of small non-coding RNAs. These short RNA 
molecules are able to mediate both transcriptional and post-transcriptional silencing in a 
variety of organisms by the association with a class of conserved proteins, the 
Argonaute protein family (reviewed in Hutvagner, 2008; Meister, 2013). So far, three 
classes of small RNA molecules were discovered in association with Argonaute 
polypeptides: microRNAs (miRNAs), short interfering RNAs (siRNAs) and Piwi-
interacting RNAs (piRNAs) (Hammond, 2001; Hutvagner, 2002; Martinez, 2002; 
Aravin, 2006; Girard, 2006).  
siRNAs are ~22 nucleotide (nt) RNA molecules derived from long double-strand RNA 
(dsRNA) precursors and represent the principal triggers of the silencing mechanism 
called RNA interference (RNAi) (Hamilton, 1999; Zamore, 2000; Bernstein, 2001; 
reviewed in Carthew, 2009). RNAi is considered a surveillance mechanism against 
genomic parasites such as transposable elements and viruses, which generate dsRNA 
molecules during their replication cycle in plants and some animals (Ratcliff, 1997; Li, 
2002). This silencing mechanism was first described in the nematode Caenorhabditis 
elegans, where the introduction of different dsRNAs was able to silence the expression 
of the complementary target genes (Fire, 1998). Similar phenomena were discovered 
also in plants and fungi and were termed post-transcriptional gene silencing (PTGS) and 
quelling, respectively (Napoli, 1990; Lindbo, 1992; Cogoni, 1996; English, 1996; 
Dalmay, 2000; Bartel, 2004). The conservation of the components of the RNAi pathway 
across the eukaryotic domain indicates the functional importance of this regulatory 
mechanism (Cerutti, 2006). Nonetheless, particular organisms such as Saccharomyces 
cerevisiae and parasites Leishmania major and Trypanosoma cruzi are refractory to 
dsRNA-induced silencing (Robinson, 2003; DaRocha, 2004; Ullu, 2004). Thus, the 
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RNAi mechanism represents a conserved, but non-essential, defence mechanism against 
genomic parasites (Cerutti, 2006). 
miRNA is a class of 21-23nt non-coding RNAs that are present in plants and metazoans 
(Cerutti, 2006; Grimson, 2008; reviewed in Carthew, 2009). They are genome-encoded 
and regulate several physiological processes both in plants and animals (Brennecke, 
2003; Johnston, 2003; Emery, 2003; Chen, 2004a; reviewed in Bartel, 2004). The first 
miRNA, lin-4, was discovered in C. elegans as a post-transcriptional regulator of the 
heterochronic gene lin-14 (Lee, 1993; Wightman, 1991; Wightman, 1993). The 
identification of a second RNA with similar features in worms, let-7, and its homologs 
in flies and human genomes opened to the hypothesis of a conserved silencing 
mechanism (Pasquinelli, 2000; Reinhart, 2000; Slack, 2000). Small RNA sequencing 
studies have then identified miRNA molecules in a broad spectrum of plants and 
animals (Lagos-Quintana, 2001; Lau, 2001; Lee, 2001; Berezikov, 2006; Ruby, 2006; 
Chiang, 2010; Kuchen, 2010). However, the absence of any miRNA in fungi and several 
unicellular eukaryotes such as Trypanosoma brucei suggests a later development of this 
silencing pathway during eukaryotic evolution (Djikeng, 2001; Reinhart, 2002). In 
addition, differences in biogenesis and mechanisms of action as well as the lack of 
conservation between plant and metazoan miRNAs indicate that this pathway has 
evolved independently in these two phyla during evolution (Bartel, 2004; Cerutti, 2006). 
Nonetheless, comparative analysis between metazoan miRNAs showed that a consistent 
group (~30) of these molecules are conserved among Bilaterians (Pasquinelli, 2000; 
Hertel, 2006; Sempere, 2006; Prochnick, 2007; Christodoulou, 2010). In addition, it is 
believed that bilaterian complexity might, in part, be due to miRNA regulation due to 
the increased number of miRNA families in higher animals (Sempere, 2006; Prochnik, 
2007; Grimson, 2008). As such, miRNAs represent a class of small regulatory RNAs 
that greatly contribute to the evolution and physiology of plants and animals. 
The third conserved class of Argonaute-bound RNAs is represented by piRNAs. They 
are 24-30nt long RNAs, which are highly expressed in germ cells where they control 
transposable element activity (reviewed in Ishizu, 2012; Luteijn, 2013). As miRNA, 
they are genome-encoded, deriving by piRNA producing clusters or transposable 
elements present in the genome (Aravin, 2006; Brennecke, 2007; Kuramochi-
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Miyagawa, 2008; Li, 2013). piRNAs were first described in mouse germ cells, but small 
RNA sequencing identified them also in zebrafish and Drosophila gonads (Aravin, 
2006; Girard, 2006; Lau, 2006; Brennecke, 2007; Houwing, 2007). Even though it has 
been demonstrated that piRNAs are essential for fertility in many bilaterians, they are 
not expressed in plants and fungi (Lin, 1997; Deng, 2002; Kuramochi-Miyagawa, 2004; 
Carmell, 2007; Grimson, 2008; De Fazio, 2011; Reuter, 2011; Di Giacomo, 2013). On 
the other hand, the sponge Amphibedon queenslandica and the sea anemone 
Nematostella vectensis express a class of small RNAs with characteristic similar to 
piRNAs (Grimson, 2008). These data suggest that piRNAs were present in the common 
eukaryotic ancestor, and their expression was lost during the evolution of plants and 
fungi. 
 
1.2 Argonaute protein family: Ago and Piwi subclades 
 
The Argonaute protein family is defined by the presence of two conserved motifs: the 
PAZ, named after fly Piwi and plant Ago1 and Zwille proteins, and the PIWI domains 
(Cox, 1998; Cerutti, 2000; Lingel, 2004; Cerutti, 2006). Three paralogous groups can be 
distinguished among Argonaute family members: Argonaute-like proteins, which are 
similar to Arabidopsis thaliana Ago1 and bind miRNAs and siRNAs; PIWI-like 
proteins, which are related to Drosophila melanogaster Piwi and associate with 
piRNAs; and group 3 Argonaute proteins, which contains 18 proteins specific for the 
nematode Caenorhabditis elegans (Lin, 1997; Bohmert, 1998; Yigit, 2006; reviewed in 
Hutvagner, 2008). The number of Argonaute genes in different species varies: for 
instance, four Argonaute- (Ago1-4) and 3 PIWI-like proteins (Mili, Miwi and Miwi2) 
are present in mouse, Drosophila melanogaster instead contains 2 Ago-like and 3 PIWI-
like coding genes, while C. elegans encodes for 5 Ago-like, 3 PIWI-like and 18 group 3 
Argonaute genes (Cerutti, 2006; Hutvagner, 2008). Sequence alignment revealed that 
several bacteria and archea encodes for proteins with a PIWI domain (Cerutti, 2000; 
Anantharaman, 2002; Ullu, 2004). Indeed, the first crystal structure of Ago-like 
polypeptides were obtained in Pyrococcus furiosus and Aquifex aeolicus and revealed 
the presence of a PIWI domain fused to variant PAZ-like motifs (Song, 2004; Yuan, 
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2005). Strangely, parasites like Leishmania major and Trypanosoma cruzi that do not 
present a functional RNAi pathway have Argonaute proteins which may have lost the 
PAZ domain and retained only the PIWI domain (Ullu, 2004). The functional role of 
these proteins have not been elucidated yet. 
Comparative computational analysis of the Argonaute family members in the five 
eukaryotic supergroups revealed that the last eukaryotic common ancestor possessed at 
least one Ago-like and one PIWI-like protein (Cerutti, 2006; Yigit, 2006; Grimson, 
2008). However, lineage-specific loss of one or both Argonaute components has 
occurred during evolution: Saccharomyces cerevisiae has no Argonaute proteins while 
Schizosaccharomyces pombe contains only 1 Ago-like protein (Volpe, 2002; Sigova, 
2004; Cerutti, 2006). Nonetheless, this Ago-Piwi silencing system has likely evolved as 
an innate immune pathway to protect organisms against foreign nucleic acids such as 
transposable elements and viruses (Cerutti, 2006; Hutvagner, 2008; Joshua-Tor, 2011). 
The ancestral PIWI protein might localize in the nucleus and control transposable 
element expression, while the ancient Argonaute protein would be localized in the 
cytoplasm and protect against viral infections. Indeed, in plants the Ago clade proteins 
form a protective system against virus infection by recognition of double-strand 
intermediates in virus replication (Ratcliff, 1997; Hamilton, 1999; Mlotshwa, 2008). 
Similar mechanisms were described for D. melanogaster and C. elegans in the animal 
kingdom (Lu, 2005; Wang, 2006). In mammals, even though there are no evidences of 
an Ago-mediated antiviral response, PIWI-like proteins are necessary to repress 
transposable elements in male germ cells (Deng, 2002; Kuramochi-Miyagawa, 2004; 
Carmell, 2007; De Fazio, 2011; Reuter, 2011; Di Giacomo, 2013). This duality of Ago- 
and PIWI-like proteins was further developed through the duplication of genes encoding 
for the two subclade members, which in turn lead to diversification of their functional 
roles. In fact, Ago-like proteins execute gene regulation through binding of miRNAs and 
siRNAs, while PIWI-like proteins bind to piRNAs and regulate genome-encoded 
transposable elements in germ cells (Hammond, 2001; Hutvagner, 2002; Martinez, 
2002; Aravin, 2006; Girard, 2006; Lau, 2006). 
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1.3 Structural domains of the Argonaute family proteins 
 
Argonaute proteins are characterized by four different domains: amino-terminal (N), 
PAZ (Piwi-Argonaute-Zwille), MID and PIWI domains. Two linker domains, indicated 
as L1 and L2, connect the N to PAZ domain and the PAZ to the MID domain, 
respectively.  
During siRNA and miRNA biogenesis (described in more details in the following 
sections “miRNA biogenesis” and “siRNA biogenesis”), both small RNAs are loaded as 
duplexes in a multiprotein complex called RNA-induced silencing complex (RISC) 
(Hammond, 2000; Elbashir, 2001; Nykänen, 2001; Martinez, 2002; Schwarz, 2002). 
Argonaute proteins bind directly the RNA duplex, and only one of the two strands is 
kept in the complex, referred as guide strand, while the other is released (passenger 
strand). The N domain is required for small RNA loading onto the protein and it 
facilitates the unwinding of small RNA duplexes (Kwak, 2012). In vitro biochemical 
assays revealed that mutation of conserved residues in the N domain of human 
Argonaute 2 impedes the maturation of the RISC complex. These mutations result in a 
higher retaining of passenger strand in RISC complexes in cell culture, suggesting a role 
in the unwinding process of siRNA and miRNA duplexes (Kwak, 2012). 
The PAZ and the MID domains of the Argonaute proteins play essential roles in the 
binding of the small RNA guide. The Argonaute-bound non-coding RNAs have two 
important common biochemical features due to their biogenesis: they have a phosphate 
group at their 5’ end and a hydroxyl group at their 3’ end (reviewed in Bartel, 2004; 
Carthew, 2009). The PAZ domain assumes an oligonucleotide binding fold, which 
creates a hydrophobic pocket for the binding of the 3’ end of the guide RNA (Song, 
2004; Ma, 2004; Jinek, 2009). The 5’ end of the small RNA interacts with several 
residues of the MID and PIWI domains (Schirle, 2012; Elkayam, 2012). Importantly, the 
5’ phosphate group of the first nucleotide is inserted in a pocket of the MID domain, 
forming a plethora of interactions with the three oxygens of the phosphate (Ma, 2005; 
Parker, 2005; Frank, 2010; Schirle, 2012; Elkayam, 2012). The MID domain was 
additionally suggested to possess the ability to bind the 5’m7G cap structure of target 
mRNAs and be important for post-transcriptional repression of target genes (Kiriakidou, 
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2007). However, compelling evidences from biochemical and functional assays on 
mutated Argonaute proteins as well as structural data demonstrated that the MID domain 
does not bind directly the cap structure of mRNAs (Eulalio, 2008; Boland, 2010; Frank, 
2010; Frank, 2011).  
The PIWI domain presents an RNase-H-like fold and some Argonaute proteins are 
capable of cutting or slicing the target RNA between residue 10 and 11 of the guide 
small RNA in case of perfect complementarity (Liu, 2004; Song, 2004; Parker, 2004). 
This cleavage releases products with a 3’-hydroxyl and a 5’-phosphate, another 
characteristic feature of RNase-H enzymes (Martinez, 2004; Schwarz, 2004). A catalytic 
triad composed of Asp-Asp-His (DDH) residues was believed to be necessary for the 
endonuclease activity of Argonaute family members (Song, 2004; Ma, 2005; Parker, 
2005; Yuan, 2005). The crystal structure of the first eukaryotic Argonaute protein from 
the budding yeast Klyveromyces polysporus instead revealed the presence of an invariant 
glutamate residue in the catalytic pocket, turning the catalytic centre in a tetrad (DEDH) 
(Nakanishi, 2012). The crystal structure of human Ago2 protein further confirmed the 
formation of a catalytic tetrad in the mammalian protein (Elkayam, 2012; Schirle, 2012). 
Interestingly, the presence of an intact catalytic tetrad in the PIWI domain is not 
sufficient to create a functional endonuclease. Indeed, human Ago3 has a functional 
catalytic centre but no endonucleolytic activity (Liu, 2004; Meister, 2004). Several 
independent works have recently showed that additional residues in both the N and 
PIWI domains are involved in the slicing of target RNAs (Faehnle, 2013; Hauptmann, 
2013; Nakanishi, 2013; Schurmann, 2013). The endonuclease activity in the PIWI 
domain is not a distinctive characteristic of Argonaute protein families. For example, 
Ago2 is the only Argonaute-like protein in mouse and humans, which retains the 
capability to slice, target RNAs in case of perfect complementarity (Liu, 2004; Song, 
2004; Meister, 2004). Among the mouse PIWI-like protein, mutation of the catalytic 
triad in Miwi or Mili leads to male sterility due to transposon derepression, while a 
similar mutation in the Miwi2 protein has no phenotypic consequences (De Fazio, 2011; 
Reuter, 2011; Di Giacomo, 2013). In conclusion, the endonuclease activity is necessary 
for the function of only some Ago- and PIWI-like proteins, allowing them to directly 
slice target mRNAs in the case of nearly perfect complementarity. 
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1.4 The miRNA and siRNA pathways 
 
1.4.1 miRNA biogenesis 
 
miRNAs are usually transcribed by RNA polymerase II from miRNA-producing loci, 
and transcripts are capped and polyadenylated (Cai, 2004; Lee, 2004; Xie, 2005; 
Ozsolak, 2008; Corcoran, 2009) (Fig. 1). These transcripts can contain one or several 
miRNAs in the same transcriptional unit (Altuvia, 2005; Baskerville, 2005). Primary 
miRNA transcripts (pri-miRNAs) have a characteristic stem-loop structure with long 5’ 
and 3’ tails, that are cleaved in the nucleus by a protein complex, the Microprocessor 
(Lee, 2003; Denli, 2004; Gregory, 2004; Landthaler, 2004). This complex is composed 
of the RNase type III enzyme Drosha and the double-stranded RNA-binding domain 
protein DGCR8: DGCR8 binds the junction between the single stranded RNA (ssRNA) 
and the double stranded RNA (dsRNA) stem of the pri-miRNA and allows Drosha to 
cleave ~11 bp downstream the junction (Gregory, 2004; Han, 2004; Landthaler, 2004; 
Han, 2006). This enzymatic reaction releases a ~60 nt long precursor miRNA (pre-
miRNA) that harbors two peculiar features: a phosphate at the 5' end and a 2nt 3’-
overhang at the base of the stem structure. Pre-miRNAs are subsequently exported to the 
cytoplasm by Exportin 5 and further processed by a second RNase type III enzyme, 
Dicer (Bernstein, 2001; Grishok, 2001; Hutvagner, 2001; Ketting, 2001; Yi, 2003). 
Dicer associates with other two proteins, TRBP (Tar RNA Binding Protein) and Ago2, 
as well as other polypeptides, in the RISC loading complex (RLC) (Chendrimada, 2005; 
Maniataki, 2005; Macrae, 2008). Within the RLC Dicer cleaves the pre-miRNA into 21-
23nt long double-stranded miRNAs. Finally, only one strand of the duplex is loaded into 
a ribonucleic complex named RNA-induced silencing complex (RISC) (Hammond, 
2000; Elbashir, 2001; Nykänen, 2001; Martinez, 2002; Schwarz, 2002). An important 
determinant for strand selection depends on the miRNA duplex: the strand with less 
stable paired 5’ end is preferentially loaded into the RISC (asymmetry rule) (Khvorova, 
2003; Schwarz, 2003; Tomari, 2004). The central components of the RISC complex are 
composed of an Argonaute-like protein, that binds directly to the single-stranded 
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miRNA, and GW182, which interacts with Ago2 and is necessary for mRNA silencing 
(Liu, 2005; Meister, 2005; Behm-Ansmant, 2006; Till, 2007). The miRNA will then 
direct the RISC complex to target genes to mediate their silencing (Hammond, 2000; 
Elbashir, 2001; Nykänen, 2001; Martinez, 2002; Schwarz, 2002). 
Several exceptions have been described to this canonical biogenetic pathway, in which 
miRNAs are produced independently of either Drosha or Dicer enzymatic activity 
(Meister, 2013). miRNAs whose generation is Drosha-independent are referred to as 
mirtrons (Okamura, 2007; Ruby, 2007; Babiarz, 2008). Mirtrons are often derived from 
the splicing process of mRNAs from protein-coding genes. Spliced intron folds in a 
structure that mimics a pre-miRNAs, thus being exported from the nucleus for 
subsequent Dicer-mediated processing in the cytoplasm (Okamura, 2007; Ruby, 2007; 
Babiarz, 2008). Dicer activity has also been shown to be dispensable for miRNA 
biogenesis. The only example so far is represented by miR-451 (Cheloufi, 2010; 
Cifuentes, 2010; Rasmussen, 2010; Yang, 2010). Pre-miR-451 presents an unusual 
structure with the guide strand of the miRNAs that is part of both the stem and the short 
loop (Cheloufi, 2010; Cifuentes, 2010; Yang, 2010). Indeed, Ago2 endonuclease activity 
is required both in mouse and zebrafish to cut the pre-miRNA, which is further 
processed by an unknown nuclease into the mature miR-451 (Cheloufi, 2010; Cifuentes, 
2010; Rasmussen, 2010; Yang, 2010). 
 
1.4.2 siRNA biogenesis 
 
dsRNA molecules are known to trigger RNAi silencing in animals, plants and fungi 
(Napoli, 1990; Lindbo, 1992; Cogoni, 1996; English, 1996; Fire, 1998; Dalmay, 2000; 
reviewed in Bartel, 2004). dsRNA precursors can derive from endogenous sources, such 
as transposable element, convergent mRNA transcripts and sense-antisense mRNA 
duplexes, or exogenous sources, such as viral replication intermediates (Fire, 1998; 
Cogoni, 1999; Ketting, 1999; Dalmay; 2000; Mourrain, 2000; Smardon, 2000; Aravin, 
2001; Li, 2002) (Fig. 1). siRNAs are structurally similar to miRNAs: they are ~22 nt 
long and exhibits a phosphate at the 5’ end and a 3’ hydroxyl at the 3’ end. Indeed, 
siRNAs are produced by the RNase type III enzyme Dicer (Bernstein, 2001; Zhang, 
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2004; Macrae, 2006). These long dsRNAs are bound by Dicer through its PAZ domain 
and cleaved in 21-23nt RNA duplexes (Hamilton, 1999; Hammond, 2000; Zamore, 
2000; Grishok, 2001; Kettings, 2001; Knight; 2001). The RNA duplex is then loaded 
into the RISC complex: a catalytically active Argonaute protein cuts one of the two 
strands, and the nicked strand is further removed by the endonuclease C3PO (Matranga, 
2005; Miyoshi, 2005; Liu, 2009; Ye, 2011). 
Since siRNAs often share high complementarity with their targets, the outcome of 
siRISC-RNA interaction results in the cleavage of targets (Hamilton, 1999; Elbashir, 
2001; Vance, 2001; Pickford, 2002). In plants and some animals, such as C. elegans and 
planarians, the sliced RNA product could become the substrate for a RNA-dependent 
RNA polymerase (RdRPs) (Sijen, 2001; Newmark, 2003; Baulcombe, 2004; Allen, 
2005; Yoshikawa, 2005; Cerutti, 2006). As such, RdRPs contribute to the production of 
secondary siRNAs from target RNAs, thus amplifying the silencing of the targets (Sijen, 
2001; Baulcombe, 2004; Wassenegger, 2006). Plants and worms use this system to 
mount a highly specific immune response against viral infections (Silhavy, 2002; 
Blevins, 2006; Deleris, 2006). Indeed, siRNA-mediated silencing is spread across 
tissues nearby the site of delivery of the dsRNA template (Fire, 1998; Newmark, 2003; 
Tretter, 2008). Notably, a similar pathway is exploited in plants for the generation of 
trans-acting siRNAs (tasiRNAs) (Allen, 2005; Xie, 2005; Yoshikawa, 2005; Dunoyer, 
2007). In fact, in Arabidopsis thaliana miRNAs mediate the cleavage of specific TAS 
non-coding RNAs, which are then transformed by the polymerase RDR6 in dsRNA 
precursor for the processing of a Dicer-like homolog, DCL4 (Allen, 2005; Xie, 2005; 
Yoshikawa, 2005). However, RdRPs proteins are absent in mammals and Drosophila, 
even though they are conserved among the eukaryotic supergroups (Cerutti, 2006). As 
such, RdRPs and the amplification cycle of siRNAs might be ancillary for the mounting 
of an effective RNAi pathway. 
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Figure 1. miRNA and siRNA biogenesis. 
The biogenesis of miRNAs and siRNAs is schematically depicted in here. For further 
details please refer to the main text. 
 
1.4.3 Determinants of miRNA-target interaction 
 
The RISC complex is able to mediate the silencing of target genes through 
complementarity between the guide small RNA and the target gene. In case of perfect 
complementarity, a catalytically active Ago protein cleaves the target molecule through 
its endonuclease activity; if the complementarity is only partial, RISC promotes 
silencing through RNA destabilization and translational inhibition (reviewed in Bartel, 
2009; Ameres, 2013). In plants, miRNA-mediated silencing is believed to rely mainly 
on endonucleolytic cleavage due to perfect match between the RNA and the target 
mRNA (Llave, 2002; Tang, 2003; Dunoyer, 2004; Souret, 2004; Addo-Quaye, 2008). 
Nonetheless, experimental data derived from mad mutants and evaluation of protein and 
mRNA levels in A. thaliana suggest that plant miRNAs also induce translational 
repression of target mRNAs (Palatnik, 2007; Brodersen, 2008; Lanet, 2009). On the 
other hand, only a few examples of perfect complementarity between the miRNA and 
the target mRNAs have been discovered in the mouse (Yekta, 2004; Hornstein, 2005; 
Karginov, 2010). 
Since animal miRNAs often bind to target RNAs through partial complementarity, 
extensive efforts were made to identify motifs in the sequence that affect miRNA 
activity. Experimental studies on miRNA-target RNA interactions proved that the 
specificity of miRNA silencing depends on the miRNA seed sequence (Lewis, 2003; 
Doench, 2004; Brennecke, 2005; Lewis, 2005). The seed sequence consists of 
nucleotides 2-8 of the miRNA guide strand and a perfect pairing between guide and 
target RNA in this region is essential for RISC action (Grimson, 2007; Bartel, 2009). 
Additional pairing at position 1 and at nucleotide 13-16 at the 3’ end of the miRNA 
strengthens the miRNA-mRNA interaction, enhancing target repression (Grimson, 2007; 
Nielsen, 2007; Wee, 2012). The structures of human Ago1 and Ago2 proteins confirmed 
the importance of the seed sequence since nucleotides 2-6 of the guide RNA are exposed 
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with Watson-Crick faces to the solvent, reducing the energy cost due to nucleic acid 
pairing (Elkayam, 2012; Schirle, 2012; Faehnle, 2013). 
Seed sequence matches can occur in any region of target mRNAs. Indeed, sites at the 5’ 
untranslated region (5’ UTR) and in the coding sequence of target mRNAs have been 
reported (Forman, 2008; Grey, 2010; Hafner, 2010; Reczko, 2012; Helwak, 2013). 
However, miRNA binding silences more efficiently target RNAs when it happens in the 
3’ untranslated region (3’ UTR) (Farh, 2005; Lewis, 2005; Lim, 2005; Grimson, 2007; 
Gu, 2009). Indeed, even though identification of miRNA-mRNA targets through 
ultraviolet (UV) induced crosslinking pinpoints that a large fraction of these interactions 
takes place in the coding region of mRNAs, seed sequence pairing mediates a higher 
silencing in binding sites present at the 3’ UTR (Hafner, 2010; Helwak, 2013). 
Recent works have discovered alternative modes of interaction that still trigger a 
functional miRISC-mRNA association. First, the seed sequence of miRNAs could 
harbor bulged or mismatched nucleotides (Lal, 2009; Chi, 2012; Helwak, 2013; 
reviewed in Ameres, 2013). Indeed, in mouse brain a set of miR-124 targets contains 
one bulged nucleotide across position 5 and 6 of the seed sequence that is not paired to 
the miRNA seed (Chi, 2012). These sites were confirmed also for let-7 targets in 
nematodes and from in vitro analysis of Ago protein in the eubacterium Thermus 
thermophilus (Vella, 2004; Long, 2007; Wang, 2008). Second, a stretch of 11-12 base 
pairing at the centre of the miRNA is able to silence target transcripts even in the 
absence of seed pairing (Shin, 2010). Central pairing sites are able to mediate cleavage 
of target mRNAs at high concentration of magnesium in vitro, but sequencing analysis 
of degraded RNA failed to detect slicing products for these miRNA-mRNA interaction 
sites in vivo, suggesting that they likely repress mRNA translational in physiological 
conditions (Shin, 2010). Third, the implementation of a new crosslinking strategy 
coupled with high-throughput sequencing showed that extensive base-pairing interaction 
in the 3’ end of the miRNA can efficiently mediate target silencing (Helwak, 2013). 
These sites were validated through luciferase reporter assays, but the strength of 
miRNA-mediate repression was lower compared to a perfect seed sequence 
complementarity (Helwak, 2013). 
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1.4.4 miRNAs silence target RNAs through multiple mechanisms 
 
As discussed in the previous section, miRNAs can silence their target genes at the post-
transcriptional level by Ago-mediated slicing in case of perfect Watson-Crick base 
pairing along the miRNA sequence (Llave, 2002; Tang, 2003; Dunoyer, 2004; Souret, 
2004; Yekta, 2004; Hornstein, 2005; Addo-Quaye, 2008; Karginov, 2010). 
Endonucleolytic cleavage occurs at the phosphodiester bond between nucleotide 10 and 
11 of the miRNA (Liu, 2004; Meister, 2004; Miyoshi, 2005; Rivas, 2005). The exosome 
together with exoribonucleases Xrn4 and Xrn1 subsequently degrade the sliced mRNA 
fragments in plants and animals, respectively (Souret, 2004; Orban, 2005).  
In case of only partial complementarity, miRNA-bound RISC can inhibit protein 
production from coding mRNAs through translational inhibition and mRNA 
destabilization (reviewed in Bartel, 2009; Ameres, 2013). Studies using ribosome 
profiling and internal ribosomal entry sites (IRES) in the mRNA of reporter genes 
showed that block of the translation process can take place both at the initiation and 
post-initiation stages (Seggerson, 2002; Humphrey, 2005; Pillai, 2005; Maroney, 2006; 
Nottrott, 2006; Mathonnet, 2007; Wakiyama, 2007). On the other hand, effects of 
miRNA binding could be readily detected at the transcriptional level, supporting 
experimental data of a destabilization of target mRNAs (Bagga, 2005; Krutzfeldt, 2005; 
Lim, 2005; Baek, 2008; Selbach, 2008; Hendrickson, 2009). The destabilization process 
involves the recruitment of the CCR4-NOT deadenylase complex through interaction 
with the GW182, a central component of the RISC complex (Behm-Ansmant, 2006; 
Giraldez, 2006; Wu, 2006). This interaction induces the deadenylation of target 
transcripts, followed by decapping and degradation through cellular exonucleases 
(Souret, 2004; Orban, 2005; Behm-Ansmant, 2006; Giraldez, 2006; Wu, 2006). In 
addition, shortening of the poly-A tail of mRNA targets can in turn reduce the rate of 
translational initiation by preventing the recircularization of the mRNA (Behm-
Ansmant, 2006; Giraldez, 2006; Wu, 2006). Recent studies shed new light on this 
controversy. Ribosome profiling demonstrated that in mammals more than 84% of the 
miRNA-directed repression depends on mRNA destabilization (Baek, 2008; Guo, 2010). 
In addition, a study in zebrafish showed that in early embryos miR-430 initially 
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suppresses translation of target RNAs and only after the maternal-to-zygotic transition 
triggers mRNA destruction (Bazzini, 2012). These data suggest a model in which 
miRNA binding first induces translational repression and only later causes mRNA 
destabilization of target mRNAs. 
Translationally inactive mRNAs often accumulate in subcellular cytoplasmic structures 
called processing bodies (P-bodies) (reviewed in Anderson, 2006; Parker, 2007). P-
bodies contain high concentrations of RNA turnover complexes, such as the deadenylase 
CCR4-NOT complex and the decapping enzymes Dcp1/Dcp2 (Ingelfinger, 2002; Sheth, 
2003; Cougot, 2004; Behm-Ansmant, 2006; Eulalio, 2007). Notably, components of the 
RISC complex such as Argonaute and GW182 proteins are found in P-bodies, 
suggesting that miRNA-dependent silencing of target mRNAs takes place in these 
granules (Liu, 2005; Ding, 2005; Meister, 2005; Behm-Ansmant, 2006). However, a 
study on Ago2 localization in mammalian cells revealed that only 1-2% of the protein is 
localized in P-bodies in normal culture conditions (Leung, 2006). In addition, depletion 
of certain P-bodies components results in P-bodies disassembly without any effect on 
miRNA activity (Eulalio, 2007). A possible explanation would be that RISC interacts 
with RNA degradation complexes in the cytoplasm, and it is then recruited to P-bodies. 
 
1.4.5 siRNAs silence target genes both at the transcriptional and post-
transcriptional levels 
 
siRNAs have been described to regulate the expression of target genes both at the 
transcriptional and post-transcriptional level (reviewed in Tomari, 2005 and Carthew, 
2009). They can regulate the RNA levels of targets through Argonaute-dependent 
slicing and further degradation through cellular exonucleases, since they often present a 
complete match with their target RNAs (Elbashir, 2001; Liu, 2004; Meister, 2004; 
Miyoshi, 2005). However, siRNAs with partial mismatches or loaded into a Slicer-
inactive Ago protein can mediate silencing of target mRNAs through post-
transcriptional mechanisms similar to animal miRNAs (Jackson, 2003; Scacheri, 2004).  
siRNAs have also the ability to regulate gene expression at the level of RNA 
transcription (reviewed in Carthew, 2009; and Grewal, 2010). In S. pombe, siRNAs 
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deriving from heterochomatic regions associate with Ago1, the only Argonaute protein, 
and together with other factors form the RNA-induced transcriptional silencing (RITS) 
complex (Volpe, 2002; Noma, 2004; Verdel, 2004). RITS uses the loaded siRNAs to 
recognize nascent transcripts at complementary loci, inducing the recruitment of histone 
methyltransferases to promote methylation on lysine 9 of histone H3 (H3K9) (Volpe, 
2002; Noma, 2004; Buhler, 2006). In addition, RITS associates with the Rdp1, an RNA-
dependent RNA polymerase, facilitating the production of secondary siRNA from 
nascent transcripts and the subsequent spreading of histone modifications to nearby 
genomic regions (Motamedi, 2004; Sugiyama, 2005). In plants, a similar mechanism 
involves a specific class of siRNAs called heterochromatin-associated siRNAs (hc-
siRNAs) (reviewed in Melnyk, 2011). hc-siRNAs are transcribed by the plant-specific 
RNA Pol IV, forming dsRNAs due to the activity of RDR2 RNA polymerase (Xie, 
2004; Herr, 2005; Onodera, 2005; Pontes, 2006). These intermediates are further 
processed by one of the four Dicer homologs, DCL-3, into 24nt siRNAs which are 
specifically loaded into Ago4, Ago6 and Ago9 (Zilberman, 2003; Xie, 2004; Zilberman, 
2004; Herr, 2005; Qi, 2006; Eun, 2011). This complex finally recognizes nascent 
transcripts from targeted loci in the nucleus, promoting both histone and DNA 
methylation (Zilberman, 2003; Wierzbicki, 2008; Havecker, 2010). 
In animals compelling works in flies and worms confirmed the presence of a siRNA-
mediated transcriptional regulation (Pal-Bhadra, 2002; Sijen, 2003; Vastenhouw, 2003; 
Pal-Bhadra, 2004; Guang, 2008). However, the existence of a functional transcriptional 
regulation by siRNAs in mammals is still debatable. Indeed, evidences for siRNA-
directed chromatin modifications were collected in transfection experiments with 
siRNAs directed to promoter sequences in human cell lines (Kim, 2006; Janowski, 
2006; Schwartz, 2008; Chu, 2010). Furthermore, nuclear localization of Argonaute 
proteins has been reported (Robb, 2005; Rudel, 2008; Ohrt, 2008; Weinmann, 2009). 
Nonetheless, other studies using tagged Ago2 protein as well as data from our lab 
suggested that Ago2 is localized only in the cytoplasm (Meister, 2005; Leung, 2006; 
Leung, 2011; Horman, 2013; Fig. 16 and 18). Further experiments using gene ablation 
techniques are necessary to shed light on this controversy.  
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1.4.6 Regulation of miRNA activity 
 
Since miRNA interaction with target RNAs is largely but not exclusively based on a 6-8 
nucletotide seed sequence, a single miRNA is predicted to regulate the expression of 
hundreds of genes (Farh, 2005; Krek, 2005; Lewis, 2005; Lim, 2005; Giraldez, 2006; 
Helwak, 2013). Since this small non-coding RNAs could modulate a vast realm of 
targets, it is fundamental for the cell to regulate miRNA function according to several 
cellular cues. Different steps of the miRNA biogenesis pathway, such as transcription 
and precursor cleavage, are amenable for the regulation of levels of miRNAs at a global 
or individual scale (reviewed in Siomi, 2010 and Kim, 2010). Transcription factors and 
DNA methylation at the promoters restrict the expression of particular miRNAs to 
specific tissues (Aboobaker, 2005; He, 2007; Zhou, 2007; Dore, 2008). In addition, the 
availability of Drosha and Dicer could regulate the global levels of mature miRNAs 
(Wulczyn, 2007; Forman, 2008; Han, 2009; Levy, 2010). Indeed, a double negative 
feedback loop regulates the two Microprocessor components. DGCR8 interaction with 
Drosha stabilizes the protein levels of the endonuclease (Yeom, 2006). On the other 
hand, Drosha recognizes and cleaves two hairpin structures in the 5’ untranslated region 
of DGCR8 mRNA, which in turn targets the mRNA for degradation (Han, 2009). A 
similar autoregulatory feedback loop mechanism involves let-7 miRNA and Dicer: let-7 
targets Dicer mRNA within its coding region, thus modulating the total rate of miRNA 
biogenesis (Forman, 2008). 
Microprocessor-dependent cleavage represents an additional point of miRNA regulation. 
RNA editing by ADAR (adenosine deaminase acting on RNA) protein reduces 
processing of pri-miR-142 and pre-miR-151 by Drosha and Dicer, respectively (Yang, 
2006; Kawahara, 2007). On the other hand, the association with accessory factors, such 
as p68 and p72 helicases, could regulate the Microprocessor function. In fact, 
transforming growth factor beta (TGF-β) and estrogen signaling pathways modulate 
Drosha-mediated pri-miRNAs processing through association with p68 and p72 (Davis, 
2008; Yamagata, 2009). Furthermore, the interaction of p53 with p68 and Drosha after 
DNA damage enhances Microprocessor-mediated processing of a subset of miRNAs 
(Suzuki, 2009). 
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Several RNA binding proteins control the maturation process of miRNAs. In fact, the 
peculiar stem-loop structure of miRNA precursors presents a binding platform for 
numerous cofactors (reviewed in Siomi, 2010). hnRNP A1 protein binds pri-miRNA-
18a in two regions within the terminal loop and the stem, thus favouring binding and 
cleavage by the Microprocessor complex (Guil, 2007; Michlewski, 2008). In addition, 
binding of KH-type splicing regulator protein (KSRP) to G-rich sequences in the 
terminal loop of a subset of miRNAs promotes both Drosha- and Dicer-mediated 
cleavage steps (Trabucchi, 2009). Furthermore, LIN28 binding to a GGAG motif of let-
7 and other miRNAs reduces both pri-miRNA and pre-miRNA processing (Heo, 2008; 
Heo, 2009; Newman, 2008; Rybak, 2008; Viswanathan, 2008). Two Lin28 homologs 
are found in mammals. LIN28b sequesters let-7 pri-miRNA to the nucleoli, thus 
preventing Drosha cleavage (Piskounova, 2011). In the cytoplasm, LIN28a instead 
recruits the terminal uridylyl transferase 4 or 7 (TUT4-7) to the pre-let-7 RNA, which 
adds a uridine tail to the pre-let-7 (Hagan, 2009; Heo, 2009). Polyuridinilation of let-7 
precursor inhibits Dicer cleavage and targets it for degradation. On the other hand, in the 
absence of Lin28, TUT4-7 mediate the addition of only one uridine residue to a subset 
of pre-let-7s and other pre-miRNAs. This creates a classical 2nt 3’ overhang in the 
precursor miRNA, promoting Dicer processing (Heo, 2012).  
In order to regulate the activity of protein in the miRNA pathway after cellular stresses, 
a fast and highly controlled means is represented by post-translational modification. For 
example, KSRP function is regulated by phosphorylation events after DNA damage 
response and BMP signaling (Zhang, 2011; Pasero, 2012). In addition, deacetylation of 
DGCR8 by histone deacetylase 1 (HDAC1) enhances association to pri-miRNAs, thus 
promoting miRNA maturation (Wada, 2012). Furthermore, TRBP phosphorylation by 
the ERK signaling pathway enhances miRNA production through stabilization of the 
Dicer-TRBP complex (Paroo, 2009). Argonaute proteins also undergo several post-
translational modifications in response to stress stimuli. A better description of such 
modification as well as their regulatory relevance is described in details in the next 
section. 
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1.5 Argonaute 2: central component of miRNA and siRNA silencing 
pathways in mammals 
 
1.5.1 Physiological relevance of Ago2 in mouse 
 
Argonaute proteins in plants and animals have undergone a series of gene duplications, 
resulting in a variable number of proteins in each species (Cerutti, 2006; Hutvagner, 
2008). In mouse and humans, 4 Ago-like proteins, called Ago1-4, are present in the 
genome (Cerutti, 2006; Hutvagner, 2008). Among them, Ago2 is the only member of the 
family, which retains the capability to slice target RNAs in case of perfect 
complementarity (Liu, 2004; Song, 2004; Meister, 2004). All four Agos are able to 
mediate post-transcriptional silencing through miRNA-target interaction, suggesting the 
possibility of an overlapping function (Liu, 2004; Meister, 2004; Pillai, 2004; Wu, 2008; 
Su, 2009). Furthermore, all Ago proteins bind similar populations of miRNAs (Azuma-
Mukai, 2008; Dueck, 2012; Wang, 2012). However, Ago1, Ago2 and Ago3 are likely 
expressed in all murine tissues, while Ago4 seems to have a less broad expression 
pattern (Petri, 2011). Genetic ablation of single Ago proteins in mice shed light to the 
possible physiological roles of these proteins. Ago4 is highly expressed in the testis, and 
male mice lacking Ago4 show mild defects in meiotic entry and division, but are 
nonetheless fertile (Modzelewski, 2012). On the other hand, Ago1- and Ago3-mutant 
animals are viable and fertile, but Ago1-Ago3 double knockout animals show lower 
resistance to pulmonary flu infection (O’Carroll, 2007; Van Stry, 2012). 
The lack of Ago2 in mouse models has shown much more severe phenotypes compared 
to loss of the other single Ago proteins. Indeed, Ago2 is the only Ago-like protein with a 
functional endonuclease activity (Liu, 2004; Song, 2004; Meister, 2004). This function 
is not only important for siRNA mediated silencing, but it is also necessary for the few 
miRNAs that show perfect complementarity with their targets and for miR-451 
maturation (Elbashir, 2001; Liu, 2004; Yekta, 2004; Meister, 2004; Hornstein, 2005; 
Cheloufi, 2010; Cifuentes, 2010; Karginov, 2010; Rasmussen, 2010; Yang, 2010). Even 
though Ago1 and Ago2 were shown to be loaded with siRNA with higher efficiency 
than Ago3 and Ago4, slicing of the siRNA duplex precursor by Ago2 enhances the 
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loading of the guide strand in a functional RISC complex (Matranga, 2005; Miyoshi, 
2005; Liu, 2009; Su, 2009). Furthermore, Ago2 endonuclease activity is required for the 
maturation of pre-miR-451, and slicing-inactive Ago2 mutants die perinatally (Cheloufi, 
2010). Finally, in vitro and in vivo studies demonstrated that Ago2 is necessary for 
Dicer-mediated cleavage of a subset of miRNAs (Diederich, 2007; O’Carroll, 2007).  
Since Ago2 is a central component of the RISC complex, germ line ablation of Ago2 
causes embryonic lethality as early as embryonic day 10.5 (E10.5) (Liu, 2004; Alisch, 
2007; Morita, 2007). The phenotypic outcome of gene ablation varied between the 
studies due to differences in the insertion of the mutagenic cassette and in the mouse 
strain used (Liu, 2004; Alisch, 2007; Morita, 2007). Similar embryonic lethality results 
from the ablation of the central miRNA components DGCR8 and Dicer (Bernstein, 
2003; Wang, 2007) 
Conditional loss-of-function approaches demonstrated the importance of Ago2 in 
several adult tissues. Depletion of Ago2 in hematopoietic stem cells (HSCs) causes a 
cell-autonomous impairment in erythroid and B-cell development (O’Carroll, 2007). 
Mice reconstituted with Ago2-deficient bone marrow showed a severe anaemia and 
splenomegaly due to impairment in orthochromatophilic erythroid progenitors. This is in 
part due to the lack of miR-451, which needs a slicing-competent Argonaute protein for 
the maturation of the pre-miRNA (Rasmussen, 2010). In addition, the number of mature 
B cells is reduced due to a partial block in the pro-B-to-pre-B progenitor cell 
differentiation (O’Carroll, 2007).  
Ago2 was demonstrated to be essential also for female fertility. Conditional ablation of 
Ago2 during oogenesis blocks oocyte maturation at meiosis due to spindle organization 
defects (Kaneda, 2009). Interestingly, a similar phenotypic effect arises from the 
elimination of Dicer in growing oocytes, but not DGCR8 (Murchison, 2007; Tang, 
2007; Suh, 2010; Ma, 2010). Since Dicer is essential for both siRNA and miRNA 
biogenesis while DGCR8 is involved only in miRNA maturation, these genetic 
observations suggest that siRNA activity is fundamental for oogenesis, while miRNA 
function is dispensable. Indeed, gene expression profiles and luciferase reporter assays 
demonstrated that mature miRNAs are present in oocytes but are not functional (Suh, 
2010; Ma, 2010). On the other hand, endogenous siRNAs are active in this cell type and 
34	  
are likely to be central for gene regulation (Watanabe, 2006; Watanabe, 2008; Suh, 
2010; Ma, 2010). 
Finally Ago2 has been shown to be necessary for miRNA function in the skin and the 
nervous system. In fact, Ago2 loss in dopaminergic neurons revealed a role for miRNAs 
in cocaine addiction (Schaefer, 2011). Furthermore, ablation of Ago2 together with 
Ago1 specifically in the skin provokes severe skin defects such as hair follicle 
degeneration and a thickened epidermis (Wang, 2012). In conclusion, Ago2 is necessary 
for the execution of miRNA and siRNA functions in several physiological processes. 
 
1.5.2 Regulation of Ago2 activity by post-translational modifications 
 
The central role of Ago2 in both miRNA and siRNA silencing pathways make it an 
amenable target to control the activity of these two post-transcriptional regulators. 
Several post-translational modifications of Ago2 protein have been described in human 
and mouse (Table 1) (reviewed in Kim, 2010, and Siomi, 2010). These modifications 
can impact the stabilization of the protein or its silencing activity during normal and 
stress conditions. Reduction of Ago2 protein levels has an impact on the stability and 
overall expression levels of miRNAs, which are not protected by degradation 
(Diederich, 2007). In addition, post-translational modification of Ago2 allows 
integrating miRNA and siRNA-mediated silencing into the signaling network during 
stress responses. 
The protein TRIM71 (also known as Lin41) is a E3 ubiquitin ligase and targets Ago2 
protein for degradation in mice (Rybak, 2009). Another TRIM-NHL family member, 
NHL-2, regulates miRNA-RISC and target interaction in C. elegans (Hammell, 2009). A 
second modification that interferes with Ago2 protein stability is prolyl-hydroxylation 
(Qi, 2008; Wu, 2011). In fact, hypoxic conditions increase the levels of type I collagen 
prolyl-4-hydroxylase (C-P4H(I)) in human cell lines. This enzyme associates with Ago2 
and mediates the hydroxylation of Proline 700. This in turn increases both miRNA- and 
siRNA-mediated silencing of mRNA in reporter assays (Qi, 2008; Wu, 2011).  
Poly-ADP-rybosilation and phosphorylation are instead post-translational modifications 
used to modulate Ago2 function in response to external cues. For example, after 
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induction of cellular stress, Ago2 and other miRNA components are assembled in 
cytoplasmic structures called stress granules (SGs), which contain stalled translation 
preinitiation complexes (Kedersha, 2002; Kimball, 2003; reviewed in Anderson, 2006). 
There, poly(ADP-ribose) polymerases (PARPs) mediate the addition of multiple ADP-
ribose molecules to Ago2 and other proteins, thus inhibiting both miRNA and siRNA 
function (Leung, 2011). Knockdown of the poly(ADP-ribose) glycohydrolase, an 
enzyme that destroys poly-ADP-ribose chains, achieved a similar reduction of RISC 
function in untreated cells (Leung, 2011). Even though the mechanism of inhibition is 
not clear yet, it is possible that Ago2 activity is reduced due to steric hindrance, blocking 
interaction with target mRNAs and/or other protein complexes. 
Phosphorylation represents one of the most common protein modifications. Mass 
spectrometry approaches identified several phosphorylated sites in the Ago2 protein that 
are present throughout the entire length of the protein (Zheng, 2008; Huttlin, 2010; 
Rudel, 2011). Only few of these post-translational modification sites were characterized 
in details. Tyrosine 529 is phosphorylated in human cell lines in normal culture 
conditions (Rudel, 2011). It is present in the MID domain, which is important for the 
binding of the 5’ end of the guide RNA (Ma, 2005; Parker, 2005; Frank, 2010; Schirle, 
2012; Elakayan, 2012). Phosphorylation of Y529 or mutation of the tyrosine in a 
glutamate (Y529E) reduces the binding of small RNA guides to the Ago2 protein 
(Rudel, 2011). Recent structural data showed that tyrosine 529 forms a hydrogen bond 
with the 5’ base of the miRNA bound to Ago2, and the presence of a negative charge 
destroys this interaction (Schirle, 2012; Elakayan, 2012). More recently, epidermal 
growth factor receptor (EGFR) was identified as the kinase responsible for 
phosphorylation of tyrosine 393 of the human Ago2 (Shen, 2013). Tyrosine 393 lies on 
the linker L2 domain of the Argonaute protein, away from the miRNA and mRNA 
binding sites and the PIWI domain. Interestingly, a subset of miRNAs with a long loop 
structure showed a reduced Dicer processivity after EGFR-mediated tyrosine 
phosphorylation. This is probably due to a reduced interaction between Ago2 and the 
other components of the RISC loading complex, namely Dicer and TRBP (Shen, 2013).  
Another phosphorylation event interests the serine 387 of the human Ago2 (Zeng, 2008; 
Horman, 2013). Mass spectrometry on overexpressed and endogenous Ago2 protein 
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revealed basal level of phosphorylation in normal cell culture conditions (Zeng, 2008). 
Phosphorylation of serine 387 was found to be increased after stress induction with 
sodium arsenite and anisomicin, which are known to stimulate the p38 mitogen-
activated protein kinase (MAPK) pathway. The p38-MAPK kinase pathway is a well-
studied signaling pathway that is activated in response to several stress stimuli, ranging 
from oxidative stress, translational inhibition and DNA damage (Rouse, 1994; Freshney, 
1994; Manke, 2005; reviewed in Ono, 2000). Use of the SB203580 specific inhibitor of 
p38 kinase demonstrated that activation of this pathway leads to phosphorylation of 
Ago2. However, an in vitro approach pinpointed that a kinase downstream of p38, called 
mitogen-activated protein kinase activated protein kinase 2 (MAPKAPK2 or MK2), but 
not p38 itself could phosophorylate Ago2 at serine 387. Functional studies with a non-
phosphorylatable Ago2 protein, where serine 387 was replaced by an alanine residue, 
demonstrated that Ago2 mutant localizes less efficiently to P-bodies during resting 
culture conditions compared to the wild type protein. However, no differences in 
subcellular localization were seen between the wild type and phosphomutant protein 
after induction of stress (Zeng, 2008). A recent study identified a second kinase, 
Akt3/PKBγ, as capable of Ago2 phosphorylation at serine 387 (Horman, 2013). Further 
biochemical and functional characterization showed a reduction of interaction between 
GW182 and the phospho-deficient Ago2 protein, which could explain a decrease in 
Ago2 localization to P-bodies. This in turn leads to a reduced capability of mutant Ago2 
to mediate miRNA-based silencing of reporter genes. Surprisingly, the phosphomutant 
protein possessed a higher endonuclease ability and thus an enhanced siRNA-mediated 
silencing of target genes (Horman, 2013). A more thorough characterization of the 
outcome of serine phosphorylation on endogenous Ago2 protein is needed to appreciate 
the meaning of this modification on miRNA and siRNA silencing pathways. In addition, 
the importance of any of the aforementioned Ago2 post-translational modifications was 
not tested in vivo thus far. Interestingly, a proteomic approach from several mouse 
tissues discovered very low amount of Ago2 phosphorylation only at serine 387 in brain, 
liver, lung and spleen (Huttlin, 2010). This points to Ago2 serine 387 phosphorylation as 
a promising target to understand the significance of miRNA and siRNA pathways 
regulation at an organismal level. 
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Modification Residue Function Reference 
Ubiquitination Unknown 
Destabilizes the Ago2 
protein 
Leung, 2011 
Prolyl 4-hydroxylation P700 
Enhances stability of Ago2 
protein 
Qi, 2008; Wu, 
2011 
Poly-ADP-rybosilation Unknown 
Reduced miRNA- and 
siRNA-mediated silencing 
Rybak, 2009 
Phosphorylation Y529 Impairs miRNA binding Rudel, 2011 
Phosphorylation Y393 
Regulation of maturation of 
miRNA subset 
Shen, 2013 
Phosphorylation S387 
Regulation of P-body 
localization 
Zeng, 2008; 
Horman, 2013 
 
Table 1: Post-translational modifications of the human Ago2 protein. 
 
1.6 The piRNA pathway 
 
1.6.1 piRNA biogenesis 
 
piRNAs represent the third class of silencing Argonaute-bound small non-coding RNAs. 
They are 24-30nt long and are bound to the PIWI subclade of the Argonaute proteins 
(Aravin, 2006; Girard, 2006; Grivna, 2006; Lau, 2006). In D. melanogaster, three PIWI 
proteins, Ago3, Aubergine (Aub) and Piwi, execute piRNA function; in mouse, Mili, 
Miwi and Miwi2 participate to piRNA-mediate silencing (reviewed in Hutvagner, 
2008). Similarly to miRNAs, piRNAs can repress the expression of target genes through 
both transcriptional and post-transcriptional mechanisms. Their expression is mainly 
restricted to germ cells, where they control the activity of transposable elements. In fact, 
mutation of any of the PIWI proteins in mouse and fly causes male sterility due to 
meiotic defects (Cox, 1998; Schmidt, 1999; Deng, 2002; Kuramochi-Miyagawa, 2004; 
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Carmell, 2007; Li, 2009). More recent works have opened the possibility that piRNAs 
can be expressed in other tissues, where they act as regulators of coding mRNAs, but 
they have not been described as ubiquitously as miRNAs (Lee, 2011; Rajasethupathy, 
2012). 
piRNA biogenesis has been studied extensively in flies and mouse (Fig. 2). Conversely 
to miRNAs and siRNAs, piRNA maturation is independent of RNase III enzymes 
Drosha and Dicer (Vagin, 2006; Brennecke, 2007; Houwing, 2007). They are generated 
by ssRNA molecules derived from intergenic regions in the genome (Aravin, 2007; 
Brennecke, 2007; Li, 2013). Two distinct pathways of piRNA production have been 
discovered so far: the primary processing pathway and the secondary amplification 
pathway, which generate primary and secondary piRNAs, respectively (Fig 2A-B). In 
Drosophila, the primary processing pathway starts from the transcription of RNA 
transcripts from piRNA clusters. These clusters are a few kilobases to 100 kilobases 
long and they are processed into many different piRNAs (Brennecke, 2007). On the 
contrary, two different sets of piRNAs are expressed during male germ cell development 
in the mouse: pre-pachytene piRNAs, which are expressed during early testis 
development and derive from transposable elements scattered throughout the genome; 
pachytene piRNAs, which are expressed in adult testis and derive from piRNA clusters 
similarly to Drosophila (Aravin, 2006; Girard, 2006; Grivna, 2006; Lau, 2006; Aravin, 
2007; Aravin, 2008). Recent works are starting to pinpoint the promoter regions and 
transcription factors necessary for the transcription of piRNA clusters both in flies and 
mammals (Brennecke, 2007; Li 2013).  
These long ssRNA precursors are processed in smaller fragments by cellular 
endonucleases in perinuclear granules known as nuage or inter-mitochondrial cement 
(Aravin, 2009; Shoji, 2009; Huang, 2011) (Fig. 2A). Several lines of work in 
Drosophila suggest that the protein Zucchini is necessary for primary piRNA biogenesis 
(Pane, 2007; Saito, 2009; Haase, 2010; Olivieri, 2010; Saito, 2010). Zucchini is a 
member of the phospholipase D superfamily and its mammalian homolog, MitoPLD, is 
able to produce the signaling molecule phosphatidic acid from lipids present in the 
mitochondrial membrane (Choi, 2006; Huang, 2011; Watanabe, 2011). In addition, 
crystallographic studies and in vitro nuclease assays demonstrated that 
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Zucchini/MitoPLD possess a three-dimensional fold of a nuclease and they are capable 
of cleaving single stranded DNA and RNA molecules (Ipsaro, 2012; Nishimasu, 2012; 
Voigt, 2012). It is proposed that Zucchini/MitoPLD play a dual role in primary RNA 
formation: they produce phosphatidic acid, which recruit the components for the 
assembly of nuage, and cleave long piRNA precursors in smaller fragments. It is 
although unclear why primary piRNAs presents a strong bias towards a uracil in position 
1 (1-U) (Brennecke, 2007; Aravin, 2008). Indeed, Zucchini/Mito-PLD do not show any 
preference to cut before a uracil residue, opening to the possibility that additional factors 
associate with them to determine the cleavage site. Another possibility consists in a later 
selection of the generated fragments by binding to PIWI proteins. 
After the generation of short RNA fragments from piRNA precursor, primary piRNAs 
are loaded onto specific PIWI proteins, which correspond to Piwi and Aub in 
Drosophila and Mili and Miwi in mouse (Li, 2009; Malone, 2009; Saito, 2009). The 3’ 
end of the piRNA is then formed through an unknown exonuclease, usually referred to 
as Trimmer (Kawaoka, 2011; Vourekas, 2012). Indeed, deep-sequencing data of piRNA 
associated with PIWI proteins showed a broad size distribution with a peak at length that 
varies between the different PIWI proteins (Aravin, 2006; Grivna, 2006; Brennecke, 
2007; Carmell, 2007; Li, 2009). In addition, 3’-5’ endonucleolytic activity was detected 
on longer RNA molecules loaded into PIWI proteins in cell extracts in vitro (Kawaoka, 
2011). After 3’ end maturation, piRNAs are 2’-O-methylated at their 3’ end by the RNA 
methylase Hen1 (Horwich, 2007; Saito, 2007; Kamminga, 2010; Kawaoka, 2011). This 
modification enhances the piRNA stability by protecting it from the addition of a poly-U 
tail and consequent degradation (Horwich, 2007; Saito, 2007; Kamminga, 2010). 
The mature primary piRNAs are then used to directly silence transposable elements at 
the transcriptional and post-transcriptional level. In addiction, they act as templates for 
the formation of secondary piRNA through the secondary amplification pathway, also 
known as the ping-pong cycle (Brennecke, 2007; Gunawardane, 2007; Aravin, 2008) 
(Fig. 2B). Indeed, primary piRNAs, especially mouse pre-pachytene piRNAs and 
Drosophila piRNA clusters, are enriched for transposon sequences with an antisense 
orientation (Aravin, 2007; Brennecke, 2007; Aravin, 2008). This permits the recognition 
of sense transposon transcripts through base pairing, which triggers the cleavage of the 
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transposon mRNA (Saito, 2006; Gunawardane, 2007; Nishida, 2007). Flies and mice 
employ two similar but distinguishable amplification pathways to produce secondary 
piRNAs. In Drosophila, Aub is responsible for the cleavage of target transcripts through 
its Slicer activity in the cytoplasm (Gunawardane, 2007; Nishida, 2007). The sense 
transposon mRNA is then further processed by an unknown mechanism into smaller 
fragments that are loaded into Ago3 (Brennecke, 2007; Gunawardane, 2007; Li, 2009; 
Malone, 2009). These secondary piRNAs have a characteristic sense orientation and 
present a strong bias for an adenine in position 10 (10-A) due to the endonucleolytic 
activity of Argonaute proteins (Brennecke, 2007). Secondary piRNAs can bind to 
antisense transcripts derived from repetitive elements or piRNA cluster and catalyse 
their cleavage. This in turn creates a new substrate for the generation of piRNAs in the 
sense orientation, allowing the amplification of piRNAs highly specific towards the 
most expressed transposons. The first evidences of the ping-pong cycle were uncovered 
in Drosophila, where Aub binds mainly to antisense piRNAs derived from primary 
processing containing a 1-U, while Ago3 is loaded with secondary sense piRNAs with a 
10-A bias (Brennecke, 2007). Since both Aub and Ago3 participate to this two-steps 
amplification process, Drosophila ping-pong cycle is referred as heterotypic. 
In mouse, a similar mechanism exists, and it was believed to involve both Mili and 
Miwi2 proteins (Aravin, 2008). However, a recent genetic study with endonucleolytic 
dead proteins demonstrated the presence of a homotypic ping-pong cycle interesting 
only Mili (De Fazio, 2011). Indeed, deep-sequencing analysis of Mili-bound piRNAs 
highlighted the presence of a characteristic ping-pong signature, which is missing 
between Mili-Miwi2 piRNA populations (De Fazio, 2011). 
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Figure 2. piRNA biogenesis. 
(A) Generation of primary piRNAs from endogenous long ssRNA precursors is depicted 
in here. (B) Graphical description of the “ping-pong” amplification cycle for the 
generation of secondary piRNAs and amplification of specific piRNA classes in 
Drosophila and mouse. For further details please refer to the main text. 
 
1.6.2 piRNA-mediated silencing mechanisms 
 
piRNAs can silence their targets both at the transcriptional and post-transcriptional 
level. At the post-transcriptional level, PIWI proteins loaded with primary and 
secondary piRNAs are able to slice their targets in case of nearly perfect 
complementarity (Reuter, 2011). The sequence modules necessary for the recognition 
are not known yet. This renders harder the identification of targets for most of mouse 
pachytene piRNAs, which do not show perfect base pairing with any RNA transcript 
(Aravin, 2006; Girard, 2006; Lau, 2006). However, data from flies and mammals 
indicate that PIWI proteins do not tolerate high degree of mismatches (Reuter, 2011; 
Huang, 2013).  
Transcriptional silencing of transposable elements requires the presence of PIWI 
proteins in the nucleus. Drosophila Piwi and mouse Miwi2 proteins are able to 
translocate to the nucleus and silence transposon elements present in the genome (Cox, 
2000; Brennecke, 2007; Carmell, 2007; Aravin, 2008). In Drosophila, loss of Piwi 
reduces the levels of histone H3 lysine 9 trimethylated (H3K9me3) at the euchromatin 
regions targeted by Piwi. This in turn increases RNA Polymerase II occupancy on these 
regions, thus augmenting transcription (Sienski, 2012; Le Thomas, 2013; Rozhkov, 
2013). It is not clear if Piwi recognizes target loci through displacement of one of the 
two DNA strands or by recognition of the transcribed RNA. However, it seems that Piwi 
silencing at specific transposon loci requires RNA Pol II transcription, supporting the 
latter hypothesis (Sienski, 2012).  
In mammals, Miwi2 is the only PIWI protein that localizes in the nucleus (Aravin, 
2008). Lack of Miwi2 induces transposon derepression during early stages of male germ 
cell development (Carmell, 2007; Kuramochi-Miyagawa, 2008). This is due to a 
defective cytosine methylation at the promoter of retrotransposons (Carmell, 2007; 
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Aravin, 2008; Kuramochi-Miyagawa, 2008). Similar to Piwi, the endonuclease activity 
of Miwi2 is dispensable for its functions (De Fazio, 2011; Darricarrère, 2013). The exact 
mechanism by which Miwi2 operates has not been elucidated yet. However, DNA 
methylation complex has been shown to be necessary for transposon silencing in male 
gonads (Bourc’his, 2004; Kaneda, 2004; Webster, 2005). 
 
1.7 Physiological relevance of piRNAs in flies and mouse germ cell 
development 
 
Genetic studies revealed the central function of the piRNA pathway in the regulation of 
transposon in germ cells. In Drosophila, Aub, Ago3 and Piwi take part to piRNA-
mediated regulation of transposable elements in the female germ line (reviewed in 
Hutvagner, 2008). Flies ovaries are divided into functional units called ovarioles. Each 
ovariole presents at the apical part of the structure a germarium, that contains a group of 
2-3 germline stem cells (GSCs) surrounded by a niche formed by somatic cells (Brown, 
1962; Brown, 1964; Wieschaus, 1979; Lin, 1993). When GSCs divide asymmetrically, 
only the daughter cell adjacent to the niche is retained as a stem cell, while the other 
daughter cell initiates the differentiation process into a cystoblast. The cystoblast 
undergoes 4 incomplete divisions to form a cyst of 16 cells interconnected through 
intracellular bridges. The cyst is then enveloped by follicle cells in the centre of the 
germarium, forming an egg chamber. This is afterwards released from the germarium 
and develops into a mature egg (reviewed in Spradling, 1993). Aub and Ago3 are 
localized in the cytoplasm of germ cells, while Piwi is expressed both in germ and 
surrounding somatic cells and is localized mainly in the nucleus (Cox, 2000; Harris, 
2001; Brennecke, 2007; Li, 2009) As such, germ cells rely on both primary piRNAs and 
secondary piRNAs derived from the ping-pong cycle to silence transposable elements: 
Aub and Ago3 deficient animals are sterile (Wilson, 1996; Harris, 2001; Li, 2009). On 
the contrary, Drosophila somatic cells rely only on primary piRNAs and Piwi to 
regulate transposable element expression. Indeed, Piwi mutants present transposon 
derepression both in somatic and germ cells, causing sterility due to defects in germ 
cells as well as in GSCs niche (Lin, 1997; Cox, 1998; Cox, 2000; Szakmary, 2005). The 
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nuclear localization of Piwi is essential for its activity, while its endonuclease activity is 
dispensable (Klenov, 2011; Darricarrère, 2013). 
In mammals, the piRNA pathway is fundamental for the control of transposon activity 
and expression during male germ cell development (Deng, 2002; Kuramochi-Miyagawa, 
2004; Carmell, 2007; Aravin, 2008; Kuramochi-Miyagawa, 2008; De Fazio, 2011; 
Reuter, 2011; Di Giacomo, 2013). Spermatogenesis is a highly organized process that 
takes place in the seminiferous tubules of the testis (Fig. 3). The first germ cell lineage 
consists of primordial germ cells (PGCs), which are specified from epiblast cells at 
embryonic day E7.0 in the mouse embryo (Chiquoine, 1954; Ginsburg, 1990; Lawson, 
1992; Ohinata, 2005). During development, PGCs migrate from the base of the allantois 
to finally reach the genital ridges at embryonic day 10.5. These cells are then engulfed 
within the chords formed by Sertoli cells and surrounded by peritubular cells, becoming 
gonocyte or prospermatogonia (Clermont, 1957; Sapsford, 1962). Sertoli cells and 
peritubular cells represent the major somatic components in the seminiferous tubules. 
After entering the genital chords, gonocytes proliferate until embryonic day E16.5, and 
then they arrest at the G1 phase of the cell cycle until 3 days after birth (PND 3) 
(Sapsford, 1962; Kluin, 1981; Vergouwen, 1991; Nagano, 2000). During this 
developmental window, a genome-wide DNA demethylation process takes place, 
followed by de novo DNA methylation to establish silencing epigenetic marks on 
transposon elements and male-specific imprinted genes (Walsh, 1998; Davis, 1999). 
Gonocytes start to proliferate again just after birth, and proliferation is accompanied by 
relocation of cells from the centre of the tubules towards the basement membrane 
(McGuinness, 1992; Nagano, 2000). Between PND 3-5, gonocytes are specified into 
spermatogonia stem cells (SSCs) (Huckinss, 1968; Kluin, 1981; McLean, 2003; 
Drumond, 2011). SSCs are part of the spermatogonia population, which represents the 
mitotic stages of germ cell development. After specification, SSCs are believed to 
proliferate to enlarge the stem cell pool and to differentiate to give rise to the first 
spermatogenic cycle (de Rooij, 2000). The first round of spermatogenesis is a highly 
synchronized process: the first meiotic cells, called spermatocytes, are produced at PND 
10, while haploid cells such round spermatids first appear at PND 20-21 (Fig. 3). Mature 
sperm is then released commencing from PND 35 (Sapsford, 1962; Kluin, 1982; Sung, 
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1986; Vergouwen, 1991). This process continues throughout the life of the individual in 
highly organized manner in the lumen of the tubules: spermatogonia reside at the 
basement, while meiotic cells are moving towards the lumen during the differentiation 
process (Bellve, 1977; de Rooij, 2000). 
The three PIWI proteins have distinctive expression patterns during embryonic and adult 
germ cell development (Fig. 3). Mili expression initiates in PGCs at embryonic day 
E12.5, and Mili protein is detected in almost all differentiating cells in the adult testis 
(Aravin, 2008; Di Giacomo, 2013). Miwi2 is highly expressed commencing from E14.5-
E15.5; its protein level declines gradually after birth, becoming undetectable at PND 4 
(Carmell; 2007; Aravin, 2008; Kuramochi-Miyagawa, 2008). Miwi is instead detected 
only in adult testis in late meiotic stages and in round spermatids (Deng, 2002; Di 
Giacomo, 2013). Loss-of-function genetic studies have demonstrated the roles of murine 
PIWI proteins, which mirror their expression patterns. In fact, loss of Miwi or its 
endonuclease activity causes male sterility due to transposon expression in round 
spermatids (Deng, 2002; Reuter, 2011). On the other hand, defects in Mili and Miwi2 
lead to sterility due to impairment of early meiotic processes (Kuramochi-Miyagawa, 
2004; Carmell, 2007; De Fazio, 2011). Both proteins are indeed needed for the 
reestablishment of DNA methylation on the promoter of transposable elements (Aravin, 
2008; Kuramochi-Miyagawa, 2008). In addition, a recent study revealed a role of Mili 
during meiotic development: conditional ablation of Mili or its endonuclease activity 
after DNA methylation induces derepression of transposons during pachytene stage of 
the meiotic division, leading to sterility (Di Giacomo, 2013). 
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Figure 3. Germ cell development in mouse testis. 
The generation and development of male germ cells is depicted. Primordial germ cells (PGCs) development is indicated until the cells 
are specified into spermatogonial stem cells (SSCs). For the meiotic and haploid cell types, the developmental time point of their first 
appearance in the mouse testis is also indicated. Expression profile of the three murine PIWI-like proteins (Mili, Miwi and Miwi2) is 
schematically represented. For further details please refer to the main text. 
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1.8 PIWI proteins contribute to stem cell maintenance in different 
organisms  
 
As for piRNAs, PIWI proteins are well-conserved throughout evolution, and it is 
hypothesized that the common eukaryotic ancestor encoded for one Ago-like and one 
PIWI-like protein (Cerutti, 2006; Grimson, 2008). Studies in bilaterian and non-
bilaterian metazoan organisms revealed that PIWI proteins are not expressed only in 
germ cells, arguing to a possible role in somatic tissues (Reddien, 2005; Lee, 2011; 
Rajasethupathy, 2012; reviewed in Juliano, 2011). In particular, in cnidarians and 
sponges, PIWI orthologs are expressed in germ cells and in adult stem cells (Seipel, 
2004; Denker, 2008; Funayama, 2010). In addition, work in the tunicate Botrylloides 
leachi showed that PIWI ortholog is expressed and is essential for the function of 
totipotent stem cells during regeneration (Brown, 2009; Rinkevich, 2010). 
More detailed studies in planarians, which are protostomes like Drosophila and C. 
elegans, confirmed the physiological importance of piRNAs and PIWI proteins in adult 
stem cells (Reddien, 2005; Rossi, 2006; Palakodeti, 2008; De Mulder, 2009). Flatworms 
possess a pool of adult stem cells, called neoblasts, which represent ~30% of total cells 
in adult planarians and have the ability to differentiate in somatic and germ cells. 
Neoblasts participate to the generation of differentiated cells both during homeostasis 
and regeneration (Baguna, 1989; Newmark, 2002). Deep-sequencing of small RNA 
libraries discovered the presence of a class of small RNAs with features similar to 
animal piRNAs in the flatworm Schmidtea mediterranea (Palakodeti, 2008). Analysis of 
the expression of the three PIWI paralogs encoded in the S. mediterranea genome 
(SMEDWI-1, -2 and -3) revealed that these proteins are mainly expressed in neoblasts 
(Reddien, 2005; Palakodeti, 2008). Specific RNAi against Smedwi-2 and Smedwi-3, but 
not Smedwi-1, demonstrated that these two proteins are necessary for tissue maintenance 
in adult animals during homeostatic and regenerative conditions, leading to lethality 
(Reddien, 2005; Palakodeti, 2008). This is likely due to defects in the differentiation of 
neoblasts, which in turn triggers a gradual depletion of stem cell pool (Reddien, 2005). 
In addition, piRNA levels are reduced after Smedwi-2 and Smedwi-3 knockdown, 
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suggesting that piRNA-PIWI complexes work to regulate expression profiles in 
neoblasts (Palakodeti, 2008).  
In flies and mice, only Piwi and Miwi2 mutants displayed a phenotypic outcome that 
suggests a role in germ stem cell maintenance (Cox, 1998; Cox, 2000; Szakmary, 2005; 
Carmell, 2007). Indeed, lack of functional Piwi lead to sterility due to a reduction of 
GSCs and egg chambers. However, this is due to defects in somatic cells in the stem cell 
niche and not to a cell-autonomous defect in GSCs lacking Piwi (Cox, 1998; Cox, 2000; 
Szakmary, 2005; Klenov, 2011). On the other hand, genetic ablation of Miwi2 in mouse 
not only blocks spermatogenic differentiation during early meiosis, but it also induces 
the gradual loss of germ cells in the seminiferous tubules (Carmell, 2007; De Fazio, 
2011). The latter defect does not depend on functional impairment of the somatic 
environment in the tubules, since transplantation of wild type germ cells in Miwi2-null 
testis reconstitutes complete spermatogenesis (Carmell, 2007). These results 
demonstrate a cell-autonomous role of Miwi2 in spermatogonia stem cell pool in 
mammals. In fact, the phenotypic consequences of Miwi2 depletion are reminiscent of 
genetic ablation of other proteins, such as Nanos2 and PLZF, which are used as markers 
for stem cell population (Tsuda, 2003; Buaas, 2004; Costoya, 2004; Nakagawa, 2007). 
Nonetheless, Miwi2 expression becomes undetectable soon after birth (Carmell, 2007; 
Aravin, 2008; Kuramochi-Miyagawa, 2008). More detailed studies on Miwi2 expression 
and function are needed to evaluate the physiological relevance of this protein in stem 
cells in mammals. 
 
1.9 The quest for the identification of the spermatogonial stem cell 
 
1.9.1 The “A single” and the “reserve stem cell” models for 
spermatogonial stem cells 
 
Spermatogenesis is a highly regulated process that produces male haploid gametes from 
diploid germ cells in the testis. In mammals, spermatogenic development takes place in 
the seminiferous tubules of the testis, which comprise both somatic and germ cells 
(reviewed in Russell, 1990 and Eddy, 2002). The two principal somatic cell components 
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are peritubular cells and Sertoli cells. Peritubular cells cover the outside of the basal 
membrane present at the base of the tubules. Sertoli cells instead form an epithelium on 
the luminal part of the basal membrane. These cells form tight junctions between each 
other, providing a physical barrier between the tubule lumen and the other tissues called 
blood-testis barrier (Russell, 1990; Yoshida, 2010). In addition, Sertoli cells support 
germ cell development through nurturing and differentiating signals (Dym, 1970; 
Russell, 1990). Germ cells are localized in an ordered fashion in the lumen of the 
tubules, and their position correlates with the stage of differentiation (Fig. 4). Indeed, 
diploid germ cells, referred as spermatogonia, are found at the base of the tubules 
between Sertoli cells and the basal membrane. Spermatogonia cells form syncytia during 
cell division due to incomplete cytokinesis, allowing the synchronization of later 
division. As such, spermatogonia are typically found as isolated cells or syncytia of 2n 
cells (Fawcett, 1959; Huckins, 1971a; Weber, 1987). Two classes of spermatogonia can 
be distinguished by morphological features: undifferentiated spermatogonia, which 
consist of single cells (A single or As) or syncitya of 2 (A paired or Apr), 4, 8, 16 or 32 
cells (A aligned or Aal); differentiated spermatogonia, which derive from 
undifferentiated spermatogonia and comprise stages A1, A2, A3, A4, Intermediate (In) 
and B spermatogonia (Huckins, 1971a; Huckins, 1978; de Rooij, 2000). B 
spermatogonia undergo the meiotic division, giving rise to spermatocytes. These cells 
translocate across the tight junction into the adluminal compartment (Bellve, 1977; de 
Rooij, 2000). 
As in many other adult tissues, the existence of a stem cell population in mouse testis 
has been postulated. Two models have been proposed to describe the identity and 
behaviour of this spermatogonial stem cell (SSC) population (reviewed in de Rooij, 
2000). The “As model” hypothesizes that single isolated As spermatogonia are bona-fide 
SSCs (Huckinss, 1971a; Oakberg, 1971). This theory is sustained by morphological 
observation on whole-mount testis sections and considers spermatogonia syncytia as 
terminally committed towards differentiation (Huckins, 1971a-b; Oakberg, 1971; de 
Rooij, 1973; Lok, 1983). As such, As spermatogonia are believed to be the true stem cell 
reservoir, with the possibility to divide asymmetrically for the formation of a stem cell 
and a daughter cell that will then form syncytia (Huckins, 1971a; de Rooij, 2000). A 
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second model, the “A0 theory” or “reserve stem cell theory”, asserts that stem activity 
does not reside only in the population of As cells but also in spermatogonia syncytia 
(Clermont, 1968; Bartmanska, 1983). This scheme envisions the possibility that 
spermatogonia syncytia can dissociate and replenish the SSC pool. In fact, Aal 
spermatogonia are not distinguished in this model, and are believed to be part of the A1-
A4 population. In normal homeostatic conditions, A1 spermatogonia become A4 without 
any change in their stemness capacity; A4 cells can then either differentiate to In 
spermatogonia or divide to reform a chain of A1 cells. The As and Apr are believed to 
represent A0 cells or reserve stem cells: these cells do not contribute to spermatogenesis 
in homeostatic conditions, but during regeneration. This model is supported by the 
presence of a constant number of As-Apr cells, which rarely divide during homeostasis 
but actively cycle in response to irradiation (Clermont, 1968; Dym, 1970; de Rooij, 
1973; Clermont, 1975; Erickson, 1978; Erickson, 1981). However, kinetics studies using 
H3-thymidine incorporation revealed that As and Apr cells are actively cycling even in 
homeostatic conditions (Huckins, 1971b; de Rooij, 1973; Lok, 1983).  
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Figure 4. Spermatogonia organization in the murine testis. 
The organization and classification of the different spermatogonia cells is schematically 
represented in here. For further details please refer to the main text. 
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1.9.2 Identification of spermatogonial stem cells: methods and markers 
 
The first attempts to identify the SSC population in mouse testis were based on the 
discovery of markers for the different spermatogonia populations. Based on the 
assumption that As spermatogonia represent a population of bona-fide SSCs, 
immunofluorescence and live imaging experiments from whole mount seminiferous 
tubules were used to identify proteins selectively expressed in these cells. Glial cell line-
derived neurotrophic factor receptor α 1 (GFRA1) and the receptor kinase c-Ret were 
first used as stem cell markers, and they have been shown to be necessary for 
spermatogonia maintenance both in vitro and in vivo (Meng, 2000; Kanatsu-Shinohara, 
2003; Kubota, 2004; Buageaw, 2005; Hofmann, 2005; Naughton, 2006; He, 2007; 
Tokuda, 2007). Immunofluorescence experiments further demonstrated that the 
transcription factor PLZF and the RNA binding proteins Lin28 and Nanos2 are 
expressed in specific subsets of undifferentiated spermatogonia (Tsuda, 2003; Buaas, 
2004; Costoya, 2004; Tokuda, 2007; Sada, 2009; Suzuki, 2009; Zheng, 2009). 
Transgenic mice expressing the fluorescent GFP protein under the promoter of Oct4 and 
Neurogenin 3 (Ngn3) genes have further enriched the number of available markers for 
spermatogonial cells (Ohbo, 2003; Yoshida, 2004). However, combination of these 
proteins revealed that As spermatogonia represent an heterogeneous cell population 
(Tokuda, 2007; Sada, 2009; Suzuki, 2009; Nakagawa, 2010). For example, GFRA1+ 
Nanos2+ PLZF+ Ngn3- cells contains a high fraction of As and Apr spermatogonia, while 
GFRA1- Nanos2- PLZF+ Ngn3+ cells largely contain all the Aal spermatogonia (Sada, 
2009; Suzuki, 2009; Nakagawa, 2010). Interestingly, it was also reported that some 
Ngn3+ cells are able to become GFRA1+ and act as stem cells (Nakagawa, 2007; 
Nakagawa, 2010). Even though As spermatogonia heterogeneity is well-described, it has 
been recently shown that Id4 is expressed exclusively in As cells (Oatley, 2011). 
Combination of the enlisted proteins as well as the discovery of new spermatogonia 
markers are needed to understand if As spermatogonia are the only stem cell population 
in mammalian testis. 
Transplantation assay represents the golden standard to test the stem cell potential of 
purified cell populations in many tissues (Spangrude, 1988; Stingl, 2006; Shackleton, 
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2006). Transplantation of testis cells is possible and gives the opportunity to test the 
self-renewal capacity of isolated cell populations (Brinster, 1994a-b). The intracellular 
localization of the aforementioned markers used for the identification of SSCs halted 
their use in transplantation assays. In addition, transfer of single cell suspension renders 
impossible to relate stem cell activity to the positional information that defines the 
different undifferentiated spermatogonia. As such, transplantation technique was 
initially used in unsorted mouse testis preparations to evaluate the effects of age on stem 
cells activity (Brinster, 1994b; Shinohara, 2001; McLean, 2003). First transplantation 
data showed that testis cells from pups (PND 5-12) have a much higher capacity to 
repopulate donor testis than neonatal (PND 0-2) cells and preparation from almost adult 
mice (PND 21-28) (Brinster, 1994b; Shinohara, 2001). A more detailed analysis 
demonstrated that cells from PND 10-12 possess the highest stem cell activity compared 
to both neonatal and adult testicular cells (McLean, 2003). However, cell preparation 
from adult cryptorchid testis, in which only spermatogonia and somatic components are 
present in the seminiferous tubules, displays the higher repopulating capacity 
(Shinohara, 2001; Kubota, 2004). Further studies coupled transplantation technique to 
cell population sorted by flow cytometry based on specific surface markers. Adhesion 
proteins such integrin α6 (CD49f) and β1 (CD29) and morphological features as low 
side scatter were used to enrich for stem cell activity (Shinohara, 2000 and 2001; 
Kubota, 2003). On the other hand, c-Kit and integrin αv (CD51) levels negatively 
correlate with repopulating activity (Shinohara, 2000 and 2001; Kubota, 2003). 
Comparison with other stem cell populations such as hematopoietic and neural stem 
cells highlighted the differences and similarities on surface marker profiles (Kubota, 
2003). A 25 fold enrichment is achieved over unsorted cells from cryptorchid testis 
when MHC-I- Thy-1+ CD49f+ cells were transplanted into recipient mice, with an 
estimated stem cell concentration of 1 out 15 cells (Kubota, 2003). Additional surface 
markers, like the tetraspanin CD9 and the adhesion molecule EpCAM, were used alone 
to select cells through Magnetic-activated Cell Sorting (MACS) for stem cell activity 
(Kanatsu-Shinohara, 2004; Kanatsu-Shinohara, 2011). Recent applications of MACS- 
and FACS-based cell purification methods allowed for the analysis of GFRA1+ and 
PLZF+ cell population in transplantation assays (Buageaw, 2005; Grisanti, 2009; Hobbs, 
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2010). Reconstitution with GFRA1-enriched cells gave opposing results, with either 
increase or reduction of donor-derived colonies (Buageaw, 2005; Grisanti, 2009). 
However, analysis of PLZF-expressing cells by flow cytometry revealed that these cells 
are mainly CD45- CD51- Thy-1+ c-Kit-. Sorting and reconstitution of donor testis with 
this cell population gives a 25 fold increase in the cologenic activity compared to 
unsorted cells (Hobbs, 2010). This sorting strategy yields a population in which 1 out of 
80 cells is estimated to have self-renewal capacity (Hobbs, 2010). Further detailed 
analysis on gene expression is needed to identify the real SSCs population. 
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Chapter 2: Materials and methods 
 
2.1 Generation of Ago2S388A and Miwi2tdTomato alleles 
 
2.1.1 Ago2S388A targeting strategy 
The strategy to create a nonphoshorylatable Ago2 allele consists in the insertion of two 
nucleotide exchanges in exon 10 of the endogenous Ago2 locus to convert the AGT 
codon for serine 388 into a GCT codon for an alanine residue. The two nucleotide 
mutations introduced maintain the codon usage to avoid alteration of translational rate of 
the mutant protein (Codon Usage Database, species Mus musculus, www.kazusa.or.jp). 
The targeting vector (pDTA-Ago2Neo-S388A) contains homology arms and a neomycin 
(neo) resistance cassette flanked by two LoxP sites between exon 8 and 9. Cre-mediated 
recombination of the neo element allows the creation of a transcriptionally competent 
Ago2S388A knock-in allele. The targeting vector pDTA-Ago2Neo-S388A was constructed 
by Dr. Philip Hublitz from the Gene Expression Facility of EMBL Monterotondo. 
 
2.1.2 Miwi2tdTomato targeting strategy 
A fluorescently-labeled Miwi2 transcriptional reporter allele was created by the direct 
insertion of a tdTomato expression cassette in the endogenous Miwi2 locus. The 
targeting vector (pDTA-Miwi2-Neo-tdTomato) carries homology arms to the Miwi2 
locus and a neomycin (neo) resistance cassette flanked by two FRT sites to allow an 
FLP-dependent excision. The tdTomato expression cassette is fused to the coding region 
of exon 1 of the Miwi2 locus, followed by a strong poly-A signal derived from the 
Simian virus 40 (Carswell and Alwine, 1989) to prevent expression of downstream 
Miwi2 regions. A synthetic intron is inserted between the 5’ untranslated region and the 
translated part of exon 1 to aid correct nuclear processing and export. The targeting 
vector pDTA-Ago2Neo-S388A was constructed by Dr. Philip Hublitz from the Gene 
Expression Facility of EMBL Monterotondo. 
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2.2 Generation of mice using homologous recombination in mouse 
embryonic stem cells 	  
The targeting constructs pDTA-Ago2Neo-S388A was electroporated into IB10 mouse 
embryonic stem cells (ESCs) (Passage 14) derived from the 129P2 genetic mouse 
background (Robanus-Maandag, 1998). In contrast, the pDTA-Miwi2-Neo-tdTomato 
targeting construct was electroporated into A9 ESCs (Passage 11) derived from a F1 
hybrid of C57Bl/6 and 129 mouse genetic backgrounds (Kind gift of A. Wutz). IB10 
and A9 ESCs were routinely maintained in standard ES cell medium (See Appendix 
“Buffers and Media solutions”) on a monolayer of Mitomycin C (MMC)(Sigma, 
M4287)-treated primary mouse embryonic fibroblasts (pMEF). Approximately 107 
ESCs were electroporated with a given targeting construct and plated onto neomycin 
resistant MMC-treated pMEFs. 24h after electroporation, selection for ESC clones 
carrying the neo resistance was started by adding G418 (250ug/ml active 
concentration)(GIBCO, 11811) to the ES cell medium. After 5 and 6 days of selection 
for A9 and IB10 ESCs respectively, 200 ES cell colonies were picked for each 
electroporation and expanded and frozen in ES cell freezing medium. Southern blot 
screening was used to identify clones undergone to homologous recombination. 
Depending on the construct, the targeting efficiency ranged between 1-10%. For 
generation of Ago2Neo-S388A/+ chimeric animals, two independent clones were expanded 
and injected in embryos at the blastocysts stage. For the generation of ESC mice from 
Miwi2Neo-tdTomato/+ A9 cells, two independent clones were expanded and injected in 
embryos at the morula stage. Upon confirmed germ-line transmission of the targeted 
allele by Southern blot, the mice were crossed either to Deleter-Cre mice (Schwenk, 
1995) or to the Flp-expressing transgenic mice (FLPeR) (Farley, 2000) to remove the 
neo cassette from the Ago2 and Miwi2 targeted loci, respectively. These genetic 
manipulations resulted in the generation of Ago2S388A and Miwi2tdTomato alleles. For the 
Ago2 phosphomutant allele, the resulting Ago2S388A/+; TgDelCre animals were backcrossed 
for one generation with C57Bl/6N mice to remove the Cre transgene. Mice in this 
129P2xC57Bl/6N mixed genetic background were employed for the first experimental 
sets. In addition, Ago2S388A/+ or Ago2Neo-S388A/+ heterozygotes in a 129P2xC57Bl/6N 
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mixed background were mated with Ago2FL/FL; Mx-Cre (O’Carroll, 2007; Kuhn, 1995) 
and Ago2FL/FL; Zp3-Cre (De Vries, 2000) for the analysis of hematopoietic and oocyte 
development, respectively. Two co-isogenic lines were created by backcrossing 
Ago2S388A/+ animals for at least 8 generation with C57Bl/6N and 129S2 inbred mice 
from Harlan. Miwi2tdTomato/+ animals employed for the analysis were backcrossed at least 
twice with C57Bl/6N mice before analysis. 
All of the mice were bred and maintained in EMBL Mouse Biology Unit, 
Monterotondo, in accordance with Italian legislation (Art. 9, 27. Jan 1992, no116) under 
license from the Italian Ministry of Health. 
 
2.3 PCR genotyping of Ago2 and Miwi2 mouse alleles 
 
To perform the genotype of the different mouse alleles, standard PCR reagents and 
protocols were used from DNA derived from mouse tail biopses. DNA isolation consists 
of the lysis of tails biopses in 200µl of 0.05M NaOH for 40 minutes at 95oC. 
Subsequently, 20µl of 1M Tris-HCl pH 7.5 was added to equilibrate the pH of the 
solution and 1µl of this solution was use for each PCR reaction as a template. TAQ 
polymerase was acquired from the PEPCF Facility in EMBL Heidelberg. 
 
Components Final concentration Volume (µ l) 
KT Buffer (10X) 1X 2.5 
dNTPs (20mM) 200µM 0.25 
Primer Mix (20µM) 200nM 0.25 
Genomic DNA N/A 1 
Taq Polimerase N/A 0.25 
PCR-grade ddH2O  Up to 25 
 
2.3.1 Genotype protocol for AgoNeo-S388A allele 
 
Primers:  
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Ago2-S388A-Tgeno-F1 5’-cctgccacgatccataacttc-3’ 
Ago2_T-geno_R1 5’-tgtccagcaactatgttacagacc-3’ 
 
 
 
Expected length: 
 
Ago2Neo-S388A 195bp       
 
PCR program: 
 
Step Temperature (oC) Time (s) Cycles 
Denaturation 95 180 1X 
Denaturation 95 30 
35X Annealing 62 30 
Elongation 72 30 
Final elongation 72 300 1X 
Pause 12 Forever 1X 
 
Resolve PCR in a 3.5% Agarose gel run at 200V for 20 minutes. 
 
2.3.2 Genotype protocol for AgoS388A, Ago2FL and Ago2- allele 
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Primers:  
 
Ago2_Geno_F38096 5’-gtgagccactcactgcac-3’ 
Ago2_Geno_R38376 5’-tgatcatggttgaggtctga-3’ 
Ago2_Geno_NR1 5’-cctgccaatctgaggtcagtc-3’ 
 
Expected length: 
 
 
Wt   301bp 
Ago2-  273bp 
Ago2FL  351bp 
Ago2S388A 376bp 
 
 
PCR program: 
 
Step Temperature (oC) Time (s) Cycles 
Denaturation 94 180 1X 
Annealing 58.4 60 1X 
Elongation 72 120 1X 
Denaturation 94 30 
34X Annealing 58.4 40 
Elongation 72 30 
Final elongation 72 180 1X 
Pause 12 Forever 1X 
 
Resolve PCR in a 3.5% Agarose gel run at 200V for 40 minutes using thin comb for a 
proper separation of bands. 
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2.3.2 Genotype protocol for Miwi2tdTomato allele 
 
Primers:  
 
Miwi2_Geno_FW1 5’-tactcccaaactccgagtc-3’ 
Miwi2_Geno_R1 5’-gtgcctatcagaaacgcaa-3’ 
Miwi2_Geno_R2 5’-ctcctagccagagtgcctt-3’ 
 
 
Expected length: 
 
Wt     329bp 
Miwi2tdTomato   230bp 
 
 
 
PCR program: 
 
Step Temperature (oC) Time (s) Cycles 
Denaturation 94 180 1X 
Denaturation 94 30 
35X Annealing 63 30 
Elongation 72 40 
Final elongation 72 300 1X 
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Pause 12 Forever 1X 
 
Resolve PCR in a 3.5% Agarose gel run at 200V for 20 minutes. 
 
2.4 Southern Blot on restriction enzyme-digested genomic DNA 
 
2.4.1 Isolation of DNA for Southern Blot 
Tail biopses or single cell suspensions were digested by incubation in 500µl of Tail 
Digestion Buffer (see Annex 1) at 56oC overnight. 500µl of phenol-chloroform mixture 
(Sigma, 77617) were added to the samples: tubes were shaken vigorously for 10 seconds 
and centrifuged at 10,000RPM for 3 minutes in a table-top centrifuge (Eppendorf, 
Centrifuge 5424). The upper aqueous phase was then removed and transferred in a clean 
1.5ml tube. This operation was repeated twice. Subsequently, a 1:1 volume of 
chlorophorm (Merck, K33534645) was added to samples. After shaking and 
centrifugation as previously described, the aqueous phase was transferred to a clean 
1.5ml tube. Then a 1:1 volume of isopronanol (Sigma, 33539) and a 1:10 volume of 3M 
sodium acetate (Sigma, S2889) were added to each sample and the purified DNA was 
precipitated by centrifugation at maximum speed for 5 minutes. The supernatant was 
removed and the DNA washed with 1ml of 70% ethanol. After centrifugation at 
maximum speed for 5 minutes, the ethanol was carefully removed and the pellet left to 
air-dry for 5 minutes. DNA was resuspended in 50µl of PCR-grade ddH2O and store at 
4oC. DNA content was quantified with a NanoDrop 8000 spectrophotometer (Thermo 
Scientific). 
 
2.4.2 Preparation of Southern Blot probes 
Southern blot probes for both Ago2 (Probe 12i) and Miwi2 (Miwi2 3’ probe) were 
synthesized by PCR reaction from tail-derived DNA. The following primers were used 
for the production of the probes: 
 
Primers Sequence Probe length 
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Ago2_probei12_F 5’-cccaaagcctgtaaagtctagc-3’ 
458bp 
Ago2_probei12_R 5’-gtgggtgtagtctcggaaaca-3’ 
Miwi2_Ex3_probe_F 5’-aaggaaggatagtcgcgtgtt-3’ 
352bp 
Miwi2_Ex3_probe_R 5’-acacccaactcttcgaagtcc-3’ 
 
PCR program: 
 
Step Temperature (oC) Time (s) Cycles 
Denaturation 95 180 1X 
Denaturation 95 30 
35X Annealing 59 40 
Elongation 72 60 
Final elongation 72 300 1X 
Pause 12 Forever 1X 
 
PCR products were resolved in a 1% Agarose gel run at 120V for 1 hour. Fragments of 
the correct size of the probes were excised from the gel using a scalpel under a 
transilluminator and purified using the QIAquick Gel Extraction Kit (Qiagen, 28704) 
following manufacturer instructions. The DNA was eluted in 50µl of PCR-grade ddH2O 
and store at -20oC. DNA content was quantified with a NanoDrop 8000 
spectrophotometer (Thermo Scientific). 
 
2.4.3 Southern Blot 
10µg of purified DNA was digested overnight at 37oC with 40U of BamHI (NEB, 
R0136S) or AseI (NEB, R0526S) for Ago2 or Miwi2 alleles screening, respectively. For 
the separation of Ago2 alleles, samples were loaded in a 1.2% Agarose gel and run at 
130V for 5 hours; for the distinction of Miwi2 alleles, a 0.8% Agarose gel was run at 
130V for 3 hours. The DNA fragments were successively transferred overnight to a 
Hybond™-N+ Nylon Membrane (GE healthcare, RPN203B) in a classic blotting 
sandwich using passive capillary transfer in alkaline solution (0.4M NaOH, 1.5M NaCl). 
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After transfer completed, the membrane was rinsed twice with 0.2M SSC, dried at 37oC 
for 20 minutes, and the DNA UV-linked at 150mJ/cm2. 
30ng of purified probe were marked with α-[32P]-dGTP using the Random primers 
labeling kit (Invitrogen, 18187-013) according to manufacturer instructions. The 
membrane was first incubated for 2 hours at 65oC in Southern hybridization buffer (See 
Annex 1), then the labeled probe was added to the solution and left for hybridization 
overnight. Membrane was thoroughly washed three times with Southern washing 
solution pre-heated at 65oC (See Annex 1), each wash step taking 20 minutes at 65oC. 
Finally, the membrane was wrapped in Saran wrap and exposed to a phosphoscreen for 
24 hours. Phosphoscreen was scanned using the Fluorescent Image Analysis System 
FLA-5100 (Fujifilm). 
 
2.5 Sequencing of wild type and Ago2S388A alleles 
 
Sequencing of tail-DNA from two wild type and two Ago2S388A/S388A littermates in a 
129P2xC57Bl/6N mixed genetic background was used to confirm the presence of two 
point mutations (AGT to GCT) for the conversion of serine 388 to an alanine codon. 
DNA was isolated with phenol-chlorophorm mixture as previously described, and a 
403bp fragment encompassing exon 9 to 10 of the Ago2 locus was amplifying using the 
following primer set: 
 
Ago2_Exon9-10_F 5’-aagagcacttggccctgtc-3’ 
Ago2_Exon9-10_R 5’-aggtctgtaacatagttgctgga-3’ 
 
PCR program: 
 
Step Temperature (oC) Time (s) Cycles 
Denaturation 95 180 1X 
Denaturation 95 30 
35X 
Annealing 61 40 
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Elongation 72 60 
Final elongation 72 300 1X 
Pause 12 Forever 1X 
 
PCR fragments were purified using the PCR purification kit (QIAgen, 28104) and 40ng 
of amplicon were used for the following sequencing reaction.  
 
Components Final concentration Volume (µ l) 
BigDye Terminator Buffer 
(AB, 4339843) 5X 
1X 3 
BigDye Terminator Buffer 
(AB, 4337454) 
N/A 2 
Primer Ago2_Exon9-11_F 
(2µM) 
160nM 1.6 
PCR fragment 40ng 1-2 
PCR-grade ddH2O  Up to 20 
 
Sequencing program 
 
Step Temperature (oC) Time (s) Cycles 
Denaturation 95 300 1X 
Denaturation 95 15 
25X Annealing 52 15 
Elongation 60 180 
Pause 12 Forever 1X 
 
Fragments from sequencing reaction were precipitated with ethanol and resuspended in 
10µl of PCR-grade ddH20. 4µl of this solution were then crosslinked with formammide 
HiDi (AB, 4311320) for 3 minutes at 95oC. Samples were then sequenced using the 
ABI310 sequencer from Applied Biosystem. 
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2.6 Isolation and PCR genotyping of mouse embryos from Ago2S388A/+ 
intercrosses 
 
2.6.1 Isolation and genotyping of embryos at embryonic day from E6.5 to E12.5 
Ago2S388A/+ heterozygous animals from a 129P2xC57Bl/6N mixed and 129S2 genetic 
background were intercrossed for embryogenetic studies. Vaginal plug was checked for 
1-4 days after mating: the day of the appearance of vaginal plug was considered as 
embryonic day E0.5. At the day of isolation, pregnant females were sacrificed by 
cervical dislocation and the isolated uterus was transferred on ice-cold 1X PBS (Gibco, 
14190-094). Single deciduas were then separated and the embryos were isolated from 
maternal tissues under a stereomicroscope. Embryos were transferred in clean ice-cold 
1X in a 10mm dish (Falcon, 351029) to take pictures using a Leica stereomiscroscope 
(Leica MZ12). For DNA isolation from E9.5-E12.5 embryos, a small piece of the 
embryo was taken and digested in 100µl of embryo lysis buffer (See Annex 1) in a 
1.5ml tube. Whole embryos isolated at E6.5-E7.5 were transferred in a 1.5ml containing 
25µl of embryo lysis buffer. Samples were incubated for 2 hours at 54oC and then 
passed at 72oC for 20 minutes to inactivate the proteinase K activity. 1-2µl of embryo 
lysis buffer was employed to genotype the embryos by PCR as described in the previous 
section. 
 
2.6.2 Isolation of embryos at embryonic day E3.5 
Ago2S388A/+ heterozygous animals from a 129S2 genetic background were intercrossed 
for embryogenetic studies. Vaginal plug was checked for 1-4 days after mating: the day 
of the appearance of vaginal plug was considered as embryonic day E0.5. At E3.5, 
pregnant females were sacrificed by cervical dislocation and the uterus was carefully 
isolated and cleaned under a stereomicroscope. Blastocysts were flushed out from the 
uterus using 1ml of M2 medium and 1ml syringe with a 26 ½ G needle (BD Plastipack, 
300015) in a 6mm plastic dish (Falcon, 353001). Each embryo was then transferred in 
10µl of embryo lysis buffer in a 1.5ml tube. Samples were incubated for 2 hours at 54oC 
and then passed at 72oC for 20 minutes to inactivate the proteinase K activity. 2µl of 
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embryo lysis buffer was employed to genotype the embryos by PCR as described in the 
next section. 
 
2.6.3 PCR genotyping of embryos isolated at E3.5 by nested PCR 
To genotype embryos at the E3.5 stage, two consecutive PCR reactions were employed 
to amplify distinctive fragments for wild type and Ago2S388A alleles. This two-step 
protocol allows the specific amplification of the Ago2 locus from low content DNA 
samples and limits the presence of contaminant bands. Indeed, a first PCR reaction 
amplifies specifically the region of interest from the genomic DNA, while the second 
reaction employs internal primers that anneal within the DNA fragment amplified during 
the first reaction. The cumulative number of amplification cycles (55 cycles) permits the 
amplification of the desire band from low quantities of DNA samples. 
 
First PCR reaction primer set: 
 
Ago2_Geno_F38096 5’-gtgagccactcactgcac-3’ 
Ago2_Geno_R38376 5’-tgatcatggttgaggtctga-3’ 
 
 
Wild type  301bp 
Ago2S388A  376bp 
 
PCR program for the first reaction: 
 
Step Temperature (oC) Time (s) Cycles 
Denaturation 95 180 1X 
Denaturation 95 30 
30X Annealing 58 40 
Elongation 72 30 
Final elongation 72 300 1X 
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Pause 12 Forever 1X 
 
Second PCR reaction: 
 
SC_Ago2_Nest2_FW 5’-tcatgccagggttacctacaa-3’ 
SC_Ago2_Nest2_RV 5’-agggagatttcagaggctgag-3’ 
 
 
 
 
Wild type  104bp 
Ago2S388A  180bp 
 
 
PCR program for the second reaction: 
 
Step Temperature (oC) Time (s) Cycles 
Denaturation 95 180 1X 
Denaturation 95 30 
25X Annealing 59 40 
Elongation 72 30 
Final elongation 72 180 1X 
Pause 12 Forever 1X 
 
Resolve in a 3.5% Agarose gel at 200V for 20 minutes. 
 
2.7 Analysis of fertility in Ago2S388A mutant animals 
 
Ago2S388A/FL; Zp3-Cre and Ago2+/FL; Zp3-Cre females in a mixed genetic background 
were mated with wild type C57Bl/6N male animals of known fertility. Females used for 
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testing were 2-4 months old. The presence of a vaginal plug was evaluated 1-4 days 
after mating, and the males were removed from the cage after the appearance of the 
plug. The size of the litter was evaluated both at birth and at weaning. Pups were 
genotyped by PCR at weaning to confirm the efficiency of Cre recombination. 
Wild type and Ago2S388A/S388A animals in a C57Bl/6N genetic background were mated 
with wild type C57Bl/6N mice of the opposite sex. The mice used for testing were 2-4 
months old. The presence of a vaginal plug was evaluated 1-4 days after mating, and the 
males were removed from the cage after the appearance of the plug. The size of the 
litters was evaluated both at birth and at weaning. 
 
2.8 Isolation of cells from bone marrow, spleen, testis and thymus for 
flow cytometry 
 
2.8.1 Isolation of single cell suspension from bone marrow 
Bone marrow cells were isolated from the femur and tibia of adult mice (2-4 months old 
if not indicated). The procedure is as follows: 
1. Sacrifice the mouse with CO2. 
2. Isolate the whole femur and tibia from the adult mouse. Remove the foot by cutting 
it near the joint. Place it in a 15ml falcon tube with ice-cold 10ml of BSS+2%FCS 
(See Annex 1). 
3. Carefully clean the femur and the tibia from the muscular and cartilaginous tissues 
by using forceps and clean paper towel. 
4. Transfer the clean tibia and femur in a 250ml porcelain mortar. Add 10ml of ice-cold 
BSS+2%FCS and use a 21cm pestle to crush the sample. Continue until all the red 
pulp of the bone marrow is separated from the rest. 
5. Further disrupt disembedded marrow by pipetting with a 10ml pipette. 
6. Filter the solution with a 70µm cell strainer (BD Falcon, 352350) directly in a 50ml 
falcon tube. 
7. Rinse with additional 10ml of ice-cold BSS+2%FCS the mortar and filter it through 
the same 70µm cell strainer. 
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8. Centrifuge cells at 1,200RPM for 5 minutes at 4oC (Eppendorf 5810R, swinging 
bucket rotor) 
9. Remove supernatant and resuspend cells in 10ml of ice-cold BSS+2%FCS. 
 
2.8.2 Isolation of single cell suspension from spleen and thymus 
Spleen and thymus cells were isolated from adult 2-4 months old mice: 
1. Sacrifice the mouse with CO2. 
2. Isolate the spleen and the thymus from the animal. For spleen, carefully remove 
from adjacent tissues with a forceps. For the thymus, open the thoracic cavity 
without damaging the lungs and the heart, and remove carefully the thymus without 
breaking the veins near it. Transfer the organ in a 15ml falcon tube containing 5ml 
of ice-cold BSS+2%FCS. 
3. Place a 70µm cell strainer in a 6mm dish. Transfer the spleen or the thymus along 
with the 5ml BSS+2%FCS on top of the cell strainer. Smash the tissue through the 
grid by using the sterile plunger of a 1ml syringe. Rinse the cell strainer with 1ml 
BSS+2%FCS. 
4. Resuspend cells repeatedly with a 10ml pipette to ensure the formation of a single 
cell suspension. Rinse the 6mm dish with 1ml of ice-cold BSS+2%FCS. Transfer the 
solution to a 15ml falcon tube. 
5. Centrifuge cells at 1,200RPM for 5 minutes at 4oC. 
6. Remove the supernatant and resuspend cells in 10ml of ice-cold BSS+2%FCS. 
 
2.8.3 Erythrolysis of bone marrow and splenic single cell suspensions 
In order to analyse the different leukocyte population, samples derived from bone 
marrow and spleen need to be depleted from erythroid cells. This is achieved by 
inducing the lysis of enucleated cells through hypotonic stress. The protocol is as 
follows: 
1. Centrifuge bone marrow and spleen samples at 1,200RPM for 5 minutes at 4oC. 
2. Remove supernatant. Resuspend cells in 1ml of ACK lysis buffer (See Annex 1) and 
incubate for 2 minutes at room temperature. 
3. Add 20ml of ice-cold BSS+2%FCS to restore the osmotic conditions. 
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4. Centrifuge at 1,200RPM for 5 minutes at 4oC. 
5. Remove supernatant. Repeat lysis in case the cell pellet has still a red colour. In case 
of a successful red blood cell lysis, resuspend cells in 10ml of ice-cold 
BSS+2%FCS. 
 
2.8.4 Isolation of single cell suspension from juvenile male testis 
Cells from juvenile (post-natal day 14) mice were isolated as follow: 
1. Sacrifice the mouse by cervical dislocation; 
2. Isolate both testes and remove the tunica albuginea. Place testes in 1ml of Goni-
MEM medium (See Annex 1) in a 1.5ml tube. 
3. Let the testes sediment by gravity, then remove the supernatant and add 1ml of fresh 
Goni-MEM to the tube. 
4. Add 40µl of collagenase (12.5mg/ml, Sigma, c7657). Incubate in shaking for 10 
minutes at 32oC. 
5. Centrifuge the sample at 1,000RPM for 5 minutes in a table-top centrifuge 
(Eppendorf, Centrifuge 5424). 
6. Remove supernatant and wash with 1ml fresh Goni-MEM. 
7. Centrifuge the sample at 1,000RPM for 5 minutes in a table-top centrifuge. 
8. Remove supernatant. Add 1ml of 0.05% trypsin+EDTA (Invitrogen, 25300-054). 
Incubate in shaking for 5 minutes at 32oC. 
9. Neutralize trypsin by addition of 200µl of FCS. Centrifuge at 1,000RPM for 5 
minutes in a table-top centrifuge. 
10. Remove supernatant, then add 100µl of Goni-MEM containing 0.05mg/ml of DnaseI 
(Sigma, DN-25-100µg). Pipette thoroughly the sample several times to help the 
fragmentation of the DNA released from dead cells. 
11. Add 1ml of Goni-MEM and centrifuge at 1,000RPM for 10 minutes in a table-top 
centrifuge. 
12. Remove supernatant. Resuspend cells in 1ml of fresh Goni-MEM. Keep cells on ice 
for immunostaining for flow cytometry. 
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2.8.5 Isolation of single cell suspension adult male testis 
1. Sacrifice the mouse by cervical dislocation; 
2. Isolate both testes and remove the tunica albuginea. Place testes in 25ml of Goni-
MEM medium in a 50ml Falcon tube. 
3. Let the testes sediment by gravity, then remove the supernatant and add 24ml of 
fresh Goni-MEM to the tube. 
4. Add 1ml of collagenase (12.5mg/ml, Sigma, c7657). Incubate in a water bath 
shaking for 10 minutes at 32oC. 
5. Let the testes sediment by gravity, then remove the supernatant and add 25ml of 
fresh Goni-MEM to the tube. 
6. Let the testes sediment by gravity, then remove the supernatant. Add 5ml of 0.05% 
trypsin+EDTA (Invitrogen, 25300-054). Incubate in a water bath shaking for 5 
minutes at 32oC. 
7. Neutralize trypsin by addition of 1ml of FCS. Centrifuge at 1,000RPM for 5 minutes 
(Eppendorf 5810R, swinging bucket rotor). 
8. Remove supernatant, then add 1ml of Goni-MEM containing 0.05mg/ml of DnaseI 
(Sigma, DN-25-100µg). Pipette thoroughly the sample several times to help the 
fragmentation of the DNA released from dead cells. 
9. Add 20ml of Goni-MEM and filter cells with a 70µm cell strainer. Centrifuge at 
1,000RPM for 5 minutes (Eppendorf 5810R, swinging bucket rotor). 
10. Remove supernatant. Resuspend cells in 20ml of fresh Goni-MEM. Keep cells on 
ice for immunostaining for flow cytometry. 
 
2.9 Poly I:C and lypopolysaccharide treatment 
 
Adult Ago2+/FL; MxCre and Ago2S388A/FL; Mx-Cre between 2-3 months old were injected 
intraperitoneally with 250µg of polyinosinic:polycytidylic acid (poly I:C, Amersham 
Biosciences, 27-4732) for a total of three times, with an interval of 3 days between each 
administration. 
Administration of 30µg/Kg of lypopolysaccharide from Escherichia Coli 0111:B4 (LPS, 
Sigma, 4391) with 800mg/Kg of D-galactose (D-gal, Sigma, G0750) was performed on 
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adult mice through intraperitoneal injection. The survival rate of each cohort of injected 
animals was scored up to 24 hours after injection. 7 mice per cohort were employed in a 
C57Bl/6N genetic background, while 10 recipient mice after 3 months from bone 
marrow transplantation were administered with LPS+D-gal for each experimental group. 
 
2.10 Generation of chimeric mice by bone marrow transplantation 
 
Bone marrow cells isolated from Ago2+/FL; Mx-Cre; Ly5.2 and Ago2S388A/FL; Mx-Cre; 
Ly5.2 adult mice in a mixed genetic background were used for transplantation in lethally 
irradiated C57Bl/6N recipients. Each control and experimental donor mouse was used to 
transplant 5 recipient animals. Three independent transplantations were completed with 
three different donors for both Ago2+/FL; Mx-Cre; Ly5.2 and Ago2S388A/FL; Mx-Cre; 
Ly5.2 animals. The procedure is listed below: 
1. 6-8 weeks old Ly5.1 females in a C57Bl/6N genetic background were irradiated with 
875rad 16-24 hours before transplantation. 
2. Bone marrow cells from Ago2+/FL; Mx-Cre; Ly5.2 and Ago2S388A/FL; Mx-Cre; Ly5.2 
animals were isolated as previously described, without lysis of red blood cells. 
3. Cells were washed 3 times with 20ml of ice-cold PBS to remove any minimal 
contamination of FCS and other contaminants to avoid an immune reaction by 
centrifugation at 1,200RPM for 5 minutes at 4oC. 
4. Cells were resuspended at a density of 107 nucleated cells/ml in ice-cold PBS. 
5. Recipient mice were briefly heated under a red bulb lamp and transplanted with 
2x106 nucleated cells through the tail vein. 
Recipient animals were under treatment with medicated water (Baytril, Bayer) for 4 
weeks after the transplantation, and they were analysed 12 to 16 weeks after 
reconstitution. 
 
2.11 Quantitative analysis of peripheral blood 
 
Quantitative analysis of blood parameters was performed on facial vein-derived blood 
collected in heparin-coated microcapillary tubes (Brand, 1303430). Samples were placed 
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in agitation before analysis, which was conducted with an automated flow cytometry-
based haematology (Hemavet HV950FS, Drew Scientific). 
 
2.12 Immunostaining of hematopoietic and testicular cells for flow 
cytometry analysis and sorting 
 
2.12.1 General immunostaining protocol for erythroid, lymphoid and myeloid 
lineages 
A common protocol for the staining of erythroid and B cell progenitors, T cell and 
myeloid populations is described: 
1. 1x106 cells from bone marrow, spleen and thymus single cell suspension were 
transferred in a well of a round-bottomed 96-well plate; 
2. Centrifuge at 1,200RPM for 5 minutes at 4oC. 
3. Remove supernatant by inverting the plate on the sink and gently tapping the bottom 
of it. Remove the remaining liquid on the wells by laying the plate on a paper towel. 
4. Add 25µl of 1X PBS+3%FCS supplemented with 1/50 dilution of purified CD16/32 
antibody (see “List of antibodies used in this study” at the end of this session). Mix 
the plate by gentle vortexing to resuspend the cells and incubate on ice for 10 
minutes. 
5. Add 25µl of 1X PBS+3%FCS containing the appropriate antibody mixture. Mix by 
gentle vortexing and incubate on ice for 20 minutes. Protect cells from light until 
analysis of the samples at the flow cytometer. 
6. Wash cells by adding 200µl of 1X PBS+3%FCS. 
7. Centrifuge at 1,200RPM for 5 minutes at 4oC. 
8. Remove supernatant as step 3. 
9. Resuspend cells in 300µl 1X PBS+3%FCS supplemented with 1µg/ml of 7-
actinomycin (7AAD) (Sigma, A9400) and transfer them in a FACS tube (12x75mm 
round bottom) after filtering with a 50µm filcon (BD Falcon, 340632). 
All the cells were acquired using a two-laser BD FACSCanto™ Flow Cytometer or a 
five-laser BD FACSAria™ II Sorp cell sorter under the guidance of Dr. Daniel Bilbao in 
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the EMBL Flow Cytometry Facility. Data was analysed off-line using FlowJo® Flow 
Cytometry analysis software (TreeStar, Inc.) 
 
Immunostainings performed with this protocol: 
1. Late erythroid progenitor: Ter119-APC, CD71-PE. 
2. Late B cell progenitors: CD45R-APC, IgM-PE, CD43-FITC. 
3. Immature B cells: CD45R-APC, IgM-PE, IgD-FITC. 
4. T cells: CD3-APC, CD8-PE, CD4-FITC. 
5. Myeloid cells: Gr-1-APC, CD11b-PE. 
6. For transplanted animals, CD45.1-PE-Cy7 and CD45.2-Pacific Blue conjugated 
antibodies were added to staining 2-5. 
 
2.12.2 Immunostaining protocol for hematopoietic stem cell and early progenitor 
populations 
A common protocol for the staining of early hematopoietic progenitor populations is 
described: 
1. 1x107 cells from bone marrow single cell suspension were transferred in a 1.5ml 
tube; 
2. Centrifuge at 1,200RPM for 5 minutes at 4oC. 
3. Resuspend cells in 100µl of 1X PBS+3%FCS supplemented with 1/100 dilution of 
lineage-specific antibody mixture. Incubate 10 minutes on ice. 
4. Wash cells by adding 1ml of 1X PBS+3%FCS and centrifuge at 1,200RPM for 5 
minutes at 4oC. 
5. Remove supernatant, and add 100µl of 1X PBS+3%FCS containing 1/200 dilution 
of GAR-TC tricolour reagent. Incubate 10 minutes on ice. Protect cells from light 
until analysis of the samples at the flow cytometer. 
6. Wash cells by adding 1ml of 1X PBS+3%FCS and centrifuge at 1,200RPM for 5 
minutes at 4oC. 
7. Remove supernatant and add 50µl of 1X PBS+3%FCS supplemented with 1/50 
dilution of purified CD16/32 antibody. Incubate on ice for 10 minutes. 
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8. Add 50µl of 1X PBS+3%FCS containing the appropriate antibody mixture. Mix by 
gentle vortexing and incubate on ice for 20 minutes. 
9. Wash cells by adding 1ml of 1X PBS+3%FCS and centrifuge at 1,200RPM for 5 
minutes at 4oC. 
10. Centrifuge at 1,200RPM for 5 minutes at 4oC. 
11. Remove supernatant, then resuspend cells in 300µl 1X PBS+3%FCS supplemented 
with 1µg/ml of 7-actinomycin (7AAD) and transfer them in a FACS tube after 
filtering with a 50µm filcon. 
All the cells were acquired using a five-laser BD FACSAria™ II Sorp cell sorter under 
the guidance of Dr. Daniel Bilbao in the EMBL Flow Cytometry Facility. Data was 
analysed off-line using FlowJo® Flow Cytometry analysis software (TreeStar, Inc.) 
 
Immunostainings performed with this protocol: 
1. HSC and LMPP: Lineage cocktail (CD4, CD5, CD8, CD11b, CD45R, Gr-1, 
Ter119), c-Kit-APC-Alexa 750, Sca-1-PE-Cy7, CD150-APC, Flt-2/Flk-3-PE. (Kiel, 
2005; Adolfsson, 2005) 
2. Early megakaryocytic-erythroid and myeloid progenitors: Lineage cocktail (CD4, 
CD5, CD8, CD11b, CD45R, Gr-1, Ter119, Sca-1, IL7Ra), c-Kit-APC-Alexa 750, 
CD41-PE, CD150-APC, CD105-Bio, Streptavidin-PE-Cy7. (Socolovsky, 2001) 
3. Early progenitor B cells: Lineage cocktail (CD11b, Gr-1, Ter119), BP-1-Alexa 647, 
CD45R-APC-eFluor780, CD43-FITC, IgM-PE, CD93-PE-Cy7, CD24-Pacific Blue. 
(Hardy, 1991; Hardy, 1996) 
 
2.12.3 Immunostaining of testicular cells for flow cytometry analysis and sorting 
A common protocol for the staining of testis cell populations is described: 
1. 3-5x106 cells from adult or juvenile testis single cell suspension were transferred in a 
1.5ml tube; 
2. Centrifuge at 1,000RPM for 5 minutes at 4oC. 
3. Resuspend cells in 25µl of 1X PBS+3%FCS supplemented with 1/50 dilution of 
purified CD16/32 antibody. Incubate 10 minutes on ice. 
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4. Add 25µl of 1X PBS+3%FCS containing a mixture of CD45 and CD51 antibodies 
conjugated with biotin. Incubate 10 minutes on ice. 
5. Wash cells by adding 1ml of 1X PBS+3%FCS and centrifuge at 1,000RPM for 10 
minutes at 4oC (Eppendorf 5810R, swinging bucket rotor). 
6. Remove supernatant, and resuspend cells in 100µl of 1X PBS+3%FCS containing 
the appropriate antibody mixture. Incubate 20 minutes on ice. Protect cells from 
light until analysis of the samples at the flow cytometer. 
7. Wash cells by adding 1ml of 1X PBS+3%FCS and centrifuge at 1,000RPM for 10 
minutes at 4oC. 
8. Remove supernatant, then resuspend cells in 300µl 1X PBS+3%FCS supplemented 
with 1µg/ml of 7-actinomycin (7AAD) and transfer them in a FACS tube after 
filtering with a 50µm filcon. 
For samples used for sorting defined cell population, the whole sample from a 
Miwi2tdTomato/+ juvenile mouse was immunostained as described. All the cells were 
acquired or sorted using a five-laser BD FACSAria™ II Sorp cell sorter under the 
guidance of Dr. Daniel Bilbao in the EMBL Flow Cytometry Facility. Data were 
analysed off-line using FlowJo® Flow Cytometry analysis software (TreeStar, Inc.). 
 
2.12.4 List of antibodies used in this study 
The table below enlists the antibody (from eBioscience, if not stated) employed for flow 
cytometry studies: 
 
Antibody Alternative 
name 
Clone Fluorophore Isotype Catalog number Dilution 
CD4 L3T4 GK1.5 Purified 
Rat 
IgG2a, k 14-0041-85 1/100 
CD5 Ly-1 53-7.3 Purified 
Rat 
IgG2a, k 14-0051-85 1/100 
CD8a Ly-2 53-6.7 Purified 
Rat 
IgG2a, k 14-0081-85 1/100 
CD11b Mac-1 M1/70 Purified 
Rat 
IgG2a, k 14-0112-85 1/100 
CD45R B220 RA3-6B2 Purified 
Rat 
IgG2a, k 14-0452-85 1/100 
Ter-119 Ly-76 Ter-119 Purified 
Rat 
IgG2a, k 14-5921-85 1/100 
Gr-1 Ly-6g RB6-8C5 Purified Rat 14-5931-85 1/100 
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IgG2a, k 
Sca-1 Ly-6a/E D7 Purified 
Rat 
IgG2a, k 14-5981-85 1/400 
Il-7 Rca chain CD127 A7R34 Purified 
Rat 
IgG2a, k 14-1271-85 1/400 
B2-
microglobulin 
MHC-I 
(associated 
to) S19.8 Purified 
Mouse 
IgG2b, k 
555299 (BD 
Pharmigen) 1/50 
Sca-1 Ly-6a/E D7 PE-Cy7 
Rat 
IgG2a, k 25-5981-82 1/100 
Rat IgG2a, k 
Control 
Isotype  PE-Cy7 
Rat 
IgG2a, k 25-4321-81  
Streptavidin   PE-Cy7  25-4317-82 1/600 
CD45.1 SJL, Ly5.1 A20 Pe-Cy7 
Mouse 
IgG2a, k 25-0453 1/50 
CD117 c-kit 2B8 Pe-Cy7 
Rat 
IgG2b, κ 25-1171 1/800 
CD93 C1qRp AA4.1 Pe-Cy7 
Rat 
IgG2b, 
kappa 25-5892-82 1/200 
Flk-2/Flt-3 Ly-72 A2F10.1 PE 
Rat 
IgG2a, k 12-1351-83 1/50 
CD41 
fibrinogen 
receptor 
eBio 
MWreg30 PE 
Rat IgG1, 
κ 12-0411-83 1/300 
CD8a Ly-2 53-6.7 PE 
Rat 
IgG2a, k 
553032 (BD 
Pharmingen) 1/400 
Mac-1 CD11b M1/70 PE 
Rat 
IgG2b, k 12-0112-83 1/200 
IgM 
Antimouse 
µ chain  PE Goat 
115-116-075 
(Jackson) 1/200 
CD71 
Transferrin 
receptor R17217 PE 
Rat 
IgG2a, k 12-0711 1/100 
Rat IgG2a 
Control 
Isotype eBR2a PE 
Rat 
IgG2a 12-4321-81  
Rat IgG2a, k 
Control 
Isotype  PE 
Rat 
IgG2a, k *12-4724-81 
Mouse 
IgG2a, k 
Rat IgG1, κ 
Control 
Isotype P3 PE 
Rat IgG1, 
κ *12-4714-81 
Mouse 
IgG1, κ 
CD4 L3T4 RM4-5 FITC 
Rat 
IgG2a, k 
553047 (BD 
Pharmingen)  1/200 
IgD  11-26c FITC 
Rat 
IgG2a, k 11-5993-85 1/400 
CD43 
LY-48, 
Leukosialin S7 FITC 
Rat 
IgG2a, k 
553270 (BD 
Pharmigen) 1/100 
CD9  KMC8 FITC 
Rat 
IgG2a, k 11-0091 1/50 
CD34 mucosialin RAM34 FITC 
Rat 
IgG2a, k 11-0341-81 1/50 
CD49f 
integrin 
alfa-6 GoH3 FITC 
Rat 
IgG2a, k 11-0495-80 1/200 
EpCam CD326 G8.8 FITC 
Rat 
IgG2a, k 11-5791-82 1/100 
CD105 Endoglin MJ7/18 Bio 
Rat 
IgG2a, k 13-1051-85 1/100 
CD51  RMV-7 Bio Rat IgG1, 104104 (Biolegend) 1/50 
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k 
CD45 
Leukocyte 
common 
agent(LCA) 30-F11 Bio 
Rat 
IgG2b, k 13-0451 1/200 
c-Kit CD117 2B8 
APC-
Alexa750 
Rat 
IgG2b, k 27-1172-82 1/600 
Rat IgG2a, k 
Control 
Isotype  Bio 
Rat 
IgG2a, k 13-4321-81  
Rat IgG2b, k 
Control 
Isotype  
APC-
Alexa750 
Rat 
IgG2b, k 27-4031-81  
Gr-1 Ly-6G RB6-8C5 APC 
Rat 
IgG2b, k 17-5931-82 1/800 
Ter-119 Ly-76 TER-119 APC 
Rat 
IgG2b, k 17-5921 1/200 
CD3e  145-2C11 APC 
armenian 
hamster 
IgG 17-0031-83 1/200 
CD45R B220 RA3-6B2 APC 
Rat 
IgG2a, k 17-0452 1/400 
Rat IgG2b, k 
Control 
Isotype A95-1 APC 
Rat 
IgG2b, k 
556924 (BD 
Pharmingen)  
CD150 SLAMf1 
TC15-
12F12.2 APC 
 Rat 
IgG2a, λ  115910 1/100 
BP-1 Ly-51 6C3 
Alexa Fluor 
647 
Rat 
IgG2a, κ 108312 (Biolegend) 1/200 
CD90.2 Thy1 30-H12 
AlexaFluor 
647 
Rat 
IgG2b, k 105318 (Biolegend) 1/100 
CD45.2 
Ly-5.2, 
LCA  104 Pacific Blue 
 Mouse 
(SJL) 
IgG2a, κ  109820 (Biolegend) 1/100 
CD24 
Heat Stable 
Antigen 
(HSA) M1/69 Pacific Blue 
Rat 
IgG2b, k 101820 (Biolegend) 1/200 
CD29 
integrin 
beta1 
hmbeta1-
1 Pacific Blue 
armenian 
hamster 
IgG 102224 (Biolegend) 1/200 
Rat IgG2b K 
Control 
Isotype RTK4530 Pacific-blue 
Rat 
IgG2b, κ 400627 (Biolegend)  
Sca-1 Ly-6a/E D7 Pacific-blue 
Rat 
IgG2a, κ 108119 (Biolegend) 1/100 
CD45R B220 RA3-6B2 
APC-eFluor 
780 
Rat 
IgG2a, 
kappa 47-0452-82 1/200 
Isotype 
Control 
Rat IgG2a 
K  
APC-eFluor 
780 
Rat 
IgG2a, 
kappa 47-4321-82  
Streptavidin   605NC  93-4317 1/100 
GARTC 
Goat 
F(ab')2 
anti-Rat 
IgG 
(H+L)  Tri-Colour  R40106 1/200 
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2.12.5 Definition of hematopoietic cell populations during this study 
The different hematopoietic populations were defined as listed below: 
 
Full name Abbrevi
ation 
Marker profile References 
Long-term 
hematopoietic stem 
cells 
LT-HSC LinI- c-Kit+ Sca-1+ Flt3- CD150+ Kiel, 2005 
Lymphoid-primed 
multipotent 
progenitors 
LMPP LinI- c-Kit+ Sca-1+ Flt3+ CD150- Adolfsson, 
2005 
Pre-
Granulocyte/Monoc
yte precursor + 
Granulocyte/Monoc
yte precursor 
Pre-GM 
+ GMP 
LinII- c-Kit+ CD41- CD105- CD150- Pronk, 2007 
Pre-
Megakaryocyte/Ery
throid precursor 
PreMeg-
E 
LinII- c-Kit+ CD41- CD105- CD150+ Pronk, 2007 
Pre-Colony-
Forming-Unit 
Erythroid 
Pre-
CFU-E 
LinII- c-Kit+ CD41- CD105+ CD150+ Pronk, 2007 
Colony-Forming-
Unit Erythroid 
CFU-E LinII- c-Kit+ CD41- CD105+ CD150- Pronk, 2007 
Pre-pro-B 
progenitor 
Fr. A’ LinIII- CD45R+ CD43+ BP-1- CD24- 
CD93+ 
Li, 1996 
Early pro-B 
progenitor 
Fr. B LinIII- CD45R+ CD43+ BP-1- 
CD24+ 
Hardy, 1991 
Late pro-B 
progenitor 
Fr. C LinIII- CD45R+ CD43+ BP-1+ 
CD24lo 
Hardy, 1991 
Late pro-B Fr. C’ LinIII- CD45R+ CD43+ BP-1+ Hardy, 1991 
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progenitor CD24hi 
Pre-B progenitors Pre-B CD45R+ CD43- IgM- Mecklenbrauker
, 2002 
Immature B  CD45Rlo CD43- IgM+ Mecklenbrauker
, 2002 
Recirculating B  CD45Rhi CD43- IgM+ Mecklenbrauker
, 2002 
Double-positive T 
cells 
DP CD4+ CD8+  
CD4 T cells CD4 CD3+ CD4+ CD8a-  
CD8 T cells CD4 CD3+ CD4- CD8a+  
Proerythroblast I Ter119int CD71hi Socolovsky, 
2001 
Basophylic 
erythroblast 
II Ter119hi CD71hi Socolovsky, 
2001 
Polychromatophylic 
erythroblast 
III Ter119hi CD71int Socolovsky, 
2001 
Orthochromatophyli
c erythroblast 
IV Ter119hi CD71- Socolovsky, 
2001 
 
LinI: CD4, CD5, CD8a, CD11b, CD45R, Ter119, Gr-1. 
LinII: CD4, CD5, CD8a, CD11b, CD45R, Ter119, Gr-1, IL7Ra, Sca-1. 
LinIII: CD11b, Gr-1, Ter119. 
 
2.13 Generation and purification of a phospho-specific S388 Ago2 
antibody (in collaboration with Sabin Antony and Maria Placentino) 
 
CD-1 female animals were immunized with a peptide (KLMRSApSFNTDP) 
encompassing a phosphorylated serine 388 of the murine Ago2 protein. 500ml of 
supernatant from culture of antibody-producing hybridoma cells were purified using a 
10ml chromatography column (BioRad, Poly-prep Chromatography Column, 731-1550) 
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coated with protein G resin (GenScript, L00209). The protocol used for antibody 
purification is as follows: 
1. Wash column with 100 ml of Wash/Binding buffer (200mM Na2HPO4, 0.15M NaCl, 
pH 8.0). Let the buffer flow through the column by gravity in a cold room. 
2. Add 500ml of supernatant from hybridoma cells secreting a phospho-specific S388 
Ago2 antibody. Let the liquid to go through the column by gravity, and collect it in a 
clean T175 flask (Falcon, 353045). 
3. When all the supernatant has passed through the column, repeat step 2 twice. 
4. After 3 runs of supernatant flow-through, wash the column three times with 250ml 
of Wash/Binding buffer. Let the liquid to pass through the column by gravity. 
5. Add 8ml of 0.1M glycine pH 2.5 solution to the column to elute all the bound 
immunoglobulins. Collect the eluted solution in 8 fractions of 1ml each in 1.5ml 
tubes containing 65µl of 1M Tris-HCl pH 9.5 solution. 
6. Quantify protein concentration in the eluted fraction by the Bio-Rad Dc Protein 
Assay Kit (Bio-Rad, 500-0111) following manufacturer instructions. 
7. Combine fractions containing the highest protein content up to a final volume of 
3ml. Add the combined fractions (max 3ml) to the Slide-A-Lyzer Dialysis cassette 
3.500 MWCO (Thermo Scientific, #66330). Dialyze the antibody against 1X PBS + 
20% Glycerol (at least 2L) in the cold room overnight. 
8. Collect the purified antibody solution from the dialysis cassette. Add sodium azide 
to a final concentration of 0.02% to the solution as a preservant. 
9. Measure the protein concentration of the purified antibody solution with the Bio-Rad 
Dc Protein Assay Kit (Bio-Rad, 500-0111) following manufacturer instructions. 
The purified phospho-specific S388 Ago2 antibody was employed for immunoblot and 
immunofluorescence assays. 
 
2.14 Overexpression of wild type and S388A mouse Ago2 in cultured 
cells (in collaboration with Maria Placentino) 
 
To induce Ago2 overexpression, both HEK293T and HeLa cells have been transfected 
with a plasmids encoding either the wild type version of murine Ago2 (pcDNA3.1-Ago2-
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WT) or a mutated S388A Ago2 protein (pcDNA3.1-Ago2-S388A). These plasmids were 
generated in the lab using the pcDNA3.1 vector backbone (Invitrogen, V790-20). 
HEK293T and HeLa cells were maintained in standard culture medium in incubator at 
37oC with 7.5% CO2 pressure. 
Cells were transfected either with pcDNA3.1-Ago2-WT or with pcDNA3.1-Ago2-
S388A plasmids or left untranfected as negative control. Moreover, cotransfection with 
a plasmid encoding for the green fluorescent protein (pCMV-eGFP, Addgene plasmid 
11153) was employed to evaluate transfection efficiency. 2.5x106 and 4x105 cells were 
transfected with 1µg of pcDNA3.1-Ago2-WT/pcDNA3.1-Ago2-S388A alone or with 8µg 
of pcDNA3.1-Ago2-WT/pcDNA3.1-Ago2-S388A together with 0.8µg of pCMV-GFP for 
protein extracts or immunofluorescence, respectively. Transfection was performed using 
LipofectamineTM 2000 (Invitrogen, 11668019) according to manufacturer instructions. 
24 hours after transfection, cells were either left untreated or incubated with 250µM of 
sodium arsenite (AS) for 90 minutes at 37 ºC. Untreated and AS-treated cells were then 
harvested for protein lysis or fixed for immunofluorescence analysis. Transfected 
efficiency was around 80-85% of total cultured cells as assayed by scoring GFP-positive 
cells using a two-laser BD FACSCanto™ Flow Cytometer. 
 
2.15 Western Blot 
 
2.15.1 Production of a phosphorylated L2 linker domain in vitro (in collaboration 
with Dr. Philipp Selenko, FMP Berlin) 
A peptide encompassing the L2 linker domain of the mouse Ago2 protein was used to 
test the specificity of the anti-phosphoserine 388 antibody we developed. The peptide 
contains residue 354-422 of the murine Ago2 protein, with a Myc tag (EQKLISEEDL) 
at the C-terminal of the peptide. A mutant peptide was also made by converting S388 
into an alanine. Both wild type and S388A peptides were incubated overnight with 
1.26µg of purified MK2 kinase. The phosphorylation at serine 388 was monitored 
through NMR.  
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2.15.2 Protein extracts preparation from transfected HEK293T cells 
After transfection and AS treatment, cells have been harvested with 0,05% Trypsin 
(Invitrogen, 25300-054) and pelleted by centrifugation at 1000 rpm for 5 minutes. After 
centrifugation, cells were resuspended in 10 ml of PBS and counted with a CellometerTM 
Auto T4 (Nexcelom Bioscience). Cells were washed twice in PBS and transferred in a 
1.5 ml eppendorf tube. The cellular pellet was then resuspended in Protein Lysis Buffer 
(See Annex 1) at a concentration of 2x104 cells/µl. The lysis was achieved by incubation 
on ice for 20 minutes. The protein extracts were then cleared from cellular debris by two 
steps of centrifugation at 14,000 RPM for 20 minutes at 4oC. Samples were then stored 
at -20oC. Protein concentration was measured with the Bio-Rad Dc Protein Assay Kit 
(Bio-Rad, 500-0111) following manufacturer instructions. 
 
2.15.3 Resolution of proteins by SDS-PAGE 
Separating gel (7.5% acrylamide for protein extracts and 15% acrylamide for purified 
Ago2 L2 peptides) and stacking gel (4% acrylamide) were prepared using standard 
procedures. Before loading into the gel, 4X Laemmli buffer (See Annex 1) was added to 
each sample to a final concentration of 1X. Samples were boiled at 95 °C for 3 minutes 
and then cleared by centrifugation. 50µg of protein extracts and 5-50ng of purified L2 
peptides were loaded onto the gel. Samples and the protein ladder (BioRad 161-0317 
Broad range) were loaded and the gel was run at 80V until the samples have reached the 
separating gel. Then, the run was continued at 120V for 90 minutes. 
 
2.15.4 Blotting of proteins onto membranes 
For the immunoblotting, two different membranes have been used: PVDF membrane 
(Immobilion®-P, Millipore IPVH00010), for protein extracts from HEK293T cells; 
nitrocellulose (BA83 Protran membrane, Whatman, 10402452), for purified Ago2 L2 
peptides. After having assembled the blotting sandwich, the blot was run for 45 minutes 
at 2,5 mA/cm2 (140 mA for one membrane) using a TE 70 ECL Semi-dry Transfer Unit 
(Amersham Biosciences). After the transfer, the membrane was stained in Ponceau S 
solution (Sigma Aldrich, P7170) for 3 minutes to assess the transfer quality.  
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2.15.5 Blocking and antibody staining 
The membrane was blocked in 5% milk in TBS-T (137 mM NaCl; 2,7 mM KCl; 20 mM 
TrisHCl pH 7.5; 0,1% Tween20, Sigma Aldrich P9416) for 1 hour at room temperature. 
Then, it was incubated with primary antibody either at 4 °C overnight or at room 
temperature 1 hour, shaking. 
The primary antibodies used for Western blot are: 
• In-house purified mouse α-phosphorylated Ago2 S388 1:200;  
• In-house purified mouse α-Ago2 MA2 1:5,000;  
• Commercial mouse α-Tubulin 1:20,000 (Sigma Aldrich, T9026);  
• Commercial mouse α-Myc 1:1,000 (Abcam, ab39688).  
The phospho-specific antibody was incubated in 5% BSA (Bovine Serum Albumine, 
Sigma Aldrich, A2153) in TBS-T, whereas the other primary antibodies were incubated 
in 5% milk in TBS-T. Immunoblot with purified phospho-specific S388 Ago2 and anti-
Myc antibodies was performed overnight at 4oC in gentle rocking. Total anti-Ago2 and 
anti-Tubulin antibodies were incubated for 2 hours at room temperature in gentle 
rocking. 
Membrane was washed 3x5 minutes in TBS-T and incubated with a anti-mouse 
secondary HRP-conjugated antibody (GE Healthcare, NA931). Secondary antibodies are 
used at 1:10,000 or 1:20,000 dilutions in TBS-T for 1 hour at room temperature in gentle 
rocking. Then, membrane was washed 3x5 minutes in TBS-T and 2 ml of 1:1 ECL 
reagent A and B (GE Healthcare, RPN2106) mixture was added and incubated for 2 
minutes at room temperature. After the incubation, the excess of ECL solution was 
removed from the membrane and placed into a plastic pocket. The immunoblot was 
developed using ChemiDocTM XRS+ (BioRad, 170-8265). 
 
2.15.6 Stripping of membrane for immunoblot 
To probe the same membrane with two different antibodies from the same host, the 
membrane was washed harshly to remove the binding of antibodies used in precedent 
immunobloting. The membrane was first incubated in 50ml of stripping solution (See 
Annex 1) at 50oC for 30 minutes in gentle shaking and further washed 2x10 minutes 
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with TBS-T. The membrane can be used again for blocking and primary antibody 
incubation. 
 
2.16 Immunofluorescence staining of human cells and mouse tissues 
 
2.16.1 Staining of transfected HeLa cells 
Hela cells were transfected with plasmids to overexpress either wild type or S388A 
murine Ago2 protein. After treatment with arsenite, the culture medium was aspirated 
and cells were washed twice with PBS. Cells were fixed in 4% paraformaldehyde (PFA) 
in PBS for 10 minutes at room temperature; then, PFA was removed and cells were 
washed twice with TBS. Coverslips were stored at 4 °C in TBS + 0.02% NaN3 (Sigma, 
S2002) until the moment of staining. 
The immunostaining was performed on a humidified chamber to avoid the cells to dry. 
Coverslips were washed once with TBS and cells were permeabilized with Triton 
Extraction Buffer (See Annex 1) for 10 minutes at room temperature. Cells were washed 
twice with TBS and then blocked with TBG (0,2% (v/v) cold water fish gelatine (Sigma 
G7765); 0,5% (w/v) Bovine Serum Albumine (BSA, Sigma A2153) in TBS 1X) for 1 
hour at room temperature. 
The primary antibody was put in TBG and incubated for 1 hour at room temperature. 
The primary antibodies used are:  
• In-house purified mouse α-phosphorylated Ago2 S388 1:200;  
• In-house purified rabbit α-Ago2 MA2 1:1,000. 
Coverslips were washed 3x5 minutes with TBG and the secondary antibody was put in 
TBG for 1 hour at room temperature protected from light. Secondary antibodies used at 
1:1,000 dilution were:  
• Alexa Fluor® 488 Goat α-Mouse (Molecular Probes, A11001); 
• Alexa Fluor® 546 Goat α-Rabbit (Molecular Probes, A11010).  
Coverslips were washed 2x5 minutes with TBG and the nuclei were stained with 2µg/ml 
DAPI (4',6-diamidino-2-phenylindole, Sigma, D1306) in TBG for 5 minutes. Coverslips 
were then washed twice with TBS and mounted on slide using ProLong® Gold Antifade 
Reagent mounting medium (Invitrogen P36930). Coverslips were placed on a 
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microscopy slide and sealed with nail polish and stored at 4 °C in the dark. Images were 
acquired with Confocal microscope Leica TCS SP5. 
 
2.16.2 Staining of embryonic day E3.5 mouse blastocyst (in collaboration with 
Maria Placentino) 
Wild type C57Bl/6N and 129S2 females were mated with male mice from the same 
genetic background. Males were segregated from females at the appearance of a vaginal 
plug, which is considered as embryonic day E0.5. Three days later, pregnant females 
were sacrificed by cervical dislocation and the uterus was carefully isolated and cleaned 
under a stereomicroscope. Blastocysts were flushed out from the uterus using 1ml of M2 
medium and 1ml syringe with a 26 ½ G needle (BD Plastipack, 300015) in a 6mm 
plastic dish (Falcon, 353001). Blastocysts were collected in M2 medium drop, and then 
the zona pellucida was digested with Tyrode's Acidic solution (Sigma, T1788) for 10 
seconds. Embryos were then fixed in 4%PFA in 1X PBS for 15 minutes at room 
temperature, and rinsed with PBS/PVP solution (1X PBS supplemented with 3mg/ml of 
polyvinyl pyrrolidone, Calbiochem, 529504). Embryos can be stored at 4oC before the 
immunostaining. 
For the staining, collected embryos were first permeabilized with 0.25% Triton-X 
(Sigma, T8787) in PBS/PVP solution for 30 minutes at room temperature. Blastocysts 
were then transferred in blocking solution (0.2% Donkey serum (Sigma, D9663), 0.1% 
BSA, 0.01% Tween20) for 15 minutes at room temperature. Samples were then 
incubated with primary antibodies diluted in blocking solution and incubated overnight 
at 4oC. The antibody and dilution employed are as follow: 
• In-house purified mouse α-phosphorylated Ago2 S388 1:200;  
• In-house purified mouse α-Ago2 MA2 1:1000; 
• Commercial rabbit α-Nanog 1:200 (Bethyl, A300-397A). 
Embryos were washed 3x15 minutes in blocking solution, and subsequently incubated 
with Alexa Fluor® 546 Donkey α-Rabbit (Molecular Probes, A10040) and Alexa 
Fluor® 488 Donkey α-Mouse (Molecular Probes, A21202) secondary antibodies, 
diluted 1:500 in blocking solution for 1 hour at room temperature. The samples were 
then rinsed 3x15 minutes in blocking solution. For mounting, embryos were passed 
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through a series of 25%, 50%, 75% and 100% Vectashield mounting medium with 
DAPI (Vector Laboratories, H-1500). Blastocysts were then passed on a microscope 
slide (Thermo Scientific, J1800AMNZ) on top of a small drop of Vectashield mounting 
medium surrounded by blobs of paraffin to avoid the crushing of the embryos. A 13mm 
coverslip (VWR, 631-0149) was placed on top and sealed with nail polish and stored at 
4°C in the dark. Images were acquired with Confocal microscope Leica TCS SP5.  
 
2.16.3 Staining of testis section from embryonic day E16.5 male mouse (In 
collaboration with Dr. Claudia Carrieri) 
Wild type and Miwi2tdTomato/+ testes were isolated from male embryos at embryonic day 
E16.5. Samples were then fixed in 4%PFA in 1X PBS at 4oC for 2 hours. Testes were 
then washed 2x5 minutes in 1X PBS at room temperature. Samples were subsequently 
transfer in a 10% sucrose solution in 1X PBS for 2 hours at 4oC; this step was further 
repeated in a 20% sucrose solution in 1X PBS and in mixture (1:1 ratio) of 20% sucrose 
in 1X PBS and OCT embedding medium (Tissue-Tek, 4583). Samples were finally 
embedded in OCT embedding medium in an embedding mould by incubation on dry ice 
for 20 minutes. Embedded tissues were stored at -80oC. 
7µm-thick transversal cryosection of embryonic testis were cut from the embedded 
samples, put on a microscopy slide and dry at room temperature for 1 hour. Samples 
were then washed 2x10 minute with 1X PBS, and sections were permeabilized with 
0.1% Triton-X in 1X PBS for 30 minutes at room temperature. Samples were incubated 
with blocking solution (5% Donkey serum (Sigma, D9663), 1% BSA, 0.1% Triton-X in 
1X PBS) for 1 hour at room temperature. Sections were then stained overnight at 4oC in 
1X PBS+1%BSA solution containing 1:100 mouse monoclonal anti-Miwi2 antibody 
(produced in house, in collaboration with Sabin Antony) and 1:200 rabbit polyclonal 
anti-RFP antibody (Rockland, 600-401-379). Sections were washed 3x10 minutes with 
0.1% Triton-X in 1X PBS at room temperature. Secondary antibodies (Alexa Fluor® 
546 Donkey α-Rabbit and Alexa Fluor® 488 Donkey α-Mouse) were diluted 1:1,000 in 
1X PBS supplemented with 1%BSA and 0.1% Triton-X. Samples were incubated with 
secondary antibodies at room temperature for 1 hour. Sections were washed 3x10 
minutes with 0.1% Triton-X in 1X PBS at room temperature and stained with 1µg/ml 
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DAPI in 1X PBS for 15 minutes. Coverslips were then washed twice with TBS and 
mounted on slide using ProLong® Gold Antifade Reagent mounting medium 
(Invitrogen P36930). Coverslips’ sides were sealed with nail polish and stored at 4 °C in 
the dark. Images were acquired with Confocal microscope Leica TCS SP5. 
 
2.17 Quantitative real-time PCR 
 
2.17.1 RNA isolation from sorted testis cells 
RNA isolation of FACS-sorted CD45- CD51- tdTom+ c-Kit- Thy-1lo, CD45- CD51- 
tdTom+ c-Kit+ Thy-1lo, CD45- CD51- tdTom+ c-Kit+ Thy-1+ and CD45- CD51- tdTom- c-
Kit+ Thy-1- from juvenile Miwi2tdTomato/+ male testis is described below: 
1. Cells were collected in 1X PBS+3%FCS during sorting procedure. Cells were then 
pelleted by centrifugation at 1,000RPM for 10 minutes at 4oC. 
2. Lyse sorted cells in 500µl Qiazol reagent (Qiagen, 79306) in 1.5ml DNA low-
binding tube (Eppendorf, 22431021). Samples were stored at -80oC at least for 24 
hours before RNA isolation. 
3. Thaw samples for 15 minutes at room temperature prior to the addition 100µl of 
chlorophorm (Merck, K33534645). 
4. Shake tubes vigorously for 15 seconds and incubate 3 minutes at room temperature. 
5. Centrifuge at 12,000g for 15 minutes at 4oC (Eppendorf, Centrifuge 5417R). 
6. Remove the aqueous phase of the solution (the lower phase containing phenol has 
red colour) and transfer it in a new 1.5ml DNA low-binding tube. Usually 320µl of 
aqueous solution were retrieved for each sample. 
7. Add 320µl of isopropanol (Sigma, 33539) and 5µg of RNase-free glycogen 
(Invitrogen, AM9510). Invert tubes several times and incubate for 10 minutes at 
room temperature. 
8. Centrifuge at 12,000g for 10 minutes at 4oC. 
9. Remove carefully supernatant without disturbing the pellet at the bottom of the tube. 
Wash with 1ml of 75% ethanol. 
10. Centrifuge at 7,400g for 5 minutes at 4oC. 
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11. Remove all the supernatant by using both a p1000 and a p200 pipettes. Let the pellet 
dry for 5 minutes at room temperature. 
12. Resuspend pellet in 15µl of Nuclease-free water (Invitrogen, AM9930). Store at -
80oC. 
RNA concentration was determined with the Qubit RNA assay kit (Invitrogen, Q32855) 
using a Qubit® Fluorometer (Invitrogen) following manufacturer instructions. 
 
2.17.2 Reverse transcription and real time PCR from isolated RNA 
50ng of total RNA from FACS-sorted cell populations were reverse transcribed with 
random hexamer primers using Superscript™ II Reverse Transcriptase (Invitrogen, 
18064-022) following manufacturer instructions. 
A quantitative real-time reaction was performed on a LightCycler 480 PCR instrument 
(Roche) using 2x SYBR green I master (Roche, 04707516001). All the expression data 
was normalized to the expression levels of GAPDH (Glyceraldehyde 3-phosphate 
dehydrogenase) reference gene using the 2-ΔΔCt method (Livak, 2001). 
 
PCR reaction program: 
 
Step Temperature (oC) Time (s) Cycles 
Denaturation 95 300 1X 
Denaturation 95 10 
45X Annealing 60 15 
Elongation 72 10 
Denaturation 95 5 1X 
Annealing 65 60 1X 
Denaturation 95 N/A Continuous 
Cooling 40 10 1X 
 
Gene-specific primer sets: 
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RefSeq Primers Sequence 
Probe 
length 
NM_001122733.1 
c-Kit_FW 5’-tcatcgagtgtgatgggaaa-3’ 
221bp 
c-Kit_RV 5’-ggtgacttgtttcaggcaca-3’ 
NM_009050.2 
c-RET_RW 5’-gcttcagtacacggtggtagc-3’ 
134bp 
c-RET_RV 5’-gcctcttgtttactgcacagg-3’ 
NM_019448.3 
Dnmt3L_FW 5’-gcgggtactgagcctttttag-3’ 
118bp 
Dnmt3L_RV 5’-gacatttgtgacatcttccacgt-3’ 
NM_010279.2 
Gfra1_FW 5’-caccatgttcctagccactct-3’ 
118bp 
Gfra1_RV 5’-tacttggtgctgcagctctgt-3’ 
NM_009864.2 
E-Cad_FW 5’-tgaagggacggtcaacaactg-3’ 
155bp 
E-Cad_RV 5’-gctctttgaccaccgttctcc-3’ 
NM_008532.2 
EpCAM_FW 5’-gagtccgaagaaccgacaag-3’ 
125bp 
EpCAM_RV 5’-agtctgcaagctctgatggtc-3’ 
NM_031166.2 
ID4_FW 5’-actcaccgcgctcaacact-3’ 
171bp 
ID4_RV 5’-ccggtggcttgtttctctta-3’ 
NM_145833.1 
Lin28_FW 5’-agaccaaccatttggagtgc-3’ 
109bp 
Lin28_RV 5’-aatcgaaacccgtgagacac-3’ 
NM_194064.2 
Nanos2_FW 5’-aacttctgcaagcacaatgg 
192bp 
Nanos2_RV 5’-caggtacctcacagggtctca-3’ 
NM_194059.2 
Nanos3_FW 5’-acaaggcaaagacacaggatg-3’ 
216bp 
Nanos3_RV 5’-cctaagcaaggtccagtctcc-3’ 
NM_009719.6 
Ngn3_FW 5’-gctgcttgacactgaccctat-3’ 
150bp 
Ngn3_RV 5’-cgggaaaaggttgttgtgtct-3’ 
NM_177905.3 
Miwi2_FW 5’-cgaccccgatgttcagtt-3’ 
250bp 
Miwi2_RV 5’-atcaatacccacgaccatca-3’ 
NM_013633.3 
Oct4_FW 5’-ggcgttctctttggaaaggtgttc-3’ 
292bp 
Oct4_RV 5’-ctcgaaccacatccttctct-3’ 
NM_001033324.2 PLZF_FW 5’-cccagttctcaaaggaggatg-3’ 88bp 
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PLZF_RV 5’-ttcccacacagcagacagaag-3’ 
NM_008084.2 
GAPDH_FW 5’-gagcgagaccccactaacat-3’ 
154bp 
GAPDH_RV 5’-ttcacacccatcacaaacat-3’ 
 
2.18 Data analysis 
 
General data analysis was performed using Microsoft Excel 2008 for Macintosh. Graph 
and statistical test analysis was performed with Graphpad Prism 5 software. All error 
bars represent standard deviation (s.d.) or standard deviation of the mean (s.e.m.) as 
indicated in the figure legend. Control and experimental samples were considered 
statistically different for p-value<0.05 using the Student’s unpaired t-test. 
 
Annex 1: Media and solutions 
 
HEK293T and HeLa S2 culture medium: Dulbecco Modified Eagle Medium (D-MEM,  
Invitrogen, 41965062); 
10% serum (Fetal Calf Serum, FCS, PAA, 
A15-104); 
1X Penicillin-Streptomycin (Invitrogen, 
15070-063). 
 
Standard ES cell medium: Knockout D-MEM (Invitrogen, 10829-018); 
12.5% Fetal Calf Serum (Hyclone, SH30071.03); 
1X Penicillin-Streptomycin (Invitrogen, 15070-063); 
2mM L-Glutamine (GIBCO, 25030); 
0.1mM 2-Mercapto-Ethanol (GIBCO, 31350-010); 
1X Non-essential amino acid (GIBCO, 11140-035); 
LIF (2µl of 1mg/ml solution per 100ml of media, PEPCF 
Facility Heidelberg). 
 
10X KT buffer: 670mM Tris-HCl pH 9.1 
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160mM (NH4)SO4 
35mM MgCl2 
1.5mg/ml BSA 
 
Tail Digestion Buffer: 50mM Tris-HCl pH 8; 
100mM EDTA (Sigma, 03609); 
100mM NaCl; 
1% SDS (Sigma, L4509); 
3mg/ml Proteinase K (Roche, 3115852001) to be added fresh. 
 
Southern Hybridization Buffer: 0.5M Na-Phosphate buffer pH 7.2; 
1mM EDTA (Sigma, 03609); 
3% BSA; 
5% SDS (Sigma, L4509). 
 
Southern Washing Buffer: 40mM Na-Phosphate buffer pH 7.2; 
1mM EDTA; 
5% SDS. 
 
Embryo lysis buffer: 100mM Tris-HCl pH 8; 
0.5% NP-40 (Sigma, 13021); 
0.5% Tween-20 (Sigma, P9416); 
0.2 mg/ml Proteinase K (Roche, 3115852001). 
A stock solution of embryo lysis buffer without Proteinase K was filtered through a 
0.22µm filter and stored at 4oC. Proteinase K was added fresh before the lysis of 
samples. 
 
ACK lysis buffer: 0.15M NH4Cl; 
10mM KHCO3; 
0.1mM Na2EDTA. 
Adjust to pH 7.2 with HCl and pass through a 0.22µm filter. Store at room temperature. 
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BSS buffer 
20X BSS Stock I: D-(+)-Glucose (Sigma, G7021); 
KHPO4 (Sigma, P5655); 
Na2HPO4 (Sigma, S5136) 
0.5% Phenol Red in water. 
20X BSS Stock II: CaCl2 2H2O (Sigma, C7902); 
KCl (Sigma, P5405); 
NaCl (Sigma, S5886); 
MgCl2 6H2O (Sigma, M2393); 
MgSO4 (Sigma, M2643); 
in water. 
Prepare the solutions separately, filter sterile and store at 4oC. To produce BSS+2%FCS 
solution, dilute the 20X BSS Stock I and 20X BSS Stock II solutions with sterile water. 
Store at 4oC for up to 4 weeks. 
 
Goni-MEM medium: DMEM (Invitrogen, 41965062); 
1X Na-Pyruvate (GIBCO, 11360-039); 
1X Non-essential amino acid (GIBCO, 11140-035); 
1X Penicillin-Streptomycin (Invitrogen, 15070-063); 
Sodium DL-Lactate (16.8µl per 100ml of medium) (Sigma, 
L4263) 
 
M2 medium: 15µl 1M HEPES (Invitrogen, 15630-056); 
10µl 100X Penicillin-Streptomycin (Invitrogen, 15070-063); 
up to 1ml with Brinster Med BMOC-3 (Invitrogen, 11126-034). 
 
Protein lysis buffer: 150 mM NaCl;  
2 mM MgAc;  
5% Glycerol (Sigma Aldrich, 15523);  
20 mM Tris HCl pH 7.5;  
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0.5% NP40 (Sigma Aldrich, I8896);  
0.2% Triton-X100 (Sigma Aldrich, T8787);  
1X Proteinase Inhibitors (complete Mini EDTA-free, Roche, 
05892791001); 
2X Phosphatase Inhibitors (PhosSTOP, Roche, 04906837001);  
2mM DTT (DL-Dithiothreitol, Sigma Aldrich, 43815); 
in water. 
A stock solution containing the salt and detergent in water was first made, filtered by a 
0.22µm filter (Millipore, SCGPT05RE) and stored at 4oC. Proteinase and 
phosphophatase inhibitors were added fresh to the lysis buffer together with DTT. 
 
4X Laemmli Buffer: 183mM TrisHCl pH 6.8;  
36% Glycerol (Riedel-De Haen 56-81-5);  
3.6% SDS;  
1% BBF (free acid fisher biotech BP115-25);  
4.2% β-mercaptoethanol (Sigma M3148); 
in water. 
 
Western Stripping solution: 62.5mM Tris-HCl pH 6.7; 
100mM 2-Mercapto-Ethanol (Sigma, M3148); 
2% SDS (Sigma, L4509); 
in water. 
 
Triton Extraction Buffer: 0,2% Triton X-100 (Sigma Aldrich, T8787); 
20 mM Hepes pH 7.9;  
50 mM NaCl;  
3 mM MgCl2;  
300 mM sucrose (Sigma Aldrich, S9378); 
in water. 
Filter the solution with a 0.22µm and store at 4oC. 
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Chapter 3: Phosphorylation of Ago2 serine 388 is necessary 
for embryonic development depending on the genetic 
background 
 
3.1 Results 	  
3.1.1 Generation of a non-phosphorylatable Ago2 allele in vivo 
 
The miRNA and siRNA pathways have been proved to shape several developmental and 
physiological processes in both animal and plants (reviewed in Carthew, 2009). In 
mammals, the central role of Argonaute 2 (Ago2) protein in both miRNA- and siRNA-
mediated gene silencing renders it an amenable target for the regulation of these 
pathways. Indeed, numerous post-translational modification of Ago2 has been described 
so far in cell lines, such as phosphorylation at serine 387 of the human protein (Table 1) 
(Zeng, 2008; Horman, 2013). Phosphorylation of serine 387 is triggered by the stress-
response p38-MAPK pathway, and the downstream MAPKAPK2 (MK2) kinase is 
responsible for Ago2 phosphorylation in vitro. The phosphorylation event has an impact 
in Ago2 localization during standard cell culture conditions, which in turns may affect 
miRNA- and siRNA- activity (Zeng, 2008; Horman, 2013). I sought to determine the 
physiological relevance of Ago2 phosphorylation at serine 387 by creating a non-
phosphorylatable Ago2 allele in the mouse.  
The serine 387 of the human Ago2 is well conserved through the animal kingdom to the 
Amphibian class, corresponding to serine 388 of the mouse protein. Furthermore, the 
MK2 consensus sequence is also conserved throughout evolution (Fig. 5A). The S388 
residue resides in the L2 linker between PAZ and MID domains, that are important for 
the miRNA and mRNA binding activity of Ago2. To study the role of S388 
phosphorylation event, we undertook a loss-of-function approach by converting serine 
388 into an alanine in exon 10 of the endogenous Ago2 locus (Fig. 5B). A 129P2 mouse 
embryonic stem cell line (IB10) (Robanus-Maandag, 1998) was electroporated with a 
targeting vector containing neomycin resistant cassette (neo) between exon 8 and 9 
flanked by two LoxP sites (Fig. 5B). I screened for clones that have successfully 
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recombined to the endogenous Ago2 locus by first selecting cells with G418 and then by 
Southern blotting using a 3’ external probe (Fig. 5C). I further confirmed the conversion 
of serine 388 into an alanine by sequencing of the endogenous Ago2 locus (Fig. 5D). 
Ago2Neo-S388A/+ ESC clones were then used for blastocyst injection for the formation of 
chimeric founder mice. In order to have a transcriptional-competent Ago2S388A knock-in 
allele, I mated the founder mice with a mouse line bearing the Cre-recombinase 
maintained in a pure C57Bl/6N genetic background (Fig. 6) (Schwenk, 1995). The 
Ago2S388A/+; TgDelCre animals were then backcrossed one generation with C57Bl/6N mice 
to obtain experimental Ago2S388A/+ animals in a 129P2xC57Bl/6N mixed genetic 
background. Heterozygous mice have been used for a first set of experiments in this 
genetic background, while two co-isogenic lines were established by backcrossing 
animals with C57Bl/6N and 129S2 inbred strains (Fig. 6). 
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Figure 5. Targeting strategy and validation of the Ago2Neo-S388A allele. 
(A) Sequence alignment of a portion of the human Ago2 protein with its orthologs from 
several species of the animal kingdom. In grey it is highlighted the residue S387 of the 
human Ago2, which corresponds to S388 of the mouse ortholog. The MK2-consensus 
sequence is highlighted in green. (B) Schematic representation of the Ago2 locus and 
targeting strategy for the creation of a nonphosphorylatable Ago2S388A allele. Squared 
boxes indicate the position of Neomycin (neo) and Diphtheria Toxin A (pDTA) selection 
marker genes. Green triangles mark the position of LoxP sites for the Cre-mediated 
excision of the neo cassette to retrieve a transcriptionally competent Ago2S388A allele. 
BamHI sites and the 3’ probe used for Southern blot screen of mESC clones after 
electroporation are indicated. The size of the fragments for the wild type, Ago2Neo-S388A 
and Ago2S388A alleles are shown. (C) Representative Southern blot image from tail-
derived DNA confirms the effective targeting of the Ago2 locus and the Cre-mediated 
recombination of the neo cassette. (D) Sequencing of tail-derived genomic DNA from 
wild type and Ago2S388A/S388A animals validates the conversion of serine 388 into an 
alanine by two nucleotide mutations. 
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Figure 6. Breeding strategy of the Ago2S388A/+ animals employed during this study. 
After the electroporation of 129P2 mouse embryonic stem cells (IB10), positive clones 
were used to create chimeric animals. Ago2Neo-S388A/+ chimeras were crossed to a mouse 
129 ESCs Ago2Neo-S388A/+
x
C57Bl/6N TgDelCRE
Ago2S388A/+; TgDelCRE C57Bl/6N
Ago2S388A/+
xN1
129xBl6N
N2
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Ago2S388A/+
N8
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Ago2S388A/+
129S2
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line bearing the Deleter-Cre transgene in a C57Bl/6N genetic background (Schwenk, 
1995) for the formation of a transcriptionally active Ago2S388A/+ allele in vivo. A second 
cross with wild type C57Bl/6N animals allowed the separation of the Cre-transgene 
from the Ago2 mutant allele. As such, Ago2S388A/+ heterozygotes in a 129P2xC57Bl/6N 
genetic background were employed for a first set of experiments. In parallel, two co-
isogenic mouse lines were obtained by mating Ago2S388A/+ animals with C57Bl/6N and 
129S2 mice for at least 8 generations. 
 
3.1.2 Homozygous phosphomutant mice are lethal in a mixed genetic 
background 
 
Compelling evidence demonstrated the importance of a functional miRNA pathway 
during embryonic development. Indeed, DGCR8- and Dicer-deficient embryos show 
significant growth defects as early as embryonic day E6.5 (Bernstein, 2003; Wang, 
2006; Suh, 2010). On the other hand, loss of Ago2 causes different phenotypic outcomes 
depending on the localization of the insertion cassette used for gene inactivation, even 
though Ago2-/- embryos do not survive after E10.5 (Liu, 2004; Alisch, 2007; Morita, 
2007). To pinpoint a putative role of serine 388 phosphorylation during embryonic 
development, heterozygous Ago2S388A/+ mutants in a mixed 129P2xC57Bl/6N genetic 
background were intercrossed. The genotype of pups at weaning revealed that only 
5.37% of newborn were Ago2S388A/S388A, much lower than the expected 25% Mendelian 
ratio (Figure 7A). The surviving homozygotes developed normally until adulthood, 
without any gross morphological defect. This is suggestive of the presence of at least 
one point during embryogenesis when Ago2 S388 phosphorylation is essential for the 
survival of the embryo, and phospho-deficient animals that are capable of going through 
this step could develop normally. The ability to overcome this developmental time point 
can be stochastic, depending on the physiological conditions each embryo experiences 
during early stages of development. On the other hand, one or more predetermined 
genetic variants present in the mouse genome could influence the response to a lack of 
Ago2 phosphorylation. Indeed, the use of a mixed 129P2xC57Bl/6N genetic background 
could support this hypothesis: animals carrying the 129 variant of one or more allele(s) 
might be more susceptible to die due to the lack of S388 phosphorylation, while the 
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C57Bl6N variants of the same alleles might render the animal resistant to the lack of this 
modification. Such phenomenon has been ascribed to determine the outcome of loss-of-
function mutation during normal and disease development (reviewed in Gerlai, 1996; 
Wolfer, 2002) For example, EGFR-/- animals die at different time point during 
embryonic development depending on the genetic background (Sibilia, 1995; Threadgill, 
1995; Strunk, 2004). TGFβ1-deficient animals die prenatally in a C57Bl/6J/Ola 
background, while they survive up to birth in a NIH/Ola genetic background (Shull, 
1992; Kulkarni, 1993; Dickson, 1995; Bonyadi, 1997; Kallapur, 1999). To test the 
possibility of a background-dependent lethality upon Ago2 S388A mutation, I mated 
heterozygous Ago2S388A/+ animals for at least 8 generations with wild type 129S2 and 
C57Bl/6N mice respectively to create two congenic mouse lines (Fig. 6). In parallel, I 
sought to use the individuals in a 129P2xC57Bl/6N mixed genetic background to 
identify at which embryonic stage Ago2 S388 phosphorylation might be essential. At 
mid-gestation, no morphologically normal homozygous mutant embryos were isolated 
(Fig. 7B). Indeed, while wild type and Ago2S388A/+ heterozygous embryos were present 
at the expected Mendelian ratio, the percentage of resorption with characteristic blood 
infiltration was similar to the number of expected homozygous mutant (Fig. 7B). At 
E9.5, embryos isolated from reabsorbing deciduas were much smaller compared to 
normal embryos (Fig. 7C). Analysis of embryos at E6.5-E7.5 revealed a reduced number 
of morphologically normal Ago2S388A/S388A embryos compared to wild type, with a 
percentage similar to the one of pups present at weaning (Fig. 7A-B). Almost one fourth 
of the total embryos were morphologically abnormal, with no clear distinction between 
the embryonic and the extraembryonic part, and most of these embryos were genotyped 
as Ago2S388A/S388A (Fig. 7C). These data indicate that Ago2 phosphorylation at serine 388 
is important for embryonic development likely at the peri-implantation stage. 
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Figure 7. Ago2S388A/S388A homozygous mutants are lethal in a mixed genetic 
background. 
(A) Ago2S388A/+ heterozygous animals in a 129P2xC57Bl/6N mixed genetic background 
were intercrossed and the resulting litters were genotyped at weaning. The numbers of 
pups born and the expected numbers for each genotype are represented in the table. A 
significant lethality is shown for the Ago2S388A/S388A mutants (X2<0.0001, chi-square 
test). (B) The table shows the number of embryos isolated at embryonic day E6.5-E12.5 
A
 Matings Wild type Ago2S388A/+  Ago2S388A/S388A  Total 
At 
weaning 18 112 (33.43%) 205 (61.20%) 18 (5.37%) 335 
 Expected 84 167 84  
 Wild type Ago2S388A/+  Ago2S388A/S388A  Abnormal  Total 
E12.5 8 (15.69%) 27 (52.94%) 0 16 (31.37%) 51 
E9.5 10 (22.72%) 21 (47.73%) 0 13 (29.55%) 44 
E7.5 16 (25.40%) 27 (42.86%) 5 (7.93%) 15 (23.81%) 63 
E6.5 14 (27.45%) 15 (29.41%) 3 (5.88%) 19 (37.25%) 51 
B
C
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from Ago2S388A/+ intercrosses for each genotype. Representative images of 
morphologically normal and abnormal deciduas isolated at E9.5 (C) and E6.5 (D) are 
shown. 
 
3.1.3 Ago2 S388 phosphorylation is dispensable for hematopoiesis 
 
The activity of Ago2 during adulthood has been shown to be important for several 
processes, such as hematopoiesis, oogenesis and skin development (O’Carroll, 2007; 
Kaneda, 2009; Schaefer, 2011; Wang, 2012). In particular, a conditional allele of Ago2 
in combination with an inducible Mx-Cre mouse line was employed to show that lack of 
this protein impacts on erythroid and B cell development in a cell-autonomous fashion 
(O’Carroll, 2007). Lethally irradiated mice transplanted with bone marrow from 
Ago2FL/FL; Mx-Cre upon Cre induction developed a severe anaemia and splenomegaly in 
the periphery, due to defects of erythroblast differentiation at the orthochromatophilic 
stage. In addition, B-cell development was impaired in the bone marrow of the 
transplanted animals, with impaired pro-B-to-pre-B stage of differentiation (O’Carroll, 
2007). Since in a mixed genetic background the Ago2S388A/S388A mutant animals are 
almost completely lethal, we employed a similar strategy to investigate the function of 
S388 phosphorylation during adult hematopoiesis. Heterozygous Ago2S388A/+ animals 
were bred with Ago2FL/FL; Mx-Cre mice to obtain experimental Ago2S388A/FL; Mx-Cre 
and control Ago2+/FL; Mx-Cre animals. Adult mice were injected with poly I:C to induce 
the Cre-mediated conversion of the Ago2FL into a null allele and the hematopoietic 
system was analysed after 4 weeks from the last injection (Fig. 8A). Analysis of DNA 
extracted from bone marrow of injected mice verified the conversion of the Ago2FL into 
the non-functional Ago2- allele (Fig. 8B). I did not detect any signs of anaemia nor 
splenomegaly between control and experimental Ago2S388A/FL; Mx-Cre mice (Fig. 8C). A 
detailed analysis of erythroid development in the bone marrow and spleen highlighted 
the absence of any developmental defects both in the percentages and cell numbers of 
erythroblast populations (Fig. 8D). No significant differences for B cell progenitors were 
present in Ago2S388A/FL; Mx-Cre mice compared to control littermates in the bone 
marrow. These data suggest that Ago2 phosphorylation of serine 388 is dispensable for 
Ago2-dependent processes in adult hematopoiesis. 
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Figure 8. No defects in adult hematopoietic development in Ago2S388A/FL; Mx-Cre 
mice upon Cre-induction. 
(A) Outline of experimental procedure. Control Ago2+/FL; Mx-Cre and experimental 
Ago2S388A/FL; Mx-Cre animals in a mixed 129P2xC57Bl/6N genetic background were 
injected with poly I:C to activate the Cre-mediated recombination of the Ago2FL alleles 
in hematopoietic tissues. Four weeks after poly I:C administration the animals were 
sacrificed for the analysis of hematopoietic lineages. (B) The efficiency of 
recombination after Cre induction was verified from bone marrow-derived DNA by 
PCR reaction. (C) Mean ±s.d. of peripheral blood values from Ago2+/FL; Mx-Cre and 
Ago2S388A/FL; Mx-Cre animals are shown in the table. Graph shows the mean ±s.d. of 
spleen to body weight ratio between control and experimental animals (n=4). RBC= red 
blood cell count; Hb= hemoglobin; HCT= haematocrit; MCV= mean cell volume; 
MCH= mean cell hemoglobin; MCHC= mean corpuscular hemoglobin concentration; 
RDW= red blood cell distribution width. (D) Representative flow cytometry analysis of 
erythroid progenitor cells from spleen of control Ago2+/FL; Mx-Cre and experimental 
Ago2S388A/FL; Mx-Cre mice. The graph represents the mean ±s.e.m. of cell numbers of  
erythroid populations as estimated from flow cytometry percentages (n=4). Roman 
numerals indicate the identity of cells of the developmentally defined subpopulations 
(Socolovsky, 2001). I) Pro-erythroblasts, II) Basophilic erythroblasts, III) Poly-
chromatophilic erythroblasts and IV) Orthochromatophilic erythroblasts. (E) 
Representative flow cytometry analysis of B cell progenitors from bone marrow of 
control Ago2+/FL; Mx-Cre and experimental Ago2S388A/FL; Mx-Cre mice. Numbers 
represent percentages of the gated cells. Bars represent mean values of cell numbers 
estimated from flow cytometry data, error bars indicate standard deviation of the mean 
(n=4). Progenitor B (pro-B, CD45R+ CD43+ IgM-), precursor B (pre-B, CD45R+ CD43- 
IgM-), immature B (CD45R+ CD43- IgM+) and recirculating B cells (CD45Rhi CD43- 
IgM+) were gated as previously described (Mecklenbrauker, 2002). The data shown are 
representative of three independent experiments. 
 
The induction of the Mx-Cre through poly I:C injections mediates the deletion of the 
Ago2FL allele not only in the hematopoietic system, but also in other tissues such as liver 
(Kuhn, 1995). In addition, these injections elicit an interferon response that can alter the 
homeostasis of hematopoietic development, skewing progenitors cells to differentiate 
into myeloid cells. As a result, subtle differences between control Ago2+/FL; Mx-Cre and 
experimental Ago2S388A/FL; Mx-Cre mice can be underestimated or even compensated in 
a non-cell-autonomous fashion. To confirm the data collected, I decided to transplant 
bone marrow cells from previously characterized mice into lethally irradiated recipients. 
This approach allows to identify any defects in hematopoiesis due to lack of Ago2 S388 
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phosphorylation in hematopoietic cells that are developing in a wild type environment. 
In addition, I take advantage of the presence of two distinct CD45 alleles (Ly5.1-Ly5.2) 
(Miller, 1985; Shen, 1985; Spangrude, 1988) that can be distinguished by antibody 
staining to evaluate the contribution of transplanted bone marrow to the hematopoietic 
lineages analysed (Fig. 9A). DNA collected from bone marrow of recipients confirmed 
the efficiency of recombination (Fig. 9B). In addition, Western Blot analysis of Ago2 
levels from bone marrow of transplanted animals showed no differences in protein 
levels, demonstrating that Ago2-S388A protein is stable (Fig. 9C). Discrimination 
between donor-derived and recipient-derived cells from the hematopoietic tissues 
analysed confirmed that more than 95% of cells originated from the transplanted bone 
marrow, highlighting no differences in homing capacity and engraftment between wild 
type and phosphomutant cells (Fig. 9D). Peripheral blood values and flow cytometry 
demonstrated the absence of anaemic phenotype in mice transplanted with Ago2S388A/-; 
Mx-Cre cells (Fig. 9E). Furthermore, no defects in B cell progenitors nor in more mature 
B cell populations in the periphery were present (Fig. 10A-B). Analysis of T cells and 
myeloid lineages in transplanted mice showed the lack of any alteration in recipients 
transplanted with control or experimental bone marrow (Fig, 10C-D). Collectively, these 
data prove that Ago2 S388A phosphorylation is dispensable for adult hematopoietic 
development in a mixed 129P2xC57Bl/6N genetic background. 
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Figure 9. Ago2 S388 phosphorylation is not necessary for erythroid development in 
a cell-autonomous fashion. 
(A) Outline of experimental setup. Control Ago2+/FL; Mx-Cre; Ly5.2 and experimental 
Ago2S388A/FL; Mx-Cre; Ly5.2 animals were injected with poly I:C to activate the Cre-
mediated recombination of the Ago2FL allele in hematopoietic tissues. Five weeks after 
drug administration, bone marrow cells were isolated and 2 million cells were used to 
transplant lethally irradiated Ly5.1 recipients. Hematopoietic development was analysed 
16 weeks after reconstitution. (B) Southern blot analysis of control and experimental 
animals from bone marrow-derived DNA confirmed the efficiency of Cre-mediated 
conversion of the Ago2FL allele into a non-functional Ago2- allele. (C) S388A mutation 
of Ago2 has no impact on the stability of the protein. Ago2 protein levels were 
evaluated in extracts from bone marrow of reconstituted recipients with an anti-Ago2 
antibody by Western Blot. Actin was used as loading control. (D) Representative flow 
cytometry analysis of thymic cells from animals reconstituted with Ago2+/FL; Mx-Cre; 
Ly5.2 and experimental Ago2S388A/FL; Mx-Cre; Ly5.2 bone marrow cells. Number 
represents the percentages of endogenous Ly5.1+ and donor-derived Ly5.2+ cells. Data 
are indicative of a complete reconstitution of the peripheral hematopoietic organs by 
transplanted cells. (E) Mean ±s.d. of peripheral blood values from Ago2+/FL; Mx-Cre; 
Ly5.2 and Ago2S388A/FL; Mx-Cre; Ly5.2 transplanted animals are shown in the table. 
Graph shows the mean ±s.d. of spleen to body weight ratio between control and 
experimental animals (n=5). RBC= red blood cell count; Hb= hemoglobin; HCT= 
haematocrit; MCV= mean cell volume; MCH= mean cell hemoglobin; MCHC= mean 
corpuscular hemoglobin concentration; RDW= red blood cell distribution width. (F) 
Representative flow cytometry analysis of erythroid progenitor cells from spleen of 
control Ago2+/FL; Mx-Cre; Ly5.2 and experimental Ago2S388A/FL; Mx-Cre; Ly5.2 
reconstituted animals. The graph represents the mean ±s.e.m. of cell numbers of 
erythroid populations as estimated from flow cytometry percentages (n=5). Roman 
numerals indicate the identity of cells of the developmentally defined subpopulations 
(Socolovsky, 2001). I) Pro-erythroblasts, II) Basophilic erythroblasts, III) Poly-
chromatophilic erythroblasts and IV) Orthochromatophilic erythroblasts. The data 
shown are representative of two independent experiments. 
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Figure 10. Ago2 S388 phosphorylation is not necessary for lymphoid and myeloid 
development in a cell-autonomous fashion. 
Analysis of lymphoid and myeloid development from transplanted mice as in Fig. 9A. 
For the flow cytometry analysis, only Ly5.2+ cells were gated for further analysis. (A-B) 
Representative flow cytometry analysis of B cell progenitors and mature B cells from 
bone marrow (A) and spleen (B) of transplanted animals. Numbers represent 
percentages of the gated cells. Bars represent mean values of cell numbers estimated 
from flow cytometry data, error bars indicate standard deviation of the mean (n=5). 
Progenitor B (pro-B, CD45R+ CD43+ IgM-), precursor B (pre-B, CD45R+ CD43- IgM-), 
immature B (CD45R+ CD43- IgM+) and recirculating B cells (CD45Rhi CD43- IgM+) 
were gated as previously described (Mecklenbrauker, 2002). (C) Representative flow 
cytometry image of the percentages of T cells from thymus of animals reconstituted with 
Ago2+/FL; Mx-Cre; Ly5.2 and Ago2S388A/FL; Mx-Cre; Ly5.2 bone marrow cells. Numbers 
in the FACS plot represent percentages. Graph shows mean ±s.e.m. of cell numbers 
estimated from flow cytometry data (n=5). DP= CD4+ CD8+ double-positive T cells. (D) 
Typical FACS analysis is shown for myeloid cells from bone marrow of transplanted 
animals. Numbers represent percentages of the gated cells. Bars represent mean values 
of cell numbers estimated from flow cytometry data, error bars indicate standard 
deviation of the mean (n=5). The data shown are representative of two independent 
experiments. 
 
3.1.4 Ago2 S388 phosphorylation is dispensable for female fertility 
 
Small non-coding RNA pathway has an important role during oogenesis: conditional 
deletion of Ago2 or Dicer in early stages of oocyte development induces a block on 
metaphase II of the meiotic process due to spindle defects (Murchison, 2007; Tang, 
2007; Kaneda, 2009). Interestingly, even though both mature miRNAs and endogenous 
siRNAs (endo-siRNAs) are present in this cell type, only endo-siRNAs seem to be 
active, since loss of DGCR8 and miRNA pathway do not affect oocyte maturation 
(Watanabe, 2006; Tang, 2008; Watanabe, 2008; Ma, 2010; Suh, 2010). These data 
insinuate a differential regulation of miRNA- and siRNA-mediated silencing in 
oogenesis at the level of Ago2, the only Argonaute family member with the capability to 
slice target mRNAs (Liu, 2004; Meister, 2004; Song, 2004). I hypothesized that 
phosphorylation of serine 388 might control a switch between miRNA-based and 
siRNA-based Ago2 silencing activity. To pursue this hypothesis, I made use of a 
conditional loss-of-function approach by combining the Ago2FL allele with a female-
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specific Zp3-Cre mouse line (De Vries, 2000; Murchison, 2007; Tang, 2007; Kaneda, 
2009). Control Ago2+/FL; Zp3-Cre and experimental Ago2Neo-S388A/FL; Zp3-Cre females 
were mated with wild type males of known fertility and the number of pups per 
pregnancy was evaluated (Fig. 11A). No differences in litter size were evident between 
control and experimental mice (7.88±1.36 and 7.50±2.65 pups per litter for Ago2Neo-
S388A/FL; Zp3-Cre and Ago2+/FL; Zp3-Cre animals, respectively) (Fig. 11B). Genotype of 
pups confirmed the high efficiency of recombination in all tested animals (Fig. 11C). I 
can conclude that Ago2 phosphorylation of serine 388 is not essential for female fertility 
and oogenesis. Furthermore, lack of Ago2 S388 modification does not affect the RNA 
interference pathway, which is active during oocyte development. 
 
 
Figure 11. Ago2 S388 phosphorylation is dispensable for oogenesis. 
(A) Outline of experimental design. Ago2+/FL; Zp3-Cre and Ago2Neo-S388A/FL; Zp3-Cre 
females were mated with wild type C57Bl/6N males of known fertility. Male mice were 
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removed from the cage after the appearance of a vaginal plug. The size of each litter was 
evaluated after weaning. (B) No significant decrease in the fertility of Ago2Neo-S388A/FL; 
Zp3-Cre females was seen compared to control animals. Graph shows the mean of litter 
size at weaning from Ago2+/FL; Zp3-Cre and Ago2Neo-S388A/FL; Zp3-Cre females. The 
number of animals used for each genotype is indicated in the graph. (C) Genotype of 
pups at weaning confirmed the high efficiency of recombination in both control and 
experimental animals. 
 
3.1.5 Ago2 S388 phosphorylation is not necessary for Ago2-dependent 
processes in the C57Bl/6N genetic background 
 
The use of this novel Ago2S388A phospho-incompetent allele has shown that this 
phosphorylation event is necessary for early stages of mouse embryonic development, 
while it is dispensable for further adult processes. The previous data were collected in a 
129P2xC57Bl/6N mixed genetic background, raising the possibility of the presence of 
one or more modifier alleles that affect the phenotypic outcome of Ago2 mutation. To 
address this problem, I mated heterozygous Ago2S388A/+ mice for 8 generations with 
C57Bl/6N animals, to reach theoretically 99.6% of the genome from this inbred strain 
(Fig. 6) (Markel, 1997). Heterozygous individuals were then intercrossed and the pups 
were genotyped at weaning. Surprisingly, homozygous mutant mice were born 
accordingly to the expected Mendelian ratios in a C57Bl/6N genetic background (Fig. 
12A). This result strongly supports the hypothesis of a background effect, suggesting 
that one or more allelic variants present in the C57Bl/6N inbred strain are capable of 
complementing the lack of S388 phosphorylation of Ago2. 
The survival of Ago2S388A/S388A animals prompted me to further test these animals in the 
respect of Ago2-dependent processes, such as oocyte and hematopoietic development. 
Homozygous male and female are fertile, since no appreciable differences between wild 
type and homozygous animals were seen in litter size (Fig. 12B). Analysis of peripheral 
blood values and spleen weight show no signs of anaemia in homozygous 
phosphomutant compared to wild type controls (Fig. 13A-B). Further flow cytometry 
analysis of several hematopoietic lineages confirms the absence of any relevant defect in 
Ago2S388A/S388A compared to wild type animals (Fig. 13C-F). 
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Figure 12. Ago2S388A/S388A animals are viable and fertile in a C57Bl/6N genetic 
background. 
(A) Ago2S388A/+ animals were intercrossed after 8 generation of mating with inbred 
C57Bl/6N animals. The numbers and percentages of pups at weaning and the expected 
Mendelian numbers of animals per genotype are shown. The data indicate the absence of 
lethality for Ago2S388A/S388A homozygous mice in this genetic background. (B-C) Male 
and female Ago2S388A/S388A animals were mated with wild type C57Bl/6N mice of known 
fertility. Males were separated from the female after the appearance of vaginal plug. The 
graphs represent the mean size of a litter for wild type and Ago2S388A/S388A littermates at 
weaning. No statistically significant differences were evident between control and 
experimental mice. The number of animals used for each genotype is indicated in the 
graph. 
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Figure 13. No defects in adult hematopoietic development in Ago2S388A/S388A animals 
in a C57Bl/6N genetic background. 
(A) Mean ±s.d. of peripheral blood values from wild type and Ago2S388A/S388A littermates 
are shown in the table (n=5). No signs of anaemia are present in phosphomutant 
homozygotes. RBC= red blood cell count; Hb= hemoglobin; HCT= haematocrit; MCV= 
mean cell volume; MCH= mean cell hemoglobin; MCHC= mean corpuscular 
hemoglobin concentration; RDW= red blood cell distribution width. (B) Graph shows 
the mean ±s.d. of spleen to body weight ratio between control and experimental animals 
(n=5). No significant differences are visible between wild type and Ago2S388A/S388A 
mutants. (C) Representative flow cytometry analysis of erythroid progenitor cells from 
spleen of wild type and experimental Ago2S388A/S388A littermates. The graph represents 
the mean ±s.e.m. of cell numbers of erythroid populations as estimated from flow 
cytometry percentages (n=5). Roman numerals indicate the identity of cells of the 
developmentally defined subpopulations (Socolovsky, 2001). I) Pro-erythroblasts, II) 
Basophilic erythroblasts, III) Poly-chromatophilic erythroblasts and IV) 
Orthochromatophilic erythroblasts. (D) Representative flow cytometry analysis of B cell 
progenitors from bone marrow of wild type and phosphomutant mice. Numbers 
represent percentages of the gated cells. Bars represent mean values of cell numbers 
estimated from flow cytometry data, error bars indicate standard deviation of the mean 
(n=5). Progenitor B (pro-B, CD45R+ CD43+ IgM-), precursor B (pre-B, CD45R+ CD43- 
IgM-), immature B (CD45R+ CD43- IgM+) and recirculating B cells (CD45Rhi CD43- 
IgM+) were gated as previously described (Mecklenbrauker, 2002). (E) Representative 
flow cytometry image of the percentages of T cells from thymus of wild type and 
Ago2S388A/S388A mice. Numbers in the FACS plot represent percentages. Graph shows 
mean ±s.e.m. of cell numbers estimated from flow cytometry data (n=5). DP= CD4+ 
CD8+ double-positive T cells. (F) Typical FACS analysis is shown for myeloid cells 
from bone marrow of wild type and phosphomutant animals. Numbers represent 
percentages of the gated cells. Bars represent mean values of cell numbers estimated 
from flow cytometry data, error bars indicate standard deviation of the mean (n=5). The 
data shown are representative of two independent experiments. 
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Since Ago2 S388 phosphorylation is catalysed by the MK2 protein kinase, I decided to 
deepen the analysis on hematopoietic progenitor populations. Indeed, in a C57Bl/6N 
genetic background mice lacking MK2 present a reduction of long-term hematopoietic 
stem cells (LT-HSCs) with a concomitant increase of multiple progenitor cells (MPPs) 
(Schwermann, 2009). In homozygous Ago2S388A/S388A animals no recognizable difference 
was present in percentages and cell numbers of LT-HSC (Lin- c-Kit+ Sca-1+ CD150+ 
Flk3-) and lymphoid-primed multipotent progenitor cells (LMPPs) (Lin- c-Kit+ Sca-1+ 
CD150- Flk3+) compared to wild type littermates (Fig. 14A). Analysis of early B cells 
and megakaryocyte-erythroid precursors also shows no significant defects between 
control and experimental animals (Fig. 14B-C). I can conclude that Ago2 S388 
phosphorylation is dispensable for MK2-dependent regulation of HSC pool. In addition, 
collective data from C57Bl/6N animals suggest that S388 post-translational modification 
is not essential for Ago2 function in this genetic background. 
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Figure 14. No defects in HSC and early hematopoietic progenitors in Ago2S388A/S388A 
animals in a C57Bl/6N genetic background. 
(A) Representative flow cytometry plot of hematopoietic stem cell and early progenitor 
populations in wild type and Ago2S388A/S388A littermates. The panel shows Lin- c-Kit+ 
Sca-1+ cells stained for CD150 and Flk3. LT-HSC (Lin- c-Kit+ Sca-1+ CD150+ Flk3-) 
and LMPP (Lin- c-Kit+ Sca-1+ CD150- Flk3+) populations are defined as previously 
described (Kiel, 2005; Adolfsson, 2005). Numbers indicate percentages of the gated 
populations. Graph represents mean ±s.e.m. of total cell numbers inferred from the flow 
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cytometry data (n=3). (B) Representative FACS analysis is shown for the c-kit-positive 
erythroid progenitors in the bone marrow of wild type and Ago2S388A/S388A mice. The 
gates illustrate following developmentally defined subpopulations: Pre-colony forming 
unit erythroid precursor (Pre-CFU-E), colony forming unit erythroid (CFU-E), 
premegakaryocyte/erythroid precursor (Pre-MegE), granulo monocyte precursor (GMP) 
and pre-granulo monocyte precursor (Pre-GM) (Pronk, 2007). Bars indicate the mean of 
cell numbers evicted from flow cytometry percentages, error bars show the standard 
deviation of the mean (n=3). (C) Indicative FACS plot representing different 
subpopulations of early progenitor B cell populations is shown. The panel presents 
CD11b- Ter119- Gr-1- CD45R+ CD43+ cells stained with antibodies against BP-1 and 
CD24. Fraction A’ is composed of CD93+ cells from Fraction A. The different 
progenitor B cells were analysed according to published works (Hardy, 1991; Li, 1996). 
Graph shows mean ±s.e.m. of total cell numbers inferred from the flow cytometry data 
(n=3). The data shown are representative of two independent experiments. 
 
3.1.6 Ago2 S388 phosphorylation is dispensable for endotoxic stress 
response 
 
The data presented so far investigated the physiological importance of Ago2 S388 
phosphorylation event in resting conditions. It has been demonstrated that 
phosphorylation levels of S387 of the human Ago2 are enhanced after stress stimuli that 
activate the p38-MK2 pathways (Zeng, 2008; Horman, 2013). MK2-/- animals are viable 
and fertile, but they are resistant to lethal doses of lipopolysaccharide (LPS) due to a 
decrease in the production of TNF-α and other proinflammatory cytokines (Kotlyarov, 
1999). It is then conceivable that Ago2S388A/S388A mice also withstand high doses of LPS 
compared to wild type littermates. In order to test this hypothesis, I challenged wild type 
and homozygous mutant mice in a C57Bl/6N genetic background with lethal doses of 
LPS together with D-galactose (D-gal) and evaluate the kinetics of survival in both 
groups. D-gal was used as an adjuvant to increase the innate response since it is present 
on the surface of many bacterial species. Homozygous Ago2S388A/S388A mice die with 
similar percentages and kinetics as wild type littermates (Fig. 15A). To prove that this 
response it is not dependent upon the genetic background used, we transplanted lethally 
irradiated recipients with bone marrow from Ago2+/FL; Mx-Cre and Ago2S388A/FL; Mx-
Cre donors upon Cre induction. In addition, this experimental strategy allowed us to 
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evaluate the cell-autonomous effect of Ago2 S388 phosphorylation on macrophages and 
dendritic cells, which are the principal responders to LPS injections. LPS+D-gal were 
administered 12 weeks after reconstitution, and the survival rate of the two groups was 
monitored for 24 hours post-injection (Fig. 15B). As for the previous experiment, no 
differences in kinetics or percentage of survivors were evident between control and 
experimental animals (Fig. 15B). These data demonstrate that Ago2 S388 
phosphorylation is not participating in the MK2-dependent regulation of endotoxic 
response in vivo. 
 
	   120	    
Ago2S388A/S388A
or
LPS + D-gal i.p.
Analysis of survival
0 5 10 15 20 25
0
20
40
60
80
100
%
 o
f s
ur
vi
va
l
Hours after injection
Wild Type
Ago2S388A/S388A
Wild type
A
B
Ago2+/FL; Mx-Cre;
Ly5.2
Ago2S388A/FL; Mx-Cre;
Ly5.2
Ago2+/-; Mx-Cre;
Ly5.2
Ago2S388A/-; Mx-Cre;
Ly5.2
or
3x pI.pC i.p.
or
Bone marrow
2x106 cells
875 rad
Ly5.1
12 weeks
C57Bl/6N LPS + D-gal i.p.
Analysis of survival
0 10 20 30
0
20
40
60
80
100
%
 o
f s
ur
vi
va
l
Hours after injection
Ago2+/-; Mx-Cre
Ago2S388A/-; Mx-Cre
	   121	  
Figure 15. Ago2 phosphorylation at S388 is not necessary for MK2-dependent 
endotoxic response. 
(A) Adult wild type and Ago2S388A/S388A mutant littermates in a C57Bl/6N genetic 
background were injected with 30µg of LPS together with 800mg/Kg D-gal and 
monitored for 24 hours after injection. Kaplan-Meyer plot of survival after injection 
shows no significant differences neither in the kinetics of response nor in the survival 
ratio between wild type and homozygous phosphomutant mice (n=7). (B) Ago2+/FL; Mx-
Cre; Ly5.2 and Ago2S388A/FL; Mx-Cre; Ly5.2 animals were injected with poly I:C to 
activate the Cre-mediated recombination of the Ago2FL alleles in hematopoietic tissues. 
Five weeks after drug administration, bone marrow cells were isolated and 2 million 
cells were used to transplant lethally irradiated Ly5.1 recipients. After 12 weeks from 
bone marrow transplantation, a lethal dose of LPS+D-gal was administered 
intraperitoneally and the survival of mice was monitored for 24 hours. Kaplan-Meyer 
graph of survival percentages indicate the absence of any phenotypic difference due to 
the lack of Ago2 S388 phosphorylation (n=10). 
 
3.1.7 Ago2 S388 phosphorylation is necessary for embryonic 
development in the 129S2 genetic background 
 
The idea of a genetic background-dependent lethality of Ago2S388A/S388A homozygous 
mice is supported by the results of heterozygote intercrosses in a mixed 
129P2xC57Bl/6N and pure C57Bl/6N genetic background. To provide conclusive proof 
of this phenomenon, I mated heterozygote Ago2S388A/+ animals with wild type 129S2 for 
8 generations in order to create a second congenic 129S2 mouse line (Fig. 6). The 
number of Ago2S388A/S388A animals at weaning is much lower compared to the expected 
25% Mendelian ratio: only 5 animals of the 32 expected were born and survived until 
adulthood (Fig. 16A). In addition, intercrosses of Ago2S388A/+ mice in the 129S2 strain 
give similar ratios of homozygous mutants as shown for a 129P2xC57Bl/6N mixed 
genetic background (compare Fig. 7A and 16A). A subtle reduction of Ago2S388A/+ mice 
at weaning was also displayed in a 129S2 genetic background (Fig. 16A). These data 
strongly support the hypothesis of a strong genetic background effect on the phenotypic 
outcome of Ago2 S388 phosphorylation. I next sought to determine at which embryonic 
stage Ago2 homozygous mutant animals die. Analysis of deciduas at E7.5 shows a 
percentage of Ago2S388A/S388A embryos with no obvious morphological defects similar to 
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the percentage of these pups at weaning. Furthermore, empty deciduas with no 
embryonic structure visible were present with a percentage close to the expected one for 
mutant homozygotes (Fig. 16B). However, isolation and genotype of blastocysts at E3.5 
showed a Mendelian number of Ago2S388A/S388A embryos (Fig. 16B). No morphological 
differences were visible between wild type and mutant blastocysts at this stage of 
development (Fig. 16C). Furthermore, no differences in the Ago2 protein levels were 
seen by immunofluorescence staining between wild type and Ago2S388A/S388A blastocysts 
(Fig. 16C). Together, the data show that Ago2 S388 phosphorylation is necessary for 
embryonic development at peri-implantation in the 129S2 genetic background. 
Secondly, these results prove for the first time the presence of a strong genetic 
background effect for a post-translational modification site mutation.  
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Figure 16. Ago2S388A/S388A homozygous mutants are lethal in 129S2 genetic 
background. 
(A) Ago2S388A/+ animals were intercrossed after 8 generation of mating with inbred 
129S2 animals. The numbers and percentages of pups at weaning and the expected 
Mendelian numbers of animals per genotype are shown. The data indicate the presence 
of a strong selection against homozygous mutant mice in this co-isogenic line 
(X2<0.002, chi-square test). (B) The table shows the number of embryos isolated at 
embryonic day E3.5-E7.5 from Ago2S388A/+ intercrosses for each genotype. The number 
and percentage of abnormal deciduas isolated at E7.5 is also indicated. The discrepancy 
in the percentage of Ago2S388A/S388A mutants between E3.5 and E7.5 embryos suggests a 
peri-implantation lethality of these animals. (C) Immunofluorescence staining of 
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blastocysts isolated at E3.5 from Ago2S388A/+ intercrosses in a 129S2 genetic 
background. An anti-Ago2 antibody was used to detect the Ago2 protein in both wild 
type and phosphomutant homozygous embryos. Nuclei are stained with DAPI. Bar = 
20µm. Data presented in this figure were collected and elaborated in collaboration with 
Maria Placentino. 
 
3.1.8 Differential phenotype of Ago2 S388 mutation between C57Bl/6N 
and 129S2 genetic backgrounds depends on loci close to the Ago2 locus 
 
During the process of backcrossing into an inbred mouse strain (i.e. C57Bl/6N) that 
differs from the mESC parental strain (i.e. 129), the genome of the parental strain is 
gradually replaced by the genomic regions of the inbred strain chosen. However, the 
creation of a co-isogenic line is based on the principle that only the individuals 
heterozygous for the mutation of interest are then used for the next step of backcrossing. 
With this method the chromosomal region close to the mutation of interest is selectively 
retained from the parental strain of origin, and it gets smaller at each backcrossing step. 
In the case of the Ago2S388A mutant allele, the absence of embryonic lethality in the 
C57Bl/6N co-isogenic strain indicates the presence of one or more genetic variants that 
can complement the lack of Ago2 phosphorylation. To shed light on the location of 
these genetic components, Ago2S388A/+ heterozygotes in a C57Bl/6N background were 
first crossed for one generation with 129S2 animals, and the resulting reverse F1 (RF1) 
generation was intercrossed to evaluate the presence of homozygous mice at weaning 
(Fig. 17A). The presence of Ago2S388A/S388A animals at the expected Mendelian ratios 
would suggest a linkage between the point mutation and the modifier alleles, reflecting 
genomic vicinity. On the other hand, a negative selection against mutant homozygotes 
would indicate random segregation of the modifier alleles compared to the Ago2 locus. 
The data presented in Fig. 17B demonstrate that Ago2S388A/S388A homozygous mutants are 
born at the expected Mendelian ratios as wild types. The lack of lethality in a reverse F2 
(RF2) clearly points to the presence of modifier alleles in genetic linkage to the Ago2 
locus, suggesting proximity in the mouse genome. Indeed, in the RF1 intercrosses the 
recombination of 129S2 and C57Bl/6N genomes is not sufficient to separate the point 
mutation from the modifier alleles derived from the C57Bl/6N strain. Since the Ago2 
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locus resides in chromosome 15, it is conceivable to hypothesize the C57Bl/6N variants 
are located in the same chromosome. These data would help to identify the modifier 
alleles in the C57Bl/6N inbred strain responsible for Ago2S388A/S388A survival. 
 
 
 
Figure 17. Ago2S388A/S388A homozygous mutants are viable in a reverse F2 genetic 
background. 
(A) Outline of breeding strategy. Ago2S388A/+ heterozygotes bred for 8 generations with 
C57Bl/6N mice were crossed for 1 generation with wild type 129S2 animals. The 
resultant Ago2S388A/+ RF1 generation was further intercrossed to test the lethality of 
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homozygous mutants. The absence of a lethal phenotype for Ago2S388A/S388A pups may 
indicate the presence of a genetic linkage between the phospho-incompetent Ago2 locus 
and the modifier alleles. (B) The table shows the numbers and percentages of pups at 
weaning and the expected Mendelian numbers of animals per genotype from the RF1 
intercross. No selection against Ago2S388A/S388A animals was present in the RF2 
generation. 
 
3.1.9 Development of an Ago2 phospho-serine 388 specific antibody 
 
The discrepancy in phenotype between the C57Bl/6N and 129S2 co-isogenic lines I 
created could be ascribed to differential levels of Ago2 S388 phosphorylation in the two 
genetic backgrounds. I decided to develop a phospho-specific antibody that recognizes 
endogenous levels of Ago2 phosphorylation of Serine 388. Mice were immunized with a 
peptide encompassing a phosphorylated S388 and subsequently purified a monoclonal 
antibody (Fig. 18A). I verified the specificity of the antibody by Western blot with a 
phosphorylated and unphosphorylated S388 from Ago2 L2 linker domain (Fig. 18B). 
The phospho-specific antibody is able to recognize only the linker domain carrying a 
phosphorylated S388, but has no reactivity against the unphosphorylated and the S388A 
mutant peptide. Overexpression of murine wild type and S388A Ago2 proteins in 
HEK293T cells demonstrate that this antibody is able to recognize phosphorylated levels 
of Ago2 in resting and stress culture conditions by Western Blot and 
immunofluorescence (Fig. 18C-D). Importantly, Ago2 S388 phosphorylation levels are 
greatly increased after treatment with sodium arsenite as described previously (Zeng, 
2008). 
Since Ago2S388A/S388A mutant animals die at peri-implantation in a 129S2 genetic 
background, I isolated E3.5 blastocysts from wild type C57Bl/6N and 129S2 matings 
and performed an immunofluorescence analysis using both an anti-Ago2 and the anti-
pS388 antibody (Fig. 18E). No differences in Ago2 localization were visible between 
C57Bl/6N and 129S2 embryos (data not shown). In addition, the signal from the anti-
pS388 phospho-specific antibody is really weak and diffused, indicating the inability of 
this antibody to recognize phosphorylation levels under endogenous Ago2 expression 
(Fig. 18E). Indeed, the signal for phosphorylated Ago2 is really weak even upon 
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overexpression of the protein in HEK293T cells without stress (Fig. 18C). These data 
suggest that no differences in Ago2 activity between the two inbred strains are present at 
this embryonic stage due to similar cellular localization. The development of a more 
powerful phospho-specific antibody would allow us to verify if differential 
phosphorylation levels of serine 388 might explain the diverse phenotypic outcomes 
between the two co-isogenic lines. 
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Figure 18. No differences in phosphorylation levels of Ago2 S388 between 129S2 
and C57Bl/6N at blastocyst stage. 
(A) The sequence of the peptide encompassing residue 382-393 of murine Ago2 protein 
used for the development of the phospho-specific S388 antibody is shown. The 
phosphorylated serine 388 is highlighted in red. (B) Western blot using a synthetic myc-
tagged L2 linker domain containing a serine 388 (WT) or S388A mutation from murine 
Ago2 and probed with a phospho-specific S388 and an anti-myc antibodies. The WT 
and S388A linker domain was incubated overnight with MK2 to induce the 
phosphorylation of serine 388 where indicated. (C) Western blot analysis of protein 
lysates from HEK293T cells transfected with wild type or S388A mutant mouse Ago2, 
untreated or treated with 250µM sodium arsenite (As) for 90 minutes. The samples were 
assayed with S388 phospho-specific and an anti-Ago2 antibodies. Tubulin was used as 
loading control. (D) Immunofluorescence analysis of Ago2 localization in HeLa cells 
transfected with murine wild type and S388A mutant Ago2 protein treated with 250µM 
sodium arsenite for 90 minutes. A phospho-specific S388 (green) and an anti-Ago2 (red) 
antibodies were used. (E) Immunofluorescence staining of two blastocysts isolated at 
E3.5 derived from 129S2 wild type matings. An anti-pS388 phospho-specific antibody 
and an anti-Nanog antibody were used to detect the phosphorylated Ago2 protein in 
embryos. Nuclei are stained with DAPI. Bar = 20µm. The data presented in this figure 
were made in collaboration with Maria Placentino. 
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3.2 Discussion 
 
3.2.1 Ago2 S388 phosphorylation and hematopoietic development 
 
Hematopoietic development is a hierarchical system in which terminally differentiated 
cells, such as white blood cells and erythrocytes, derive from the mitotic division of a 
hematopoietic stem cell (Goldsby, 2003). Hematopoietic stem cells divide 
asymmetrically to give rise to a daughter cell, which retain the ability to self-renew, and 
a second daughter cell that is instead committed for differentiation. Several progenitors 
have been identified in the past, with a lineage potential that becomes restricted during 
the differentiation process (Goldsby, 2003). miRNAs have been discovered to play 
essential roles during hematopoietic development (Chen, 2004b; Li, 2007; Xiao, 2007; 
Johnnidis, 2008; Ventura, 2008; Xiao, 2008; Rasmussen, 2010;	  Sangokoya, 2010; Yu, 
2010). For example, genetic ablation of miR-223 triggers an increase in granulocytes 
number, which in turn lead to an aggressive inflammatory response after endotoxic 
stimuli (Johnnidis, 2008). In addition, miR-150 and miR-17-92 clusters have been 
implicated in B cell progenitor differentiation (Xiao, 2007; Ventura, 2008; Xiao, 2008). 
Furthermore, miR-181a expression is instrumental for B and T cell lineage decisions as 
well as well to modulate T cell response (Chen, 2004b; Li, 2007). Finally, miR-451 is 
necessary for the differentiation of erythroid progenitors (Rasmussen, 2010;	  Sangokoya, 
2010; Yu, 2010). 
Global reduction of miRNA pathway functionality through ablation of the biogenetic 
factor Dicer or the effector factor Ago2 augmented the number of hematopoietic 
processes that are under miRNA regulation. Since Dicer and Ago2 conventional 
knockout mice are lethal (Bernstein, 2003; Liu, 2004; Alisch, 2007; Morita, 2007), 
combination of conditional alleles with several hematopoietic-specific recombinase 
carriers were employed to characterize their role in different hematopoietic lineages 
(Cobb, 2005; Muljo, 2005; Cobb, 2006; O’Carroll, 2007; Koralov, 2008; Belver, 2010; 
Xu, 2011; Alemdehy, 2012; Buza-Vidas, 2012). Indeed, Dicer ablation during T cell 
development causes several defects, such as reduction of T cell progenitors, cytotoxic 
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and regulatory T cells, as well as biased CD4 T cell differentiation (Cobb, 2005; Muljo, 
2005; Cobb, 2006). In addition, B cells development is severely blocked at the pro-B-to-
pre-B transition stage when Dicer is ablated in B cell progenitors (Koralov, 2008). 
Furthermore, Dicer inactivation in early hematopoietic progenitors and granulocyte-
macrophage progenitors reduces erythroid and myeloid differentiation, respectively 
(Alemdehy, 2012; Buza-Vidas, 2012). 
Ago2 deletion in hematopoietic stem cells results in the impairment of erythroid and B-
cell development (O’Carroll, 2007). Bone marrow transplantations demonstrated that 
these defects are cell-autonomous and do not depend upon Ago2 inactivation in other 
tissues. In particular, a partial arrest of B cell development was seen at the pro-B-to-pre-
B transition, similarly to Dicer inactivation (O’Carroll, 2007; Koralov, 2008). 
Furthermore, animals transplanted with Ago2-/- cells present a severe anaemia with 
reduced red blood cell and haematocrit values in peripheral blood and splenomegaly. 
This is due to a defective erythroid differentiation: orthochromatophilic erythroblasts are 
reduced, while early basophilic erythroblasts are increased in numbers (O’Carroll, 
2007). The red blood cell defect is in part ascribed to the loss of miR-451, which 
biogenesis has been shown to depend on Ago2 endonuclease activity (Cheloufi, 2010; 
Cifuentes, 2010; Rasmussen, 2010; Yang, 2010). Given the possibility that 
phosphorylation at serine 388 regulates Ago2 endonuclease activity (Horman, 2013), I 
aimed to uncover the importance of this modification during hematopoiesis. 
Furthermore, analysis of protein phosphorylation by mass spectrometry from several 
mouse tissues discovered very low amount of Ago2 phosphorylation at serine 388 in 
spleen, suggesting a role in this primary lymphoid organ (Huttlin, 2010). A strategy 
using a conditional Ago2FL and a nonphosphorylatable Ago2S388A alleles in combination 
with an inducible MxCre recombinase allowed us to induce the expression of only a 
mutant Ago2 protein in hematopoietic cells (Fig. 8A-B). Analysis of peripheral blood 
parameters in mice after Cre induction failed to detect any signs of anaemia or 
splenomegaly (Fig. 8C). Analysis of erythroid and B cell development by flow 
cytometry did not reveal any impairment in progenitor differentiation in these two 
lineages (Fig. 8D-E). Similar results were achieved after bone marrow transplantation of 
Ago2S388A/-; MxCre cells in wild type recipients, demonstrating that S388 
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phosphorylation does not affect Ago2 function in a cell-autonomous manner (Fig. 9-10). 
Previous results are further reinforced by the absence of any hematopoietic defects in 
homozygous mutant mice in a defined C57Bl/6N genetic background (Fig. 13). As such, 
the data presented prove that lack of S388 phosphorylation has no impact on Ago2 
functionality in the hematopoietic system. This is suggestive that Ago2 phosphomutant 
protein is capable to execute miRNA-dependent silencing as well as contribute to miR-
451 maturation through its slicing activity. However, a recent report showed that Ago2 
phosphomutant protein presents a lower miRNA-dependent silencing activity compared 
to wild type (Horman, 2013). In addition, phosphomutant protein displays a reduced 
localization to P-bodies, sites where miRNA silencing is believed to take place 
(Anderson, 2006; Zeng, 2008; Horman, 2013). Differences between the data presented 
in here and in the mentioned works could be ascribed to the expression levels and on the 
particular cellular system used, since Ago2 variants were overexpressed in HeLa and 
H1299 cell lines (Zeng, 2008; Horman, 2013). In addition, the use of luciferase 
construct with binding sites for an endogenous miRNA showed no differences in the 
activity between wild type and Ago2 mutant (Horman, 2013). The analysis of the lack of 
Ago2 phosphorylation from the endogenous Ago2 locus during developmental processes 
possesses a much greater physiological meaning compared to the aforementioned 
studies. As such, it is likely that Ago2 phosphorylation does not affect miRNA activity 
per se in unperturbed conditions, as suggested by the data presented in this thesis. 
 
3.2.2 Ago2 S388 phosphorylation significance during oocyte maturation 
 
The meiotic process consists of two successive cell divisions with only one replication 
of the genome for the generation of haploid cells. In mammals, oocyte development 
starts prenatally, but it stops at the end of prophase I of the first meiotic division. After 
the pubertal period, hormones stimulate the entry of resting oocytes into the second 
meiotic division (Solter, 2004). Strikingly, transcription is blocked from early oocyte 
stages, referred to as growing oocytes, up to the mid-S phase in the 1-cell zygote (Solter, 
2004). As such, the entire meiotic process as well as the first mitotic division of the 
embryo relies on the mRNA transcripts stored in the female egg (Solter, 2004). MiRNA 
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silencing represents a likely candidate to regulate post-transcriptionally the genetic 
program in maturing oocytes. In fact, in zebrafish maternally derived miR-430 is 
necessary for clearance of maternal transcripts and proper embryonic formation 
(Giraldez, 2005; Giraldez, 2006). 
Expression studies in growing and fully mature oocytes demonstrated that various 
classes of miRNAs are highly expressed in murine female germ cells, and 1-cell zygotes 
inherited a miRNA pool from the egg cell (Watanabe, 2006; Murchison, 2007; Tang, 
2007; Tam, 2008; Watanabe, 2008). In addition, deep sequencing of small RNA 
libraries derived from fully grown oocytes blocked at prophase I of the meiotic division 
showed that other RNA classes are expressed in these cells (Watanabe, 2006; Tam, 
2008; Watanabe, 2008). Aside from a small fraction of piRNAs, endogenous siRNAs 
(endo-siRNAs) are derived from naturally occurring dsRNA molecules. Transcripts 
derived from pseudogenes can form complex secondary structures, which can be 
recognized and cut by Dicer (Watanabe, 2008). In addition, dsRNA can be formed by 
transcription of overlapping genes oriented in opposite direction, or by the annealing of 
coding genes transcripts with complementary regions in pseudogenes (Tam, 2008; 
Watanabe, 2008). However, the majority of endo-siRNAs are derived from 
retrotransposons, suggesting a role in the silencing of these genetic elements (Watanabe, 
2006; Tam, 2008; Watanabe, 2008). In fact, conditional deletion of Dicer in growing 
oocytes by the use of the specific Zp3-Cre transgene (de Vries, 2000) renders female 
animals sterile: oocyte development is blocked at the level of metaphase I due to spindle 
arrangement and chromosomal defects (Murchison, 2007; Tang, 2007). Furthermore, 
RNA levels of some transposable elements, like mouse transcript (MT) and short 
interspersed repetitive sequence (SINE), are increased upon Dicer ablation (Murchison, 
2007; Tang, 2008; Watanabe, 2008). Consistent with the notion that Ago2 is the only 
Ago-like protein with endonuclease activity in mammals (Liu, 2004; Meister, 2004; 
Song, 2004), loss of Ago2 in growing oocytes resulted in a similar phenotype of Dicer 
ablation (Kaneda, 2009). Indeed, female mice are infertile, and oocytes are blocked at 
metaphase II of the second meiotic division (Kaneda, 2009).  
Even though miRNA are abundantly expressed in mouse oocytes, search for short 
sequences on the 3’ UTR of upregulated genes on Dicer-deficient cells and Ago2-
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deficient cells did not reveal any significant miRNA seeds (Murchison, 2007; Tang, 
2007; Ma, 2010; Suh, 2010). Strikingly, a clear enrichment for endo-siRNA motifs on 
the 3’ UTR of upregulated transcripts was recognized, suggesting that these molecules 
are fundamental for oocyte maturation (Ma, 2010; Suh, 2010). To prove this hypothesis, 
luciferase reporter assays were employed to verify miRNA- and endo-siRNA-mediated 
silencing (Ma, 2010). A reporter containing one perfectly complementary site for an 
endogenous miRNA on its 3’ UTR was silenced all along oocyte maturation stages, with 
a comparable decrease of both mRNA and protein levels. A reporter with several bulged 
sites for endogenous miRNAs instead had almost complete abolition in silencing activity 
in mature oocytes compared to growing oocytes: this action is dependent mainly on 
translational inhibition (Ma, 2010). In addition, P-bodies, which are sites of mRNA 
degradation, are not present during oocyte maturation (Anderson, 2006; Flemr, 2010). 
Further supporting data were obtained from the analysis of Drosha conditional ablation 
in growing oocytes (Suh, 2010). Indeed, loss of the Microprocessor component DGCR8 
does not impact on egg maturation: DGCR8-/FL; Zp3-Cre females are fertile (Suh, 2010). 
In addition, no abnormal spindle assembly nor gene expression perturbation were 
detected upon DGCR8 deletion in mature oocytes, even though canonical miRNA levels 
were greatly reduced (Suh, 2010). Since the Microprocessor is involved in the 
biogenesis of the major part of miRNAs but not in siRNA production, the absence of 
any phenotype in DGCR8 conditional mice points to the fact that endo-siRNAs are 
important for oocyte development, while miRNA contribution is negligible. 
Since both mature miRNAs and endo-siRNAs are detectable in mature oocytes 
(Watanabe, 2006; Murchison, 2007; Tang, 2007; Tang, 2008; Watanabe, 2008), why are 
miRNAs not participating to gene expression regulation? Two possible answers could be 
proposed: the presence of other RNA binding proteins that mask the 3’ UTR to miRNA-
loaded RISC complex; differential regulation of miRNA and siRNA activity at level of 
RISC function. It has been shown that RNA binding proteins can relieve miRNA-
mediated silencing for a subset of miRNAs (Bhattacharyya, 2006; Kedde, 2007; Takeda, 
2009). However, this masking activity should prevent miRNA-binding at a global level. 
It is more plausible that a modification of one of the RISC components is accountable 
for the differential activity of miRNA and endo-siRNA pools. Ago2 meets this criterion: 
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it is the only Ago-like protein in mammals with a functional endonuclease activity and 
its loss impairs oocyte development (Liu, 2004; Meister, 2004; Song, 2004; Kaneda, 
2009). I then investigated if phosphorylation on serine 388 is necessary for the endo-
siRNA pathway during female oogenesis. I employed a conditional strategy in which, 
upon Zp3-Cre activation in growing oocyte, Ago2 activity derives exclusively from the 
phosphomutant allele (Fig. 11A). Experimental females presented a fertility and 
fecundity rate similar to control littermates (Fig. 11B). Except for 1 case out of 63 pups 
examined, recombination was successfully achieved in vivo (Fig. 11C). In addition, 
analysis of Ago2S388A/S388A homozygous females in a C57Bl/6N genetic background 
confirmed the absence of any issue with female fertility (Fig. 12B). As such, the data 
collectively prove that serine 388 phosphorylation is dispensable for oocyte 
development. Furthermore, the nonphosphorylatable Ago2 protein is shown to 
efficiently perform siRNA-mediated regulation of gene expression during oocyte 
development. As such, it is unlikely that modification of serine 388 represents a way to 
control Ago2 activity between miRNA and siRNA pathways in female egg maturation. 
Other modifications of the Ago2 protein or of the RISC complex can then be responsible 
for the differential regulation of miRNAs and siRNAs in this cellular system. 
 
3.2.3 Ago2 S388 phosphorylation in embryonic development: a 
background-dependent effect 
 
3.2.3.1 Lack of Ago2 phosphorylation at serine 388 causes embryonic defects at the 
peri-implantation stage 
 
Embryogenesis is a complex developmental process that consists in the formation of all 
tissues and structures starting from a fertilized egg, the zygote. In mammals this process 
takes place in the uterus of the mother. In mice, the entire gestation period is around ~19 
days. The zygote first divides symmetrically for 3 times to form an 8-cell embryo, which 
is then compacted, becoming morula at embryonic day E2.5. The blastocyst is formed at 
E3.5 through proliferation and reorganization of the blastomeres: the outer cells will 
form the trophoectoderm, a monolayer of cells located beside the zona pellucida; the 
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inner cells instead will give rise to the inner cell mass (ICM). A cavity, called 
blastocoele, is present at the centre of the blastocyst. The blastocyst implants onto the 
uterine wall around embryonic day E4.5: the zona pellucida, a membrane derived from 
the oocyte that physically protected the embryo during early stages, breaks down, 
allowing the attachment to the uterus. At E6.5, gastrulation process begins through the 
formation of the primitive streak from the posterior side of the embryo: this process will 
give rise to all three germ layers. At mid-gestation (E9.5) the whole body plan and body 
axes are defined. Organogenesis continues throughout the remaining gestation, and 
some tissues proceed their maturation even after birth (Nagy, 2003). 
During embryonic development, several differentiation and migration processes require 
a tightly regulated genetic program. MiRNAs have been recently appreciated to be part 
of such complex networks: germline loss of single miRNAs or miRNA clusters can lead 
to embryonic lethality (Zhao, 2007; Kuhnert, 2008; Liu, 2008; Ventura, 2008; Wang, 
2008; Medeiros, 2011). The physiological relevance of overall miRNA activity was 
further investigated by the deletion of specific miRNA biogenetic factors in mice 
(Bernstein, 2003; Harfe, 2005; Yang, 2005; Wang, 2007; Suh, 2010). Indeed, deletion of 
the Drosha cofactor DGCR8 causes malformations of homozygous mutants at 
embryonic day E6.5 (Wang, 2007; Suh, 2010). No defects in DGCR8-deficient embryos 
were detected at blastocyst level, suggesting a role for miRNAs at the peri-implantation 
stage (Suh, 2010). On the other hand, germline ablation of Dicer induces a more severe 
phenotypic outcome (Bernstein, 2003; Harfe, 2005). About half of Dicer-null embryos 
are lost before embryonic day E7.5; the surviving embryos are smaller and display a 
very low expression of Oct4 and Brachyury transcripts compared to wild type embryos 
(Bernstein, 2003). On the other hand, a hypomorphic Dicer allele was created by the 
insertion of a neomycin resistant cassette at the beginning of the gene, replacing exon 1 
and 2 (Yang, 2005). Transcripts are produced from exon 3 of the Dicer locus in this 
hypomorphic allele, producing a shorter protein, which is only partially functional. Mice 
homozygous for this Dicer allele die around embryonic day E12.5-E14.5 due to 
angiogenic defects in both the embryo and the yolk sac (Yang, 2005). 
Loss of RISC key components should present a similar phenotypic outcome of DGCR8 
and Dicer germline depletion in embryonic development. Ablation of Ago1, Ago3 and 
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Ago4 does not impair embryogenesis, since mice are viable (O’Carroll, 2007; 
Modzelewski, 2012; Van Stry, 2012). On the other hand, three independent studies have 
shown that Ago2 is essential for embryonic development (Liu, 2004; Alisch, 2007; 
Morita, 2007). The first Ago2 null allele was created by the introduction of a puromycin 
selection cassette and the duplication of exons 3 to 6 of the Ago2 gene (Liu, 2004). 
Homozygous mutant mice present an abnormal morphology at embryonic day E9.5, 
with heart swelling and several neural tube defects (Liu, 2004). In addition, Ago2-
deficient embryos are smaller compared to wild type littermates, suggesting the presence 
of placental deficiency (Liu, 2004). Subsequently, a second Ago2 knockout allele was 
created by the insertion of a gene trap cassette between exon 12 and 13 of the mouse 
locus: the presence of a splice acceptor site at the 5’ end and of a strong polyadenylation 
signal at the 3’ end of the inserted cassette impedes the production of the Ago2 protein 
(Alisch, 2007). This study revealed a more severe phenotype compared to the work of 
Liu et al. In fact, only a small fraction of Ago2-deficient embryos are present at E9.5, 
displaying similar neural and placental defects; the major part of these embryos instead 
dies after E7.5 (Alisch, 2007). At E7.5, homozygous embryos are smaller and present an 
expanded expression profile for Brachyury and other markers of the primitive streak. 
These data pointed to a second function of Ago2 in the control of mesodermal genes 
during gastrulation (Alisch, 2007). A third work from Morita et al. created a mutant 
Ago2 allele by insertion of a gene-trap cassette after exon 1 of the Ago2 gene (Morita, 
2007). At E7.5, Ago2 knockout embryos were smaller compared to wild type 
littermates: in situ hybridization data revealed no differences in the expression of Oct4, a 
marker of epiblast cells, but a reduction and mislocalization of the Brachyury expression 
(Morita, 2007). In addition, Ago2-deficient embryos presented an abnormal morphology 
already at embryonic day E5.5 (Morita, 2007). Taken together, the aforementioned 
studies demonstrated that Ago2 is essential for embryonic development, but there are 
some important differences that need to be noted. In fact, in the work of Liu et al. Ago2-
deficient embryos die later than in the following studies (Liu, 2004; Alisch, 2007; 
Morita, 2007). This could be ascribed to the fact that the Ago2 null allele created is 
instead a hypomorphic one. In fact, the entire Ago2 coding capacity still exists in the 
locus: no messenger RNA for Ago2 was detected from homozygous embryos and cell 
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lines by RT-PCR, but Ago2 protein levels were never assessed (Liu, 2004). On the other 
hand, there is a clear disagreement about Brachyury expression patterns upon Ago2 loss 
in embryos at E7.5 between the study from Alisch et al. and Morita et al. (Alisch, 2007; 
Morita, 2007). Even if the two Ago2 alleles were employed on two different genetic 
backgrounds, these opposing data might derive from the use of different antisense 
probes for the Brachyury transcript (Alisch, 2007; Morita, 2007). 
I sought to determine if phosphorylation at serine 388 is necessary for Ago2 function 
during embryonic development. Homozygous phosphomutant embryos are partially 
lethal in two different genetic backgrounds (Fig. 7 and Fig. 16). In a mixed 
129P2xC57Bl/6N6N genetic background, phospho-deficient homozygotes present an 
abnormal morphology at E6.5: they are smaller compared to wild type and heterozygous 
littermates, with a reduced extraembryonic part (Fig. 7C). Conversely, in a defined 
129S2 genetic background, no morphologically malformed embryos were isolated at 
E7.5, but a number of empty decidua close to the expected mendelian ratios for 
homozygous mutants was collected (Fig. 16B). Collection of blastocysts at E3.5 does 
not reveal any difference in the morphology nor in the localization of the Ago2 protein 
between wild type and phospho-deficient animals (Fig. 16C). As such, in both genetic 
backgrounds, Ago2 phosphorylation is necessary during peri-implantation. The 
phenotype described for Ago2 phosphomutant displays similarity with the arrest of 
development in DGCR8- and Dicer-null embryos (Bernstein, 2003; Harfe, 2005; Wang, 
2006; Suh, 2010). In addition, the phospho-deficient embryos isolated at E6.5 in a mixed 
genetic background show similar morphological features as Ago2-deficient embryos 
from Alisch et al. and Morita et al. (Alisch, 2007; Morita, 2007). It is important to note 
that in a defined 129S2 genetic background, lack of Ago2 phosphorylation triggers a 
more severe phenotype, since I found a significant percentage of empty decidua as early 
as E7.5. Alisch et al. backcrossed for 10 generation the Ago2-null allele into C57Bl/6 
mice, while Morita et al. used a mixed 129xC57Bl6 genetic background similar to the 
first set of experiments presented here (Alisch, 2007; Morita, 2007). As such, this study 
is readily comparable to the one from Morita et al.: Ago2-null and phospho-deficient 
embryos present similar morphological defects, suggesting that serine 388 
phosphorylation is critical for Ago2 function at the peri-implantation stage (Morita, 
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2007). However, lack of serine 388 phosphorylation does not simply phenocopy Ago2 
loss by inactivating the protein. In fact, the phosphomutant allele is able to sustain 
normal hematopoietic and oocyte development in a mixed 129P2xC57Bl/6N genetic 
background (Fig. 8-11). Furthermore, in a C57Bl/6N genetic background, 
phosphomutant homozygotes are viable, fertile and present no haematological pathology 
(Fig. 12-14). Finally, phosphomutant animals that survive to adulthood do not show any 
gross morphological abnormalities. It is conceivable that serine 388 phosphorylation is 
fundamental for Ago2 function at a specific time point during early embryonic 
development, but it is dispensable in later developmental stages. Fluctuation in 
environmental stimuli or in gene expression might help to overcome the requirement for 
serine 388 phosphorylation at this early embryonic stage. Conversely, one or more 
genetic determinants might be responsible for the different phenotypic outcome in 
129S2 and C57Bl/6N genetic backgrounds. 
 
3.2.3.2 Mutation of Ago2 serine 388 reveals the importance of genetic background 
on the phenotypic consequences of post-translational modification site mutations 
 
Functional studies on the gene function are accessible in mice thanks to the possibility to 
specifically target embryonic stem cells to ablate or modify almost any locus of interest. 
Nonetheless, mouse genetics first began with the selection of numerous diverse mouse 
strains accordingly to specific physiological characteristic. In particular, generation of 
inbred mouse strains contributed enormously to genetic studies in the mouse model. An 
inbred mouse strain is created by brother-sister mating for at least 20 generations: this 
allows to have approximately 98.6% of all loci in homozygosity. Different strains are 
indeed more amenable for particular studies: C57Bl/6 animals are used for studies on 
substance preferences, while BALB/c and C3H mice are employed for ethyl nitrosurea 
mutagenesis programs due to their sensitivity to this compound. In addition, 129 inbred 
strain is widely used for the production of targeted ESC clones since several ESC lines 
are available. However, recent works revealed an extensive variability in 129 substrains 
(Simpson, 1997; Threadgill, 1997). As a consequence, a revised nomenclature for 129 
substrains was defined: Parental (129P1-3), substrains were derived from the original 
	   140	  
129 colony; Steel (129S1-8) substrains originated from an outcross with the C3H strain 
and harbor a mutation in the c-Kit gene; Ter (129T1-2) substrains were created by a 
mating with a hybrid WCxC57Bl/6 line and are susceptible to teratoma formation due to 
a mutation in the Ter gene; genetically-contamined X strain (129X1) which harbors 
several unique polymorphic loci (Simpson, 1997; Festing, 1999). 
The genomic heterogeneity present in the 129 substrains from which ESC lines have 
been derived is not the only source of variability in the analysis of loss of function mice. 
In fact, inbred mouse strains do not only harbor in homozygosity allelic variants that 
make them suitable for specific physiological studies, but also other variants that can 
interfere with the phenotypic outcome of any targeted gene loss. This is a well-known 
effect and is referred to as genetic background effect (reviewed in Gerlai, 1996; Wolfer, 
2002). Several examples have been reported in the literature about the influence of 
modifier alleles on gene-specific loss of function analysis (Shull, 1992; Kulkarni, 1993; 
Veis, 1993; Dickson, 1995; Sibilia, 1995; Threadgill, 1995; Bonyadi, 1997; 
Casademunt, 1999; Kallapur, 1999; LeCouter, 1998a-b; Benzel, 2001; Bilovocky, 2003; 
Strunk, 2004; Lin, 2012). For example, germline deletion of epidermal growth factor 
receptor (EGFR) causes embryonic or postnatal lethality depending on the genetic 
background (Sibilia, 1995; Threadgill, 1995; Strunk. 2004). In fact, three distinguished 
phenotypes have been described for EGFR-null animals: peri-implantation lethality, due 
to ICM proliferation defects; growth arrest at E11.5-12.5 because of abnormalities in the 
placental spongiotrophoblast and labyrinthine layers; postnatal lethality before PND 20 
thanks to severe developmental defects in various organs (Sibilia, 1995; Threadgill, 
1995). A mixed genetic background of 129xCF-1 and 129xFVB/N inbred strains favour 
embryonic lethality at early implantation stages in EGFR-deficient embryos. On the 
other hand, congenic 129 mice and mixed 129xC57Bl/6 EGFR homozygous mutants die 
at mid-gestation, while crosses with outbred MF-1 or the inbred ALS/Ltj strains allow 
survival up to term (Sibilia, 1995; Threadgill, 1995; Strunk, 2004). A similar genetic 
background effect has been described for loss of TGFβ1 protein (Shull, 1992; Kulkarni, 
1993; Dickson, 1995; Bonyadi, 1997; Kallapur, 1999). 50% of TGFβ1-/- animals and 
25% of TGFβ1+/- die around E11.5 in mixed 129xC57Bl/6J genetic background due to 
defects in vasculogenesis and erythroid development in the yolk sac. Surviving TGFβ1-
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null embryos die before PND 20 from an aggressive inflammatory disease (Shull, 1992; 
Kulkarni, 1993; Dickson, 1995). However, most of the mice in a 129S2xCF-1 mixed 
and prevalent C57Bl/6J genetic background stop to develop before E7.5, and present 
defects in morula formation (Bonyadi, 1997; Kallapur, 1999). Furthermore, upon mating 
for 4 generations with NIH-Ola inbred animals, more than 80% of the expected TGFβ1-
deficient mice survive up to birth (Bonyadi, 1997). Genomic analysis of polymorphic 
markers from F2 C57Bl/6JxNIH-Ola pups revealed the association of a region at 
chromosome 5 with the ability to survive to birth (Bonyadi, 1997). 
EGF- and TGFβ1-deletion interests numerous developmental processes during 
embryogenesis, and the employment of several inbred mouse strains shed light to 
possible modifier alleles (Bonyadi, 1997; Strunk, 2004). On the other hand, a 
differential phenotype between two mouse strains could involve only one specific 
developmental process. In fact, deletion of NRIF, a cytoplasmic interactor of the 
neurotrophic receptor, leads to embryonic lethality in a C57Bl/6J genetic background, 
while mice are viable in both mixed 129S2xC57Bl/6J and 129S2 genetic backgrounds 
(Casademunt, 1999; Benzel, 2001). In addition, germline loss of ARIH2, an E3 ubiquitin 
ligase, causes the death of mutant mice in a pure C57Bl/6 genetic background due to 
defects in fetal liver functionality (Lin, 2012). Conversely, in a mixed 129P2xC57Bl/6 
genetic background ARIH2 homozygous null animals were born at the expected 
mendelian ratios (Lin, 2012). The presence of a milder phenotype in mixed genetic 
backgrounds is generally ascribed to a phenomenon called “hybrid vigour”. Indeed, the 
presence of genetic variants from two different inbred strains complement for the 
deleterious alleles that both strains harbor in homozygosity. Nonetheless, exceptions to 
this general principle exist. For example, germline deletion of the Engrailed 1, which is 
important for the establishment of midbrain/hindbrain region in the developing brain, 
causes perinatal lethality due to loss of cerebellum in 129 and 129xC57Bl/6J mixed 
genetic backgrounds, but not in a C57Bl/6J genetic background (Bilovocky, 2003). 
Since genetic background can strongly affect the outcome of targeted mutations, the 
Banbury Conference on Genetic Background in Mice proposed simple recommendations 
on the breeding and maintenance strategy for newly targeted mice. They proposed to 
maintain the targeted mutation in two different mouse strains, creating two congenic 
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lines by several backcrosses. They suggested to employ 129 and C57Bl/6 mouse strains 
since 129-derived ESC lines are widely used for gene targeting and C57Bl/6 is a 
commonly used inbred strain (Mice, 1997). Phenotypic analysis of gene knockout in 
both congenic lines might reveal the presence of genetic background effects. In this 
breeding strategy I followed these recommendations (Fig. 6). A 129P2-derived ESC 
line, IB10 (Robanus-Maandag, 1998), was used to create an Ago2S388A 
nonphosphorylatable allele in the endogenous Ago2 locus, and I mated chimeric mice 
with C57Bl/6N animals to first induce the recombination of the neomycin resistance 
cassette and second to segregate away the Cre transgene. I then established two 
congenic mouse lines by backcrossing heterozygous phosphomutants with 129S2 and 
C57Bl/6N strains for at least 8 generations. I showed that Ago2 phosphomutant animals 
are prevalently lethal at peri-implantation stage in mixed 129P2xC57Bl/6N and 129S2, 
but not C57Bl/6N, genetic backgrounds (Fig. 7, 12 and 16). These data strongly support 
the presence of allelic variants that are able to mask the lack of Ago2 serine 388 
phosphorylation during early development in the C57Bl/6N strain. Surprisingly, only a 
partial hybrid vigour effect was visible in a mixed 129P2xC57Bl/6N background 
compared to a defined 129S2 genetic background, since abnormal Ago2S388A/S388A 
embryos could be readily isolated at E7.5. I investigated this phenomenon by mating 
heterozygous mutants in a C57Bl/6N background with wild type 129S2 animals in order 
to create a “reverse F1” (RF1) generation (Fig. 17) (Wolfer, 2002). This strategy allowed 
us to evaluate the effects of genes flanking the Ago2 locus on Ago2S388A/S388A survival. 
These data demonstrate that no embryonic lethality is present upon RF1 intercrosses for 
homozygous mutants, pointing to the presence of one or more modifying alleles that are 
in close proximity to the Ago2 locus. However, this genetic strategy does not permit to 
identify precisely which area of mouse chromosome 15 near to the Ago2 gene is 
modifying homozygous mutant phenotype. A combination of genome sequencing and 
breeding with other inbred strains could be useful to get insights on the modifier alleles. 
The effect of genetic background on genetic studies using loss-of-function alleles has 
been widely described in the past years (reviewed in Gerlai, 1996; Wolfer, 2002). The 
data presented here represent the first example of a background effect onto a post-
translational modification site. Secondly, lack of phosphorylation of serine 388 does not 
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impair the functionality of the Ago2 protein since phosphomutant homozygotes are 
viable in a C57Bl/6N genetic background. In addition, Ago2S388A allele is able to sustain 
hematopoietic and oocyte development in both mixed 129P2xC57Bl6N and C57Bl/6N 
backgrounds. This work is of broad interest, since it establishes for the first time the 
presence of genetic interaction between a post-translational modification site and other 
genomic variants in the mouse genome. This is of fundamental importance for studies of 
complex human diseases. In the past decade, the onset of genome-wide association 
studies (GWAS) initiated to investigate the genetic bases of human diseases derived 
from complex traits. Previously, linkage analysis was used to identify causative genetic 
mutations for human traits by the analysis of the co-segregation of the putative gene 
with the phenotype. With the availability of a high quality reference genome and 
advanced sequencing techniques, GWAS analyse the correlation of millions of 
polymorphic markers in the genome between large cohorts of control individuals and 
individuals with the phenotype of interest (reviewed in Stranger, 2011). Collaborative 
projects such as International HapMap Consortium and the 1000 Genomes Project were 
created to identify and catalogue single nucleotide polymorphisms (SNPs) and copy 
number variants (CNVs) and group them in single haplotypes (International HapMap 
Consortium, 2003; Genomes Project Consortium, 2010). As such, GWAS are able to 
map hypothetical causative variants to narrow regions of the genome. However, the 
polymorphic markers that associate with the trait study unlikely represent the causative 
genetic variants of the phenotypic trait (Graham, 2007; Dideberg, 2007; Yeager, 2007; 
Musunuru, 2010; Teslovich, 2010). They instead help to define the haplotype that 
harbors the causative variant. The genomic region is further analysed for the presence of 
annotated genes and sequenced for the identification of possible functional variants 
(Graham, 2007; Dideberg, 2007; Musunuru, 2010; Teslovich, 2010). In this context, this 
study points to the importance of the analysis of allelic variants that alter post-
translational modification sites. In addition, it posits the possibility of epistatic 
relationships with other genomic regions, which may or not have been associated to a 
specific trait of interest in the same GWAS. In conclusion, the data presented in this 
thesis have important implications for the interpretation of genetic variation of post-
translational modification sites in relation to genotype-phenotype association studies. 
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3.2.3.3 Embryonic lethality of Ago2 S388A mutants points to other kinases involved 
in Ago2 phosphorylation 
 
Ago2 phosphorylation at serine 387 was first discovered in human cell lines under 
homeostatic conditions (Zeng, 2008; Horman, 2013). The phosphorylation levels are 
increased upon cellular stress, and treatment of cells with the p38-MAPK inhibitor 
SB203580 reduced stress-induced phosphorylation (Zeng, 2008). In vitro kinase assays 
revealed that the MK2 kinase downstream of p38 MAPK is responsible for Ago2 
phosphorylation at human serine 387 (Zeng, 2008). A more recent study used a 
combination of RNAi silencing and biochemical assays to show that PKB/Akt protein 
kinases are also able to phosphorylates Ago2 (Horman, 2013). 
The p38-MAPK pathway is activated upon several stress stimuli, ranging from UV 
irradiation, bacterial endotoxins and genotoxic stress (Rouse, 1994; Freshney, 1994; 
Manke, 2007; reviewed in Ono, 2000). To date, 4 isoforms of the p38 kinase 
(p38α/β/γ/δ) are encoded in the mammalian cells from four separate loci (Ono, 2000). 
p38 activity is stimulated by external and cellular stimuli through phosphorylation of 
key amino acid residues by the upstream MAP kinase kinase MKK3/6 (Xia, 1995; 
Raingeaud, 1996; Ono, 2000). Upon activation, the p38 kinase amplifies the signaling 
cascade through phosphorylation of downstream kinases and it regulates gene 
expression and translational activity through phosphorylation of transcription and 
initiation factors (Raingeaud, 1996; Wang, 1998; Ono, 2000). Among the downstream 
kinases, p38 is known to activate the MAPKAPK protein family, which consists of three 
members (MK2, MK3 and MK5) (Stokoe, 1992; Sithanandam, 1996; New, 1998; 
reviewed in Gaestel, 2006). MK2 and MK3 associates with p38α/β isoforms and are 
activated exclusively by these two isoforms (Clifton, 1996; Ben-Levy, 1998; Allen, 
2000). After p38α/β activation, the associated MK2 is phosphorylated and a nuclear 
export signal is uncovered, mediating the cytoplasmic export of the entire complex 
(Ben-Levy, 1998). The physiological relevance of the upstream p38 isoforms and of the 
three downstream MK proteins was investigated with the use of loss-of-function alleles. 
Germline deletion of the p38α isoform causes embryonic lethality at embryonic day 
E10.5 due to placental defects; some homozygous embryos survive up to E16.5, but die 
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later due to anaemia (Mudgett, 2000; Tamura, 2000). Surprisingly, single p38 β/γ/δ and 
double p38 γ/δ mouse knockouts are viable and fertile (Beardmore, 2005; Sabio, 2005). 
Similarly, deletion of MK2, MK3 and MK5 alone or MK2/3 double ablation do not 
affect embryonic development in mice (Kotlyarov, 1999; Shi, 2003; Ronkina, 2007). 
These results are in evident contrast with the phenotype described here for Ago2 
phosphomutant embryos in a mixed 129P2xC57Bl/6N and 129S2 defined background 
(Fig. 7 and 16). MK2 and MK3 single as well as double knockout animals were first 
analysed in a 129xC57Bl/6 genetic background (Kotlyarov, 1999; Ronkina, 2007). 
Furthermore, germline depletion of p38α gives similar phenotypic results in F2 
generations derived from matings of original 129 chimeric animals with 4 different 
mouse strains (Mudgett, 2000; Tamura, 2000). It is conceivable that Ago2 
phosphorylation during peri-implantation might not be dependent only upon MK2 
activity. Alternatively, compensatory mechanisms masking the lack of Ago2 
phosphorylation can derive by the broad effectors that the p38-MK2 axis regulates. 
p38 MAPK has been shown to be important in hematopoietic stem cell maintenance as 
well as erythroid and myeloid differentiation (Tamura, 2000; Kirito, 2003; Ito, 2006; 
reviewed in Geest, 2009). Furthermore, ablation of MK2 in stem cells reduces HSC 
numbers and ability to reconstitute lethally irradiated recipients (Schwermann, 2009). In 
addition, both MK2 and MK3 participate in the production of pro-inflammatory 
cytokines upon endotoxic stress. Ablation of MK2 alone or in combination with MK3 
reduces the levels of inflammatory cytokines like tumour necrosis factor α (TNF-α) and 
interleukin 6 (IL-6), rendering homozygous mice more resistant to lethal doses of LPS 
(Kotlayrov, 1999; Ronkina, 2007). I first verified if Ago2 phosphomutant mice present 
any impairment in hematopoietic development in homeostatic conditions. The data 
included here show that both in a mixed 129P2xC57Bl6N and C57Bl/6N genetic 
backgrounds lack of serine 388 phosphorylation does not impair HSC numbers nor 
differentiation (Fig 8-10 and 13). In addition, I tested if mutation on serine 388 confers 
resistance to lethal doses of LPS endotoxin as described for MK2 ablation (Kotlyarov, 
1999). I demonstrated that the absence of phosphorylation does not influence the 
sensitivity to LPS in both mixed 129P2xC57Bl/6N and C57Bl/6N genetic background 
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(Fig. 15). Taken together, these data prove that Ago2 phosphorylation at serine 388 is 
dispensable for p38-MK2 functions in the hematopoietic system. 
A recent study demonstrated that PKB/Akt protein kinases have the ability to 
phosphorylate human Ago2 at serine 387 in addition to MK2 (Horman, 2013). The 
PKB/Akt protein family consists of three members in mammals, PKBα/Akt1, 
PKBβ/Akt2 and PKBγ/Akt3 (reviewed in Hers, 2011 and Polak, 2012). Akt proteins are 
downstream of the phosphatidylinositide 3-kinases (PI3K): PI3K produces 
phosphatidylinositol 3,4,5 triphosphate [PI(3,4,5)P3] from a biphosphate precursor found 
in the plasma membranes of cells (Hers, 2011; Polak, 2012). Inactive Akt kinases 
relocalize from the cytoplasm to the cell membrane by binding of [PI(3,4,5)P3] 
molecules, triggering a conformational change that recruits PDK1 protein and mTORC2 
kinase complex. PDK1 and mTORC2 phosphorylates threonine 308 and serine 473 on 
Akt, respectively, in order to activate the protein kinase domain (Alessi, 1996; Frias, 
2006; Jacinto, 2006; Calleja, 2007; Hers, 2011). Compelling evidences demonstrated the 
importance of the Akt signaling in a plethora of physiological and disease processes, 
including cancer and diabetes (reviewed in Hers, 2011). Deletion of the three Akt 
isoforms in mice revealed that the different isoforms have distinct functional roles. 
Indeed, germline ablation of Akt1 showed a partial perinatal lethality, and surviving 
animals are smaller and present a reduce growth rate compared to wild type littermates 
(Chen, 2001; Cho, 2001a). Furthermore, Akt1-/- adult animals have a higher degree of 
apoptosis in several tissues, such as the thymus and the testis, in both homeostatic and 
stress conditions (Chen, 2001). Further studies showed that Akt1 deletion affects 
vasculogenesis, muscle fibre formation, thymic development and spermatogenesis in 
mice (Chen, 2005; Fayard, 2007; Goncalves, 2010; Kim, 2012). On the other hand, 
germline ablation of Akt2 impairs glucose metabolism: homozygous mice are diabetic 
due to impaired insulin-dependent glucose uptake in peripheral tissues (Cho, 2001b; 
Garofalo, 2003). Finally, Akt3-/- mice are viable, but present a reduction of 20% of brain 
mass (Easton, 2005). Recent work showed that Akt3 is important for platelet activation 
and thrombosis in vivo (O’Brien, 2011). Combined deletion of Akt1/2 and Akt1/3 
causes much more severe phenotype compared to ablation of single Akt isoforms. 
Akt1/2 double knockout mice die shortly after birth for several developmental defects 
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on adipose, bone, muscle and skin development (Peng, 2003). In addition, analysis of 
hematopoietic progenitors from fetal liver of Akt1-/-; Akt2-/- embryos revealed a role of 
these cells in HSC homeostasis and T and B lymphocyte development (Juntilla, 2007; 
Calamito, 2010; Juntilla, 2010). On the other hand, simultaneous deletion of Akt1 and 
Akt3 triggers embryonic lethality at mid-gestation due to reduced vasculogenesis in 
placenta and in the embryos as well as increased apoptosis in brain (Yang, 2005). 
Analysis on embryonic development of mice lacking Ago2 phosphorylation showed that 
in a mixed 129P2xC57Bl/6N and 129S2 homozygous mutant prevalently die at the peri-
implantation stage (Fig. 7 and 16). It is evident that even deletion of two Akt isoforms 
could not trigger such an early arrest in embryogenesis (Peng, 2003; Yang, 2005). It is 
important to note that Akt3 showed a much higher kinase activity towards Ago2 serine 
phosphorylation than the other Akt family members, but Akt3-/- mice are born in the 
expected Mendelian ratios (Easton, 2005; Horman, 2013). As such, Akt3 might not be 
the kinase responsible for Ago2 phosphorylation at this early embryonic stage. Together 
with the data derived from MK2 knockout animals, I hypothesize that a yet unknown 
protein kinase might be involved in Ago2 serine 388 phosphorylation in the peri-
implantation period. Nonetheless, since both Akt3 and MK2 proteins could modify 
Ago2 in vitro, it is conceivable that both PI3K-Akt and p38-MK2 pathways are 
cooperating to regulate Ago2 function at this developmental stage. Hence, loss of Akt3 
would be compensated by MK2 activity, and vice versa. It would be interesting to test 
this hypothesis by the analysis of Akt3-MK2 double mutant mice in light of the data 
presented in this thesis work. These results would either corroborate or confute the 
hypothesis of a third kinase that regulates Ago2 function in early mouse development. 
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3.3 Conclusions and future plans 	  
Compelling efforts have been recently focused on the discovery and characterization of 
post-translational modification of Ago2 protein to understand how miRNA and siRNA 
pathways are regulated (Qi, 2008; Zeng, 2008; Rybak, 2009; Leung, 2011; Rudel, 2011; 
Wu, 2011; Horman, 2013; Shen, 2013). We created a nonphosphorylatable Ago2S388A 
allele by inserting two point mutations in the endogenous Ago2 locus in murine ESCs to 
investigate the physiological role of this phosphorylation event. Our data showed that 
Ago2 phosphorylation at serine 388 is dispensable for Ago2 functions during 
hematopoietic development in a mixed 129P2xC57Bl/6N and C57Bl/6N background 
(Fig. 8-10 and 13-14). In addition, we proved that modification of serine 388 is not 
important for siRNA-mediated function of Ago2 during oocyte development using both 
homozygous Ago2S388A/S388A females as well as a conditional deletion approach (Fig. 11-
12). Finally, we were able to demonstrate that lack of Ago2 phosphorylation on serine 
388 shows an almost complete lethality in mixed 129P2xC57Bl/6N and defined 129S2 
genetic backgrounds, but not in the widely used C57Bl/6N background (Fig. 7, 12 and 
16). Isolation of mouse embryos from heterozygote intercrosses allowed us to pinpoint 
Ago2 phosphomutant animals die at the peri-implantation stage (Fig. 7 and 16). 
Therefore, we demonstrated for the first time that post-translational modifications of 
Ago2 might be important at the organismal levels for some but not all Ago2 functions. 
In addition, we first proved the existence of a genetic background effect on a protein 
post-translational modification site, which has major implications for the investigation 
of causative genes in human pathologies and diseases using GWAS studies. 
The lethality seen in the mixed 129P2xC57Bl/6N and the 129S2 genetic backgrounds 
appeared to be incompletely penetrant (Fig. 7 and 16). In addition, the analysis of 
reverse F2 offspring allowed us to hypothesize that the modifier variants responsible for 
the differential effects of Ago2S388A phosphomutant allele in the genetic background 
tested are likely in the vicinity of the Ago2 locus (Fig. 17). The identification of such 
genomic variants could not depend only between the comparison of C57Bl/6N and 
129S2 genomes. In fact, a recent work presented the sequence of 17 mouse genomes, 
including the genomes of C57Bl/6NJ and three 129 strains (Keane, 2011). The 
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comparison of C57Bl/6NJ and the three 129 strains revealed the presence of 4 million 
SNPs and 0.8 million insertions/deletions, uncovering an enormous genetic variation 
between these mouse strains (Keane, 2011). Hence, to pinpoint the modifier allele(s) 
accountable for the differences between 129S2 and C57Bl/6N background, we would 
need to sequence the genome of Ago2S388A/S388A survivor animals in a 129S2 background 
with wild type animals of the same genetic background. The comparison of these two 
datasets could reveal the presence of any common variant derived from the C57Bl/6N 
genome that is still segregating with the Ago2S388A allele and allows the survival of such 
animals. Alternatively, we could take advantage of the identified linkage disequilibrium 
present between the endogenous Ago2 locus and the genomic variant(s). We could then 
backcrossed heterozygotes animals in a 129S2 background with C57Bl/6N wild type 
mice: intercross of the offspring during each generation will verify the presence of any 
lethality against homozygous mutants. When the Ago2S388A allele segregates away from 
the modifier allele(s), Ago2S388A/S388A homozygotes will be vital and sequencing of these 
animals will reveal the genomic area in the C57Bl/6N genome that accounts for the 
rescue of this lethality. In parallel, a similar experiment could be conducted by mating 
heterozygote mutants from the C57Bl/6N background with wild type 129S2 animals and 
screen these animals for the appearance of any lethal phenotype against homozygotes. 
The identification of genetic variant(s) that modifies the output of Ago2 phosphomutant 
allele would shed light on the molecular function of this post-translational modification. 
The partial lethal phenotype that Ago2 phosphomutant animals demonstrated do not 
mimic the effects of germline deletions of the kinase which are possibly responsible for 
Ago2 modification (Kotlyarov, 1999; Mudgett, 2000; Tamura, 2000; Chen, 2001: Cho, 
2001a-b; Garofalo, 2003; Shi, 2003; Peng, 2003; Easton, 2005; Yang, 2005; Ronkina, 
2007; Zeng, 2008; Horman, 2013). Indeed, ablation of MK2 alone or in combination 
with MK3 does not lead to embryonic lethality (Kotlyarov, 1999; Shi, 2003; Ronkina, 
2007). Furthermore, deletion of Akt isoforms alone or in combination could be lethal, 
but always after mid-gestation (Chen, 2001: Cho, 2001a-b; Garofalo, 2003; Peng, 2003; 
Easton, 2005; Yang, 2005). It could be interesting to understand if the combination of 
MK2 and Akt3 null alleles would then be able to phenotypically copy the absence of 
Ago2 serine 388 phosphorylation, regarding the peri-implantation lethality as well as the 
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genetic background effect. Furthermore, we were able to raise and purify a specific 
antibody against phosphorylated serine 388 of the mouse Ago2 protein (Fig. 18). Even 
though the antibody is not able to recognize phosphorylation levels of the endogenous 
protein, it is a promising tool to identify other kinases, which could be responsible for 
Ago2 phosphorylation. Indeed, we could evaluate the effects of a broad range of stimuli 
together with specific kinase inhibitors by using our phosphoantibody on cell lines 
overexpressing the Ago2 protein. The discovery of other protein kinase(s) might link 
Ago2 function with other signaling pathways, thus potentially clarifying the phenotypic 
outcome of Ago2S388A/S388A in the 129S2 strain. 
The physiological relevance of Ago2 has been studied using conditional deletion 
approaches to overcome the lethality of Ago2 germline ablation (Liu, 2004; Alish, 2007; 
Morita, 2007; O’Carroll, 2007; Kaneda, 2009; Schaefer, 2011; Wang, 2012). We 
investigated the importance of phosphorylation of serine 388 for Ago2 function during 
embryonic, hematopoietic and oocyte development. Nonetheless, lack of Ago2 in 
dopaminergic neurons increases the self-administration of cocaine in mice (Schaefer, 
2011). Furthermore, ablation of Ago1 and Ago2 in the developing skin causes gross 
morphological abnormalities in the epidermis (Wang, 2012). Ago2S388A/S388A adult 
animals in both 129S2 and C57Bl/6N were not tested for any behavioural abnormalities. 
Therefore, a more thorough testing for cocaine addiction would be useful to understand 
if lack of phosphorylation is necessary for Ago2 function in this system. Furthermore, 
combination of the Ago2S388A mutant allele with the Ago1- allele is needed to 
demonstrate a possible role of Ago2 serine 388 phosphorylation during skin 
development. In conclusion, phenotypic characterization of Ago2 phosphorylation at 
serine 388 might reveal new physiological systems in which it regulates the 
functionality of the Ago2 protein. 
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Chapter 4: Miwi2 expression marks a population of 
spermatogonia with stem cell characteristics 
 
4.1 Results 
 
4.1.2 Generation of reporter allele to mark Miwi2-expressing cells in 
vivo 
 
The Piwi-like subclade of Argonaute proteins plays an essential role in the maintenance 
of transposon silencing in the mouse male germ line (Deng, 2002; Kuramochi-
Miyagawa, 2004; Carmell, 2007; De Fazio, 2011; Reuter, 2011; Di Giacomo, 2013). 
Among this sub-clade, Miwi2 and Mili are necessary for the DNA methylation of 
transposable elements (Carmell, 2007; Aravin, 2008; Kuramochi-Miyagawa, 2008). 
Intriguingly, lack of Mili or Miwi2 halts the spermatogenic process in adult animals at 
the level of meiotic divisions, but only Miwi2-/- animals present an accompanying 
progressive loss of germ cells with age (Carmell, 2007; De Fazio. 2011). This is 
suggestive of a secondary role of Miwi2 protein in the stem cell compartment in adult 
animals. Since the precise identity of spermatogonial stem cell (SSC) is not known, I 
hypothesize that Miwi2 could be a useful marker for the isolation of this elusive cell 
type. To this end, I generated a Miwi2tdTomato allele to fluorescently label Miwi2-
expressing cells. I targeted the Miwi2 locus by electroporating mESC from a mixed 
129xC57Bl/6 genetic background (A9 cells) (kind gift of A. Wutz) with a construct that 
would insert in the endogenous Miwi2 locus a cassette encoding for the tdTomato 
protein and the neomycin resistance, the latter flanked at the 5’ and 3’ end with FRT 
sites (Fig. 19A). The positive clones were then used to generate ESCs mice by injection 
at the morula stage. ESC mice were then crossed to a Flp-expressing mouse strain 
(Farley, 2000) to remove the neo cassette in vivo: Southern blot analysis confirmed the 
excision of the neo from the Miwi2 locus (Fig 19B). The overlap of Miwi2 and 
tdTomato proteins was verified in fetal testis isolated from wild type and Miwi2tdTomato/+ 
	   152	  
embryos at E16.5 by immunofluorescence (Fig. 19C). Miwi2tdTomato/+; TgFLP mice were 
backcrossed one generation with C57Bl/6N animals to remove the FLP recombinase 
before being used for further experiments. 
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Figure 19. Targeting strategy and validation of the Miwi2tdTomato allele. 
(A) Schematic representation of the Miwi2 locus and the targeting strategy for the 
formation of a Miwi2tdTomato allele. Squared boxes indicate the neomycin (neo) and 
Diphtheria Toxin A (pDTA) resistance cassettes for the selection of embryonic stem 
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cells. Red triangles represent FRT sites at both sides of the neo resistance to allow a 
FLP-mediated excision of this cassette. A synthetic intron was introduced between the 
3’ untranslated region of exon 1 and the starting codon of the endogenous Miwi2 locus, 
which is then followed by the ORF for the fluorescent tdTomato protein. AseI sites used 
for the Southern blot screen of positive clones are indicated along with the size of the 
fragments recognized by a 3’ probe. (B) Representative Southern blot image of genomic 
DNA isolated from the tail of mice of the indicated genotype. A correct targeting of the 
Miwi2 locus and recombination of the neo resistance confirmed the formation of a 
functional Miwi2tdTomato allele in vivo. (C) Immunofluorescent analysis of Miwi2 and 
tdTomato localization from fetal E16.5 testis from wild type and Miwi2tdTomato/+ embryos 
using antibodies specific for Miwi2 and tdTomato proteins. Both Miwi2 and tdTomato 
localized in the gonocytes present at the centre of the tubule but not in the external 
Sertoli cells. The data presented in B-C of this figures were made in collaboration with 
Dr. Claudia Carrieri. 
 
4.1.2 The Miwi2tdTomato allele labels two distinct populations of germ 
cells in juvenile mice 
 
Several efforts were made in order to identify bona fide SSC markers in mice using flow 
cytometry (Brinster, 1994a-b; Shinohara, 2000 and 2001; Kubota, 2003; Hobbs, 2010). 
Recently, Hobbs et al. used testis isolated from mice at postnatal day 10-14 (PND 10-
14) to identify a population of CD45- CD51- Thy-1lo c-Kit- spermatogonia with a high 
repopulating capability (Hobbs, 2010). I undertook a similar approach by analysing the 
juvenile wild type and Miwi2tdTomato/+ testis at PND 14 by flow cytometry. First, I 
selected CD45- CD51- cells to exclude hematopoietic and endothelial cells from the 
analysis (Fig. 20). Second, I searched for tdTomato-positive (tdTom+) cells in 
correlation with c-Kit expression, using a wild type mouse as negative control for 
tdTomato signal. I identified 2 separate populations: tdTom+ c-Kit- cells, that represent 
around 3-4% of the CD45- CD51- fraction, and tdTom+ c-Kit+ cells, which represent 8-
10% of CD45- CD51- subpopulation (Fig. 20). I estimated that there are about 35 
thousand tdTom+ c-Kit- and 72 thousand tdTom+ c-Kit+ per testis in juvenile PND 14 
testis. 
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Figure 20. Miwi2 expression marks two populations of spermatogonia in juvenile 
mouse testis. 
Representative flow cytometry graphs of testis cells isolated from PND 14 wild type and 
Miwi2tdTomato/+ males are shown. CD45- CD51- live cells were first selected (upper 
panels) and plotted for c-Kit and tdTomato protein levels (lower panels). Numbers 
represent the percentages of gated cells. Two distinct populations of tdTom+ c-Kit- and 
tdTom+ c-Kit+ cells are distinguishable from the flow cytometry analysis. The data 
presented are representative of four independent experiments. 
 
Since the expression of c-Kit correlates with the differentiation of spermatogonia during 
the mitotic phase of the spermatogenic cycle (Yoshinaga, 1991; Shinohara, 1999), I 
believe that tdTom+c-Kit+ cells derive from the commitment of tdTom+ c-Kit- 
population. To further characterize these two populations, I tested the expression of 
multiple surface antigens that have been used alone or in combination to enrich or 
deplete for stem cell activity (Shinohara, 1999 and 2000; Kubota, 2003; Kanatsu-
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Shinohara, 2004; Kubota, 2004; Hobbs, 2010; Kanatsu-Shinohara, 2011). Indeed, MHC-
I- Thy-1+ c-Kit- cell population sorted from adult animals showed a 25 fold enrichment 
of repopulating activity compared to unsorted cells (Kubota, 2003). In addition, this 
population shares with the HSC population the expression of integrin α6 (CD49f) and 
CD24 but no other surface markers (Kubota, 2003). Selection of CD9+ cells alone also 
enriched for stem cell activity from adult rat and mouse testis cells (Kanatsu-Shinohara, 
2004). The tdTom+ c-Kit- cells present low side scatter and a Thy-1lo CD9Hi CD24+ 
CD49f+ CD29+ EpCAMlo CD34- Sca-1- MHC-I-/lo marker profile, which is suggestive of 
a stem cell population (Fig. 21). tdTom+c-Kit+ cells present similar surface profile, but 
with lower protein levels of Thy-1 and CD9 and a broader forward scatter profile, 
indicating a more differentiated population (Fig. 22). On the other hand, tdTom+ c-Kit+ 
cells show higher surface levels of EpCAM protein, which is known to mark more 
differentiated progenitor cells (Fig. 21-22) (Kanatsu-Shinohara, 2011). Collectively, 
these data demonstrate the potential existence of two Miwi2-expressing cell populations 
in the testis, with the tdTom+ c-Kit- fraction likely to be a high-ranked stem cell 
population in the spermatogenic hierarchy. 
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Figure 21. TdTomato+ c-Kit- cell population possesses a surface marker profile 
reminiscent of SSCs.  
Representative flow cytometry analysis of surface marker expression from juvenile 
Miwi2tdTomato/+ male testis is depicted. TdTom+ c-Kit- cells were gated and stained with 
specific antibodies against Thy-1, CD9, CD24, CD49f, CD29, EpCAM, CD34, Sca-1 
and MHC-I. The forward and side scatter profile of this selected population is also 
reported in the upper right panel. TdTom+ c-Kit- cell pool expresses all the markers 
employed to enrich for stem cell activity, suggesting that these cells represent a highly 
stem cell population. The data presented are representative of two independent 
experiments employing 3 different Miwi2tdTomato/+ individuals. 
 
 
Figure 22. TdTomato+ c-Kit+ cell population possesses a surface marker profile of 
more differentiated spermatogonia. (next page) 
Representative flow cytometry analysis of surface marker expression from juvenile 
Miwi2tdTomato/+ male testis is depicted. TdTom+ c-Kit+ cells were gated and stained with 
specific antibodies against Thy-1, CD9, CD24, CD49f, CD29, EpCAM, CD34, Sca-1 
and MHC-I. The forward and side scatter profile of this selected population is also 
reported in the upper right panel. TdTom+ c-Kit+ subset represents a more differentiated 
population of spermatogonia cells for the higher expression of c-Kit and EpCAM and a 
concomitant reduction of Thy-1 and CD9 protein levels. The data presented are 
representative of two independent experiments employing 3 different Miwi2tdTomato/+ 
individuals. 
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4.1.3 The tdTomato+ c-Kit- cellular fraction has cell cycle and gene-
expression profile typical of a stem cell population 
 
The stem cell theory postulates a hierarchical structure in the differentiation process of 
adult tissues: the stem cell atop of the hierarchy divides slowly to form a pool of 
multipotent progenitor cells, that highly proliferate in order to amplify the number of 
differentiated cells produced for each stem cell division. Indeed, low cycling activity has 
been proven to inversely correlate with stem cell activity (Clermont, 1968; Dym, 1970; 
de Rooij, 1973; Stingl, 2006; Orford, 2008; Wilson, 2008). I analysed the cell cycle 
profile of both tdTom+ c-Kit- and tdTom+ c-Kit+ cells in testis from PND 14 animals. 
tdTom+ c-Kit- cells are mainly in the G0/G1 phase of the cell cycle, with only ~10% of 
the total cell population in the S- and G2-M phases (Fig. 23). Conversely, tdTom+ c-Kit+ 
cells show a high rate of proliferation, coherent with this population representing a 
transit-amplifying set of spermatogonia (Fig. 23). 
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Figure 23. Cell cycle profile of tdTomato+ c-Kit- and tdTomato+ c-Kit+ cells. 
Representative flow cytometry analysis of tdTomato+ cell populations from wild type 
and Miwi2tdTomato/+ juvenile testis is shown. Cells were gated according to tdTomato and 
c-Kit protein levels (upper panel), and the DNA content of tdTom+ c-Kit- and tdTom+ c-
Kit+ cells was analysed using Hoechst 33342 incorporation (lower panels). Numbers 
indicate percentages of cells in the indicated gates. Only a small fraction of tdTom+ c-
Kit- cells is actively cycling, while tdTom+ c-Kit+ cells are mostly in active division. The 
data presented are representative of three independent experiments employing 2 
different Miwi2tdTomato/+ individuals. 
 
I further isolated live tdTom+ cells from juvenile testis by cell sorting to study the 
expression levels of genes previously used to mark SSCs in the testis. The expression of 
glial cell line-derived neurotrophic factor family receptor alfa-1 (GFRA1) is commonly 
used to define a population of As spermatogonia, which are believe to represent a 
population of SSCs in the testis (Hofmann, 2005; Tokuda, 2007; Suzuki, 2009). In 
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addition, several transcription factors, such as PLZF and Oct4, and RNA-Binding 
proteins, like Nanos2 and Lin28a, have proven to mark undifferentiated spermatogonia 
cells (Yoshimizu, 1999; Ohbo, 2003; Buaas, 2004; Costoya, 2004; Sada, 2009; Zheng 
2009). Since Thy-1 expression is decreasing in tdTom+ c-Kit+ cell fraction (Fig. 21-22), 
I decided to subdivide this population in Thy-1lo and Thy-1- cells to have a better insight 
of the transition step during the loss of Miwi2 expression (Fig. 24A). RT-PCR analysis 
revealed that tdTom+ c-Kit- cells express higher levels of SSC-enriched genes such as 
Lin28, GFRA1, Oct4 and PLZF (Fig, 24B). In addition, the mRNA levels of c-Kit and 
EpCAM reflects the flow cytometry data presented in Fig. 21-22, confirming that 
tdTom+c-Kit+ cells are more differentiated progenitor cells (Fig. 24B). It is important to 
note that Miwi2 expression levels present similar profiles to the other stemness-related 
genes, decreasing of 75% between tdTom+ c-Kit- and tdTom+ c-Kit+ Thy-1lo cell 
populations (Fig. 24B). Altogether, the cell cycle and gene expression profiles of 
tdTom+ c-Kit- cells indicate that this population could define a bona-fide spermatogonial 
stem cell population. 
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Figure 24. Expression profile of tdTomato+ c-Kit- reveals a stem cell signature. 
(A) Representative flow cytometry plots show the strategy to obtain tdTom+ c-Kit- Thy-
1lo, tdTom+ c-Kit+ Thy-1lo, tdTom+ c-Kit+ Thy-1- and tdTom- c-Kit+ Thy-1- populations 
for RNA extraction from Miwi2tdTomato/+ PND 14 testis by fluorescent-activated cell 
sorting. Numbers indicate percentages of gated cells. Cells were first selected for 
CD45/51 and Thy-1 expression, and then gated according to tdTomato and c-Kit 
staining. (B) Real-time PCR reactions were carried out using primer specific for the 
indicated genes. The mRNA levels of the tested genes are normalized according to 
GAPDH expression. Graphs show the mean ±s.e.m from three independent biological 
samples. 
 
4.1.4 Comparison of tdTomato+ c-Kit- cellular fraction from adult and 
juvenile testis shows similar surface marker profile 
 
Stem cells in adult and young animals are known to have diverse differentiation capacity 
and cologenic potential. Indeed, fetal HSCs derived from E14.5 embryos tend to give 
rise to innate-like lymphocyte subsets and outcompete adult HSCs in the repopulation of 
lethally irradiated mice (Morrison, 1995; Bowie, 2007). In the testis, analysis of 
colonization capacity revealed that cells derived from juvenile mice have a higher stem 
cell potential compared to adult testis cells after transplantation (Brinster, 1994b; 
Shinohara, 2001; McLean, 2003). This differential colonization ability could be ascribed 
to differences in the percentage of SSCs between juvenile and adult cell preparations or 
to intrinsic differences between adult and juvenile SSCs. To test this hypothesis, I made 
use of the Miwi2tdTomato allele to compare the surface marker profiles from tdTom+ c-Kit- 
cells isolated from pre-pubertal and adult mice. Flow cytometry analysis shows that 
tdTom+ c-Kit- fraction is present in lower percentage in adult samples compared to 
juvenile testis (Fig. 25): I estimated that there are ~8000 tdTom+ c-Kit- cells per million 
of testis cells in juvenile mice, while only ~1500 in adult mice. However, adult and 
juvenile tdTom+ c-Kit- pools present very similar surface marker profiles, with the only 
exception of Thy-1, which is expressed at higher levels in juvenile cells (Fig. 25). 
Therefore, the elevated expression level of Thy-1 in juvenile cells could be indicative of 
a higher stem cell potential compared to adult counterparts. 
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Figure 25. Adult and juvenile tdTomato+ c-Kit- cells share similar surface marker 
expression profiles. 
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Representative flow cytometry analysis of adult and juvenile testis cells from 
Miwi2tdTomato/+ males. Numbers represent percentages of the gated cells. CD45- CD51- 
live cells were first selected (upper left panels), and then analysed according to 
tdTomato and c-Kit protein levels (upper right panels). TdTom+ c-Kit- populations from 
adult and PND 14 testis were stained with antibody specific for Thy-1, CD9, CD24, 
CD49f, CD29 and EpCAM. Adult and juvenile gated cells differ only for the surface 
levels of Thy-1. The data shown are representative of three independent experiments. 
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4.2 Discussion 
 
4.2.1 Miwi2 is expressed in the testis of juvenile male mice 
 
In the mouse, three PIWI-like protein exists: Mili, Miwi and Miwi2 (Cerutti, 2006; 
Hutvagner, 2008). These proteins are expressed mainly in the germ cell lineage, even 
though recent studies showed the presence of PIWI-related proteins in the brain of 
mouse and Aplysia (Kuramochi-Miyagawa, 2001; Deng, 2002; Kuramochi-Miyagawa, 
2004; Carmell, 2007; Aravin, 2008; Kuramochi-Miyagawa, 2008; De Fazio, 2011; Lee, 
2011; Rajasethupathy, 2012; Di Giacomo, 2013). Miwi protein is detected only in adult 
testis, and its expression is restricted to late spermatocytes and spermatids (Kuramochi-
Miyagawa, 2001; Deng, 2002; Kuramochi-Miyagawa, 2004; Di Giacomo, 2013). Mili 
initiates to be expressed in both female and male germ cells as early as embryonic day 
E12.5, and it is further expressed in spermatogonia and in spermatocytes at the 
pachytene-diplotene stages (Kuramochi-Miyagawa, 2001; Kuramochi-Miyagawa, 2004; 
Aravin, 2008; De Fazio, 2011; Di Giacomo, 2013).  
The detection of Miwi2 protein has been more challenging due to the absence of good 
antibodies specific to this protein. First characterization by semiquantitative RT-PCR 
revealed that Miwi2 transcripts are present in male testis starting from E15.5 up to 10 
days after birth (PND 10) (Carmell, 2007; Kuramochi-Miyagawa, 2008). Later, 
detection of Miwi2 protein by antibody staining and fluorescently labeled Miwi2 protein 
in transgenic mice confirmed the narrow window of Miwi2 expression (Aravin, 2008). 
Surprisingly, Miwi2 transcript could be detected in testis from adult mutant W/Wv 
animals (Carmell, 2007). W/Wv male mice harbors a mutation in the c-Kit gene that 
create an hypomorphic allele, blocking the differentiation of spermatogonia cells. 
Homozygous mutant testes contain undifferentiated spermatogonia cells and somatic 
cells in the seminiferous tubules (Silvers, 1979). Furthermore, analysis of Miwi2-/- testis 
revealed an age-related loss of germ cells, which begins at 3 months after birth (Carmell, 
2007). These observations suggested the possibility of a functional role of Miwi2 in the 
adult SSC compartment. 
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In order to understand if Miwi2 is expressed after early postnatal days, I created a 
Miwi2tdTomato transcriptional reporter allele by inserting the expression cassette for the 
tdTomato fluorescent protein in the endogenous Miwi2 locus (Fig. 19). I first verified 
that tdTomato protein expression mirrors Miwi2 expression in fetal testis by 
immunofluorescence (Fig. 19). Further analysis of tdTomato fluorescence by flow 
cytometry revealed that in both pre-pubertal and adult mice two distinct populations of 
testicular cells are fluorescently labeled, tdTom+ c-Kit- and tdTom+ c-Kit+ (Fig. 20 and 
25). Quantitative RT-PCR from RNA isolated from tdTom+ c-Kit- and tdTom+ c-Kit+ 
population as well as tdTom- c-Kit+ control cells confirmed that Miwi2 transcript is 
selectively present in tdTomato-expressing cells (Fig. 24). Taken together, the data 
presented demonstrated that Miwi2 is indeed expressed in juvenile and adult testis, 
corroborating the hypothesis that Miwi2 is indeed required for adult spermatogenesis. 
 
4.2.2 The Miwi2tdTomato allele marks a population of germ cells 
presenting several stem cell properties 
 
Identification of stem cell population in the mouse testis is based on data derived from 
morphological studies as well as transplantation assays. Since mouse spermatogenesis 
takes place in highly ordered manner inside the seminiferous tubules, pioneering studies 
used morphological, positional and cell cycle kinetics information to define the SSC 
population in testis (Clermont, 1968; Dym, 1970; Huckin, 1971a-b, Oakberg, 1971, de 
Rooij, 1973; Clermont, 1975; Erickson, 1978; Lok, 1983). The population of As 
spermatogonia was hypothesized to possess the self-renewal capacity in mouse testis 
since they do not present any intercellular bridge and divide rarely (Clermont, 1968; 
Dym, 1970; Huckins, 1971a-b; de Rooij, 1973; Lok, 1983). Efforts were thus 
concentrated to discover markers specific for the undifferentiated spermatogonia cells, 
and in particular for the As population. The GFRA1 receptor and the receptor kinase c-
Ret were first identified as possible stem cell markers (Meng, 2000; Kanatsu-Shinohara, 
2003; Kubota, 2004; Buageaw, 2005; Hofmann, 2005; Naughton, 2006; He, 2007; 
Tokuda, 2007). Indeed, deletion of one of the two GFRA1 alleles in mice leads to 
degeneration of seminiferous tubule due to lack of germ cells. Conversely, 
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overexpression of GFRA1 leads to the accumulation of undifferentiated spermatogonial 
cells in the testis lumen, with a consequent block in formation of differentiated cells 
(Meng, 2000). In addition, GFRA1 is necessary for the maintenance of SSC culture in 
vitro (Kanatsu-Shinohara, 2003; Kubota, 2004). Immunofluorescence experiments 
demonstrated that GFRA1 is expressed in As and Apr cell population in the mouse testis 
(Tokuda, 2007; Suzuki, 2009). In addition to GFRA1, transcription regulators such as 
PLZF, Oct4, Neurogenin 3 (Ngn3) and Id4 were identified as spermatogonia markers 
(Buaas, 2004; Costoya, 2004; Yoshida, 2004; He, 2007; Oatley, 2011). Genetic deletion 
of PLZF induces increased apoptosis and an age-related loss of germ cells (Buaas, 2004; 
Costoya, 2004). Similarly, ablation of Id4 causes a progressive but not complete 
depletion of germ cells (Oatley, 2011). PLZF and Ngn3 expression marks all type A 
spermatogonia, from As to Aal, while Id4 expression seems to be specific for As cells 
(Tokuda, 2007; Suzuki, 2009; Oatley, 2011). Further efforts revealed that the RNA 
binding proteins Nanos2, Nanos3 and Lin28a are expressed in undifferentiated 
spermatogonia (Sada, 2009; Zheng, 2009; Suzuki, 2009; Nakagawa, 2010). Nonetheless, 
immunofluorescence studies on whole-mount seminiferous tubules show that the As 
population is quite heterogeneous in the respects of the expression of the 
aforementioned markers (Tokuda, 2007; Sada, 2009; Suzuki, 2009; Nakagawa, 2010). 
The heterogeneity of As protein expression points to the limitations on morphological 
studies alone to define SSC population. The identification of bona fide stem cell 
population requires the assessment of the ability to differentiate into all the cell lineages 
present in the tissue of origin. This ability has been tested in testis as well as other 
physiological systems through transplantation procedures (Spangrude, 1988; Brinster, 
1994a-b; Stingl, 2006; Shackleton, 2006). FACS-based purification of raw testis 
preparation was used to enrich for stem cell activity using particular surface markers. 
The first studies employed single antibody staining against integrin α6 (CD49f) or 
integrin β1 (CD29) to enrich for stem cell population, while expression of c-Kit or 
integrin αv (CD51) was discovered to deplete for stem cell activity (Shinohara, 2000; 
Shinohara, 2001). In addition, selection of small cells, evaluated by low forward and 
side scatters, by flow cytometry enhances stem cell potential in sorted cells (Shinohara, 
2001). Isolation of MHC-I- Thy-1+ CD49f+ from cryptorchid mouse testis revealed a 
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higher enrichment for stem cells, with an estimated stem cell concentration of 1 out of 
15 cells (Kubota, 2003). Further analysis of these cell population revealed that it 
expresses CD24, but not the known HSC stem cell markers Sca-1 and CD34 
(Spangrude, 1988; Osawa, 1996; Kubota, 2003). Similar to flow cytometry based cell 
purification, Magnetic-Activated cell sorting (MACS) was employed for enrichment of 
stem cell activity. Selection for GFRA1-positive cells enriches for stem cell activity 
from both pups and adult testis cell preparations compared to GFRA1-negative cells 
(Buageaw, 2005; Ebata, 2005; Grisanti, 2009). In addition, enrichment for Thy-1, E-
cadherin and CD9 expressing cells improves the repopulating capacity of transplanted 
cells compared to depleted fractions, while enrichment for EpCAM expression inversely 
correlates with stem cell potential (Kubota, 2004; Kanatsu-Shinohara, 2004; Tokuda, 
2007; Kanatsu-Shinohara, 2011). 
Several of the markers used to define undifferentiated spermatogonia are present inside 
the cells. These markers are not accessible for antibody staining for FACS- or MACS- 
sorting. To overcome this issue, transgenic mice expressing fluorescent protein markers 
under the regulatory elements of these genes could be extremely useful. The first 
example is represented by a transgenic animal that expresses the GFP protein under a 
genomic fragment encompassing Oct4 promoter and enhancer sequences (Yoshimizu, 
1999; Ohbo, 2003). Oct4, a POU domain transcription factor known to be necessary for 
ESC self-renewal, is expressed in PGCs during early embryonic development and in 
undifferentiated spermatogonia after birth (Ovitt, 1998; Pesce, 1998). The analysis of 
Oct4-GFP transgenic mice demonstrated that GFP-expressing cells are present in testis 
cells up to PND10, and immunofluorescence studies confirmed that Oct4 and GFRA1 
are co-express in a population of type A spermatogonia at PND 6 (Yoshimizu, 1999; 
Ohbo, 2003; Hofmann, 2005; He, 2007). Flow cytometry analysis of testis cells at PND 
7.5 revealed that two populations of GFP-expressing cells exist: GFP+ c-Kit- and GFP+ 
c-Kit+ fractions (Ohbo, 2003). GFP+ c-Kit- population expresses integrin β1/CD29 and 
in transplantation assays have an higher capacity to repopulate recipient testis than GFP+ 
c-Kit+ fraction (Ohbo, 2003). 
A recent work studied the surface marker profile and repopulating capability of PLZF+ 
cells in juvenile testis between PND 10-14 (Hobbs, 2010). Flow cytometry analysis 
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revealed that PLZF-expressing cells are all CD45- CD51- Thy-1+, while resulting both 
positive and negative for c-Kit surface expression. The CD45- CD51- Thy-1+ c-Kit- 
fraction also expresses CD9, CD49f and CD29 markers, and are mainly in the G0/G1 
phase of the cell cycle (Hobbs, 2010). Transplantation assay demonstrated that CD45- 
CD51- Thy-1+ c-Kit- population has 25-fold enrichment on stem cell activity compared 
to unsorted cells when transplanted into adult recipient testis (Hobbs, 2010). 
I sought to employ a similar approach to characterize the two tdTom+ cell populations I 
identified in Miwi2tdTomato/+ juvenile testis. I showed that tdTom+ c-Kit- cells present low 
side scatter and a CD45- CD51- Thy-1lo CD9Hi CD24+ CD49f+ CD29+ EpCAMlo CD34- 
Sca-1- MHC-I-/lo marker profile, which is suggestive of a stem cell population (Fig. 21). 
Comparison between the two tdTomato-expressing populations showed that tdTom+ c-
Kit+ fraction expresses higher levels of the adhesion molecule EpCAM and lower levels 
of Thy-1 (Fig. 21-22). To my knowledge, this is the first example of such a detailed 
expression profile, which combines all the surface markers previously used in the 
literature to enrich or deplete for stem cell activity. Cell cycle analysis also demonstrates 
that more than 80% of the tdTom+ c-Kit- cells are not actively dividing, while the 
tdTom+ c-Kit+ fraction possesses a high proliferation rate (Fig. 23). Finally, I evaluated 
the gene expression profile of tdTom+ c-Kit- cells by quantitative RT-PCR to test the 
expression levels of type A spermatogonia markers. These cells express high levels of 
GFRA1, c-Ret, Lin28a, Nanos2, Nanos3, Ngn3 and Oct-4 compared to tdTom+ c-Kit+ 
and tdTom- c-Kit+ populations (Fig. 24). Conversely, both c-Kit and EpCAM expression 
levels are increased in c-Kit+ populations, in accordance with flow cytometry data (Fig. 
21-22 and 24). On the other hand, tdTom+ c-Kit+ cells are likely to be more committed 
transit-amplifying progenitor cells. Nonetheless, the levels of the Miwi2 transcript are 
gradually decreasing from tdTom+ c-Kit- to tdTom+ Thy1+ c-Kit+ and tdTom+ Thy1- c-
Kit+ fractions, implying that these cells do not express any Miwi2 protein. The fact that 
these cells have comparable tdTomato fluorescence levels might depend on the high 
stability of this dimeric protein. A similar phenomenon has been described previously 
for intestinal stem cells marked by a GFP marker from the Lgr5 endogenous locus. 
Indeed, progenitor cells derived from GFPHi intestinal stem cells still maintain low 
levels of GFP protein, and can be readily isolated by flow cytometry (Sato, 2009). 
	   172	  
In conclusion, the tdTom+ c-Kit- population possesses three important properties 
believed to be present in SSCs. First, they express surface markers used to enrich for 
stem cell activity, such as CD49f, CD29, Thy-1 and CD9, and are devoid of markers 
present in more differentiating spermatogonia, such c-Kit and EpCAM (Shinohara, 
2000; Shinohara, 2001; Kubota, 2003; Kanatsu-Shinohara, 2004; Hobbs, 2010; Kanatsu-
Shinohara, 2011). Second, a high percentage of tdTom+ c-Kit- cells are quiescent. Stem 
cells in other tissues also divide only rarely and a high mitotic rate inversely correlates 
with stem cell activity (Clermont, 1968; Dym, 1970; Huckins, 1971a-b; de Rooij, 1973; 
Stingl, 2006; Orford, 2008; Wilson, 2008). Third, tdTom+ c-Kit- cells express higher 
levels of type A spermatogonia markers, like Lin28a, Nanos2, GFRA1 and c-Ret (Meng, 
2000; Kanatsu-Shinohara, 2003; Buaas, 2004; Costoya, 2004; Kubota, 2004; Yoshida, 
2004; Buageaw, 2005; Hofmann, 2005; Naughton, 2006; He, 2007; Tokuda, 2007; Sada, 
2009; Zheng, 2009; Suzuki, 2009; Hobbs, 2010; Nakagawa, 2010 Oatley, 2011). 
Collectively these data suggest that tdTom+ c-Kit- population represents a potential bona 
fide SSC population. Transplantation assay is needed to test the self-renewal ability and 
reconstitution capacity of these cells. Alternatively, the creation of a mouse line 
expressing the Cre-Ert2 transgene under the control of Miwi2 regulatory regions would 
allow us to trace the progeny of Miwi2-expressing cells after pulse labeling in 
homeostatic conditions. These future experiments will be pivotal to consolidate the 
hypothesis that tdTom+ c-Kit- population comprehends a potential SSC population. 
 
4.2.3 Miwi2 marks two similar cell populations in both adult and 
juvenile mouse testes 
 
Early transplantation assays of testis cell preparation aimed to understand when the 
SSCs population is established in neonatal and juvenile testis as well as compared the 
repopulating capacity of stem cells at different ages (Brinster, 1994b; Shinohara, 2001; 
McLean, 2003). A first analysis demonstrated that testicular cell preparations from pups 
(PND 5-12) have a much higher repopulation capacity compared to neonatal (PND 0-2) 
and almost adult (PND 21-28) cell preparations (Brinster, 1994b). Subsequently, a more 
detailed analysis revealed that transplantation of cells from juvenile PND 10-12 mice 
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produces a greater number and larger colonies compared to both neonatal and adult 
donor (McLean, 2003). Similar studies were conducted between fetal HSCs derived 
from the fetal liver of E14.5-15.5 embryos and adult HSCs isolated from bone marrow 
(Morrison, 1995; Bowie, 2007; Yuan, 2012; Copley, 2013). Fetal HSCs have a lower 
capacity to engraft when transplanted in lethally irradiated adult recipients, but they 
present a higher proliferation and repopulating capacity than adult HSCs (Morrison, 
1995; Bowie, 2007). Recent studies compared the expression profiles from purified 
adult and fetal HSCs population and discovered that Lin28b is highly expressed in fetal 
cells while it is completely absent in adult counterparts (Yuan, 2012; Copley, 2013). 
Overexpression of Lin28b alone is able to convert adult bone marrow-derive HSCs to 
self-renewal potential and hematopoietic differentiation patterns similar to fetal HSCs 
(Yuan, 2012; Copley, 2013). The let-7-HMGA2 axis seems to be necessary for this 
reprogramming: Lin28b reduces mature let-7 miRNA levels in fetal cells, thus 
increasing HMGA2 expression (Yuan, 2012; Copley, 2013). 
Transplantation of unfractionated testis cells revealed that cell preparations from 
juvenile testis show a greater repopulating capacity compared to cells isolated from 
adult mice (McLean, 2003). However, this could depend on a higher stem cell potential 
of juvenile SSCs, as it happens for fetal HSCs, or on a higher percentage of stem cells in 
juvenile testis. Indeed, differentiated spermatocytes and haploid spermatids accumulate 
gradually during the first wave of spermatogenesis in a time-dependent manner 
(Sapford, 1962; Kluin, 1982; Sung, 1986; Vergouwen, 1991). Hence, the percentage of 
spermatogonia cells in adult testis will be lower compared to pre-pubertal mice, where 
haploid cells are not yet present. In support to this idea, single cell suspensions from 
cryptorchid mice, where undifferentiated spermatogonia represent the only germ cell 
type in the seminiferous tubules, are more enriched for stem cell activity compared to 
juvenile cells (Shinohara, 2001; Kubota, 2004). I decided to further test these two 
hypothesis by comparing surface marker expression in tdTom+ c-Kit- population in adult 
and pre-pubertal PND 14 Miwi2tdTomato/+ male animals. I did not observe significant 
differences in the expression levels of CD9, CD24, CD29, CD49f and EpCAM. 
Conversely, Thy-1 expression results to be higher in juvenile cells compared to adult 
cells (Fig. 25). This difference could be suggestive of a differential self-renewal 
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capacity. In fact, Thy-1 is widely used for the enrichment of stem cell potential from 
adult testis preparations prior to transplantation (Kubota, 2004; Oatley, 2006; Hobbs, 
2010). Nonetheless, in order to prove a differential cell intrinsic capacity of juvenile 
versus adult testis preparations, sorted tdTom+ c-Kit- cells from adult and juvenile mice 
need to be transplanted in recipient testis. Number of colonies as well as the area 
colonized by transplanted cells will allow us to quantitatively compare the repopulating 
capacity of these two populations, similarly to what has been previously done for fetal 
and adult HSCs (Morrison, 1995; Bowie, 2007; Yuan, 2012; Copley, 2013).  
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4.3 Conclusions and future plans 	  
The creation of a new Miwi2tdTomato transcriptional reporter allele allowed me to discover 
that Miwi2 is expressed in two populations of spermatogonia in prepubertal testis (Fig. 
19-20). Flow cytometry analysis showed that one of these two populations, the tdTom+ 
c-Kit- population, is defined by the expression of surface markers that enrich for stem 
cell activity, while it is depleted of differentiation markers (Fig. 21). Furthermore, these 
cells are mainly quiescent, a characteristic which positively correlates with stem cell 
potential (Fig. 23). Finally, tdTom+ c-Kit- cells possess a transcriptional profile 
suggestive of a population highly enriched for stem cells (Fig. 24). Collectively, our data 
represent the first proof that Miwi2 is expressed in a subpopulation of spermatogonia 
cells in juvenile testis. Furthermore, Miwi2 expression might be used for the isolation of 
bona fide SSC population from the adult testis. 
Transplantation assay is recognized as the golden standard to test the regenerative 
capacity of stem cell population in several tissues (Spangrude, 1988; Brinster, 1994a-b; 
Stingl, 2006; Shackleton, 2006). Hence, we will use tdTom+ c-Kit- cells purified by flow 
cytometry to reconstitute insulted testis and compare the repopulating capacity of this 
population compared to bulk testis cells. We are currently crossing the Miwi2tdTomato 
allele with a reporter allele that will help us to identify the colonies derived from donor 
cells in the recipient testis. As an alternative, stem cell potential can be assessed through 
lineage tracing technology (Sada, 2009; Nakagawa, 2010). An inducible recombineering 
enzyme, often the Cre recombinase fused with a mutated estrogen receptor (Cre-Ert2), is 
posed under the control of the regulatory regions of the gene of interest. The 
combination with a reporter gene activated after Cre induction allows to follow the 
progeny of cells that expressed the Cre at the moment of the induction. We are now 
developing a transgenic strategy in which the Cre-Ert2 transgene is inserted in the 
mouse genome by Bacterial Artificial Chromosome (BAC) technology with the 
regulatory regions of the Miwi2 locus. We will then couple this with an inducible 
fluorescent marker to monitor the fate of Miwi2-expressing cells and their progeny. The 
combination of these two approaches will further strengthen our hypothesis that Miwi2-
expression is an important marker for the isolation of SSCs in mouse testis. 
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The first transplantation studies using testis cell preparations revealed that cells isolated 
from juvenile males possess a higher stem cell potential compared to neonatal and adult 
preparations (Brinster, 1994b; Shinohara, 2001; McLean, 2003). We therefore compared 
the surface marker profile of tdTom+ c-Kit- cells from juvenile and adult Miwi2tdTomato/+ 
males, and discovered only a difference in the expression of Thy-1 marker (Fig. 25). 
Since Thy-1 is widely used to enrich for stem cell activity (Kubota, 2004; Oatley, 2006; 
Hobbs, 2010), we speculate that the lower expression level detected in adult cells could 
implicate an intrinsically lower stem cell capacity of adult cells compared to the juvenile 
population, as it has been shown for fetal and adult HSC (Morrison, 1995; Bowie, 2007; 
Yuan, 2012; Copley, 2013). To prove this, it is needed to transplant tdTom+ c-Kit- cells 
isolated from adult and juvenile Miwi2tdTomato/+ testis in adult recipients and compared 
the cologenic capacity of these two populations. In addition, we are planning to compare 
the gene expression profile of sorted tdTom+ c-Kit- cells from juvenile and adult males 
by microarray to identify any other interesting candidate that is differentially regulated 
with age. These further experiments will clarify if the greater stem cell potential of 
juvenile testis preparations in transplantation assay depends on a superior intrinsic self-
renewal capacity or a higher concentration of stem cells compared to adult samples. 
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